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Abstract: 
The Mel1a G-coupled Protein receptor (GPCR) was modelled 
using the I-Tasser online web service. All-atom molecular 
dynamics was used to improve the structure. The primary 
ligand melatonin was docked to the structure post molecular 
dynamics and structurally aligned to the X-ray 
crystallographic structures of the β2 adrenergic and rhodopsin 
GPCR’s, of the same family of proteins. A second set of all-
atom molecular dynamics was undertaken with melatonin in 
the proposed active site which was parameterized ab initio in 
Gaussian16 to note any key conformational changes due to 
binding. The Mel1a GPCR becomes depolarized as a result of 
binding in the proposed active site by melatonin, based on Van 
der Waal interaction with amino acid residues on the 
extracellular side of the membrane (Ser176, Cys177, Tyr281 
and Ser103). 
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Introduction. 
 
Melatonin. 
Melatonin also known as N-acetyl-5-methoxytryptamine is the primary hormone 
released from the pineal gland in the suprachiasmatic nucleus (SCN) (Carter and 
Juurlink, 2012). Melatonin is a derivative molecule of the amino acid tryptophan. This 
process follows a 4-step pathway, where tryptophan is converted into 5-
hydroxytryptophan. This is performed by the enzyme tryptophan 5-monooxygenase. 
Following this, L-amino acid carboxylase catalyses the conversion of 5-
hydroxytryptophan into the hormone serotonin (5-hydroxytryptamine). Another 
enzyme called Arylalkyl amine‐N‐acetyltransferase acetylates serotonin resulting in N-
acetylserotonin, which is the immediate precursor molecule of melatonin. This 
process is performed in the pineal gland. The final enzyme responsible for the 
conversion to melatonin is hydroxy-indole-O-methyltransferase (also known as 
acetylserotonin methyltransferase) – which attaches a final methyl group to the OH 
group forming melatonin (Tan et al., 2015) (Figure 1.1). The structure of melatonin 
was crystallised by (Wakahara, Fujiwara and Tomita, 1972). 
The release of melatonin from the pineal gland is performed in a rhythmic fashion 
and peaks in the dark portion of the 24-hour day-night cycle performing a ‘sleep 
cue’. The absence of light initiates the light-inhibited production of melatonin in the 
superchiasmatic nucleus (Dollins et al., 1994).  The role of melatonin in sleep 
regulation has led to research into the potential treatment of human disease, most 
prominently sleep disorders (Jan, Espezel and Appleion, 1994). Examples of this 
research show hippocampal restoration of neural precursor cell proliferation and has 
also shown to reduce cognitive defects caused by sleep wake cycle displacement. 
Which is more commonly known as jet-lag after long journeys in an eastward bound 
direction (Caspi, 2004). Melatonin has also been observed to have an influence on 
blood pressure regulation (hypertension), influencing endothelial dysfunction, 
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inflammation and reducing free radical burden (Dollins et al., 1994). Abnormal 
melatonin synthesis has also been a research focus in behavioural disorders such as 
the autism spectrum where low levels of melatonin have been reported by 
independent groups described through review by Melke et al., 2008. The sleep 
quality of people suffering from schizophrenia has also been shown to be enhanced 
by melatonin supplement (Shamir et al., 2000). It has also been shown to improve 
sleep quality in several disease and physical states including but not limited to - 
insomnia, broken bones and the terminally ill (Bourne, Mills and Minelli, 2008). At 
current, melatonin is available as a health supplement which is available without a 
prescription but is cautioned as a short-term solution as less is known about long-
term safety. The slow release melatonin drug Circadin is a prolonged release 
formulation of the hormone which is designed to mimic the melatonin release pattern 
during the night cycle and is taken orally. The target audience of Circadin is the 
elderly over the age of 55 for which it is currently licenced, as studies show that 
melatonin hormone release deteriorates with age (Lemoine and Zisapel, 2012). 
Melatonin is the primary ligand of the G-protein coupled receptors (GPCR) Mel1a 
(Slaugenhaupt et al., 1995) and Mel1b (Reppert et al., 1995) in humans, and many 
eukaryote species (also known as 𝑀𝑇1 and 𝑀𝑇2, or MTNR1A and MTNR1B).  
G-Protein Coupled Receptors (GPCR). 
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Heterotrimic guanine nucleotide-binding protein (G-protein)-coupled receptors, are a family of 
cell surface proteins which respond to stimulus such as light, amines, hormones, peptides and 
even large proteins (Kobilka, 2007). They play a large variety of roles in the body. The protein 
family share a common architecture, consisting of a single polypeptide which is embedded in 
the membrane of the eukaryotic cell. Seven trans-membrane helix sections span the entire 
length of the membrane, which is why they are also commonly known as 7-trans-membrane 
receptors (7TM). They are the largest, most diverse group of membrane receptors in 
eukaryotes. Understanding of GPCR’s has affected modern medicine and it is was estimated 
that 26.8% of approved drugs target the rhodopsin-like GPCR family of proteins in 2007 
(Sriram and Insel, 2018). In 2017, 134 approved drugs are for the GPCR Family. The figure 
below shows an example of state change due to agonist binding in a GPCR and its following 
interactions with the heterotrimic g-proteins (Figure 1.2). 
The first crystal structure of a GPCR was the bovine derived rhodopsin GPCR, which was 
diffracted with a resolution of 2.8Å and described as a highly organised structure with a 
conserved di-sulphide bridge (Palczewski et al., 2000). Rhodopsin’s are a large member of the 
subfamily and constitute ~90% of all GPCR’s. Rhodopsin is a light sensitive receptor which is 
involved in phototransduction. It is found in the rods of the retina and when activated by light. 
The Active conformation of rhodopsin binds the rod cell G protein transducin, which catalyses 
the exchange of Guanine di-phosphate (GDP) for a guanine tri-phosphate (GTP), sending 
appropriate signals to the cell. The alpha subunit of the g-protein activates the effector enzyme 
cGMP phosphodiesterase, binding to its inhibitor subunit causing hyperpolarization of the ROS 
plasma membrane through hydrolysis of cyclic guanosine monophosphate (cGMP). Reduced 
flux of 𝑁𝑎+ ions through the cGMP-gate channels generates the neuronal signal in response to 
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light. Another crystal structure with a 2.4Å resolution was published in 2007 for the β2-
adrenergic GPCR (Rasmussen et al., 2011). The GPCR is responsible for cell signalling in the 
fight-or-flight response caused by its primary hormone epinephrine. The β2 adrenergic receptor 
signal is transmitted through adenylyl cyclase, which is an enzyme with key regulatory rolls in 
eukaryotic cells. This causes a signalling cascade which is initiated by the secondary messenger 
Cyclic adenosine monophosphate. This mediates physiological response resulting in smooth 
muscle relaxation and bronchodilation. By fusing the structure to a T4 lysosome sourced from 
Escherichia coli, which replaced the loop section of the third intracellular loop of the GPCR. It 
was then crystallized with the presence of the agonist carazolol. Static analysis of proteins 
however alone, only infer structure in an instant (Dror et al., 2011). Attempts to see the 
dynamic change seen due to ligand binding have been attempted for protein complexes. When 
first characterized in the 1970’s, GPCR’s were often regarded as static signalling proteins 
active and in active states. Many studies since have shown GPCR’s to be versatile in distinct 
conformation depending on bound ligand. An example of this has been performed with the β2 – 
adrenergic GPCR, Crystal structures provide snapshots in conformational character. From 
those, dynamic energy landscapes can be constructed (Nygaard et al., 2014). Nuclear magnetic 
resonance (NMR) spectroscopy and Molecular dynamic (MD) simulations (Karplus and 
McCammon, 2002) are used to characterize conformational dynamics of the protein.  The 
structures of resultant protein conformation can be cross referenced to provide details about 
function with the addition of certain stimulus.  
 
 
Homology modelling. 
Homology modelling of proteins based on the information available of similar structures 
presents a solution to X-ray crystallization of proteins (Dolan, Noah and Hurt, 2012). Since the 
GPCR is believed to share a similar architecture amongst its own family, it is reasonable to use 
previous data from same family proteins to predict a model of a protein. By using a known 
protein or DNA sequence which transcripts a protein, it is possible to build a representative 
model. The Swiss-model workspace is an example of a homology modelling web-based 
program which is used for 3-dimensional modelling. At the time of publishing in 2005, 33,000 
experimentally determined protein structures were deposited in the protein databank. While the 
Uniprot protein knowledge database held more than 2.3 million protein sequences in the same 
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period (Arnold et al., 2006). This leaves homology modelling a vast swathe of potential for 
structurally characteristic models. This method of building a 3-dimensional structure comprises 
steps which can lead to a representative model for detailed study. By building a model using the 
characteristic templates via sequence alignment, a model which is suitable can be chosen and 
modified manually post generation (Dolan, Noah and Hurt, 2012). This is performed by a 
selected modelling server like I-Tasser (Zhang, 2008) (iterative threading assembly refinement 
algorithm) uses the LOMETS (local meta-threading server) online web service (Wu and Zhang, 
2007), which predicts a 3-dimensional structure based on target-to-template alignments from 
locally installed threading programs. A nucleotide sequence known to be responsible for an 
identified protein, can be taken from a website such as the protein data bank or the universal 
Protein Resource (UniProt) (Wu, 2006). Once obtained, I-Tasser searches for possible folds by 
four simple variants of PPA (profile to profile alignment threading algorithms) methods. 
Modelling is achieved using The Hidden Markov model (Karplus, Barrett and Hughey, 1998)  
PSI-BLAST (Altschul et al., 1997), and the Needleman-wunch (Needleman and Wunsch, 
1970) and smith-waterman (Smith and Waterman, 1981) alignment algorithms. Continuous 
fragments are then removed from the aligned regions and used to re-assemble full length 
models. Remaining structure such as loops are constructed by ab initio modelling. The 
SPICKER algorithm is used both as a simple strategy to identify protein folds by clustering 
protein structures, and for structure trajectories - which are generated during computer 
simulations (Smith and Waterman, 1981). This helps in predicting a native state for the protein 
model, using minimum energy confirmation rather than a model at a fixed temperature with a 
fixed energy state. I-Tassers scoring function (C-score) - based on the relative clustering 
structural density. The consensus significance score of multiple threading templates is 
presented to evaluate the accuracy of the I-TASSER predictions (Zhang, 2008). 
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Where M is the multiplicity of structures in the SPICKER cluster 
• 𝑀𝑡𝑜𝑡 Is the number of I-Tasser structure decoys in the clustering. 
• RMSD is the average Root Mean Square Deviation of the decoys to the cluster 
centroid. 
• Z is the highest Z-score or the energy to mean in the unit of standard deviation of 
templates given by the PPA threading program.  
• 𝑍0 Is the z-score cut-off specified for distinguishing good and bad templates.  
 
The first two factors of the equation account for the structure convergence caused by 
SPICKER. This correlates with external restraints and inherent I-Tasser potentials. The third 
factor accounts for threading quality in alignments. The logarithm in the equation is to adjust 
C-score values to an even distribution. C-score accounts for confidence of alignment using 
multiple threading programs rather than one threading program. The equation has been shown 
to give a strong correlation when used to determine quality of predicted protein models. RMSD 
can sometimes be low for a structure - but it does not always correlate with quality of the 
model. The loops of a protein often being the highest degree of error in a digital model. 
Another issue with homology modelling is sequence identity. If the model is made using 
nucleotide sequence which has a low identity to known structures of the same type, the degree 
of error in the prediction process is larger.  
 
 
 
 
Figure 1.3 – C-score equation for I-Tasser homology model quality. 
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Molecular Dynamics. 
All-atom MD simulation of membrane proteins provides a computational tool to probe 
membrane proteins at scales ranging from femtoseconds to nanoseconds (Lindahl and Sansom, 
2008). NAMD is a parallel MD code designed for high performance simulation of biological 
systems which uses a TCL file script (Phillips et al., 2005). This code scales to hundreds of 
processors and works with the CHARMM forcefield (Brooks et al., 2009), which uses 
empirical energy functions to model molecular systems and is focused on proteins, peptides, 
lipids nucleic acids, carbohydrates and small molecule ligands.   It can be used with a variety of 
different canonical ensembles to represent the state of a biological system in thermal 
equilibrium. NPT is the temperature, pressure and absolute temperature ensemble (McDonald, 
1972). It allows variation in volume, but keeps temperature in Kelvin, the number of atoms in 
the system and the pressure constant following the universal gas law.  This ensemble plays an 
important role in chemistry as chemical reactions are usually carried out under constant 
pressure condition ((Yang et al., 2014)). Molecules are simulated using physics and chemistry 
parameters to numerically solve newton’s 2nd law of thermodynamics. The Langevin equation 
is an expansion of Brownian motion mechanics based on newton’s second law (Olson, 
Chaudhury and Lee, 2011), with the addition of common phenomena including friction and 
random forces – which are not experienced in the vacuum environment of MD calculations 
(Figure 1.4).  
 
 
• M   = Mass. 
• F   = Force. 
• ɣ   = Friction Co-efficient. 
• υ  = Random forces Co-efficient. 
• 𝐾𝑏   = The Boltzmann Constant. 
• T   = Temperature. (In °Kelvin). 
• R(t)   = Univariate Gaussian process. 
Figure 1.4 – the Langevin equation use to solve newtons second law in CHARMM 
simulations. The variables are summarized below. 
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The Boltzmann-constant is used to determine the thermal equilibrium of a system. Using the 
kinetic energy of every atom in the system (temperature in °K is ∝ to the average kinetic 
energy in a molecular system).  
𝑓(∊𝑘) =  
2
√𝜋
1
(𝐾𝐵𝑇)
3
2
√∊𝑘 exp(−
∊𝑘
𝑘𝐵𝑡
) 
 
Following the equilibration analysis of the system molecular dynamics can be performed to 
analyse the complex nature of proteins. 
Biological macromolecules interacting with various other complexes or small molecules, such 
as ligands with high specificity and affinity, are the basis of all processes in living organisms. 
Proteins are a class of molecule which relay messages and biological function by interfacing 
with other proteins or macromolecules to deliver a signal - providing function or response 
within the cell. Proteins play a vast majority of roles in the cell, ranging from structural (i.e. 
microtubules), mechanical (i.e. Muscular), biochemical and hormonal cell signalling. Protein 
signalling is realized through direct physical interaction via complex forces in its environment.  
By quantifying said interactions and understanding molecular recognition between 
macromolecules - it is possible to make use of the detailed structural data obtained to aid in the 
process of designing new drugs to improve or alleviate symptoms of disorder or illness by 
being rationally designed for a dynamic model of a proteins active site. By modelling the 
Mel1a GPCR and its primary ligand melatonin, a representative descriptive dynamic model of 
the protein will be obtained with a proposed active site for its primary interacting ligand. No 
crystallographic structural data for the Mel1a GPCR exists. since no interactive data exists with 
either its primary ligand or in its biological environment at current, a dynamic model can be 
build using structural analogues of other GCPR’s and dynamic data can be attained through this 
method. 
 
 
 
Tryptophan.  
Serotonin. 
5-Hydroxytryptophan.  
N-acetyl Serotonin. 
Melatonin. 
Tryptophan 5-monooxygenase, adds a oxygen-
hydrogen hydroxyl group to the indole of  
tryptophan. 
L-amino acid carboxylase, catalyses the  
conversion of 5-hydroxytryptophan into 5-
hydroxytryptamine. 
Arylalkyl amine‐N‐acetyltransferase acetylates 
serotonin resulting in the addition of an acetyl 
group. 
hydroxy-indole-O-methyltransferase adds the 
final methyl group to the OH group attached the 
indole of the molecule. 
The N-acetyl-5-methoxytryptamine 
(melatonin) molecule is synthesised. 
Figure 1.1- Melatonin Synthesis from tryptophan. 
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Materials and Methods 
2.0 Generation of Initial Homology model.  
No structural data exists for Mel1a therefore the protein amino acid sequence for the Mel1a G-
coupled protein receptor (GCPR) was acquired from Uniprot accession number P48039 and 
saved as a fasta file (UniProt Consortium, 2018). The protein sequence used is shown below; 
10         20         30         40         50 
MQGNGSALPN ASQPVLRGDG ARPSWLASAL ACVLIFTIVV DILGNLLVIL 
60         70         80         90        100 
SVYRNKKLRN AGNIFVVSLA VADLVVAIYP YPLVLMSIFN NGWNLGYLHC 
110        120        130        140        150 
QVSGFLMGLS VIGSIFNITG IAINRYCYIC HSLKYDKLYS SKNSLCYVLL 
160        170        180        190        200 
IWLLTLAAVL PNLRAGTLQY DPRIYSCTFA QSVSSAYTIA VVVFHFLVPM 
210        220        230        240        250 
IIVIFCYLRI WILVLQVRQR VKPDRKPKLK PQDFRNFVTM FVVFVLFAIC 
260        270        280        290        300 
WAPLNFIGLA VASDPASMVP RIPEWLFVAS YYMAYFNSCL NAIIYGLLNQ 
310        320        330        340        350 
NFRKEYRRII VSLCTARVFF VDSSNDVADR VKWKPSPLMT NNNVVKVDSV 
 
The sequence was then submitted into the online I-Tasser (iterative threading assembly 
refinement algorithm) server (available at -https://zhanglab.ccmb.med.umich.edu/I-TASSER/) 
developed by Zhang Lab, to attain an initial homology model (Zhang, 2008). I-Tasser uses the 
local meta-threading server (LOMETS) program which is locally installed to predict 3-
dimensional structures from target-to-template alignments using locally installed threading 
programs including; FUGUE (Shi, Blundell and Mizuguchi, 2001) and HHSEARCH (Shi, 
Blundell and Mizuguchi, 2001). The second step excises the relevant fragments from PDB 
templates and reassembles them into full length models. Loop sections are built by ab-initio 
modelling. The SPICKER algorithm identifies near-native folds in protein structures by 
clustering protein structure decoy information on similar family proteins which are generated 
during computer simulation (Zhang and Skolnick, 2004). The structures with the lowest energy 
conformation are then selected. Four variants of profile to profile alignment threading 
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algorithms (PPA) the Hidden Markov (Karplus, Barrett and Hughey, 1998) PSI-BLAST 
(Altschul et al., 1997), Needleman-Wunsch (Nordström et al., 2011) and Smith-Waterman 
(Smith and Waterman, 1981) algorithms - are then used by the program to align protein 
sequences.  
Five representative models were produced. The model with the lowest C-score, which is the 
estimated confidence score in the final model predicted by I-Tasser - is based on the quality of 
alignment with known family proteins, and convergence parameters of the structure produced. 
This returned a score of -0.01. A TM-Score (A proposed scale for measuring the similarity 
between two structures via root mean square deviation (RMSD) which is sensitive to local 
error)  of 0.71± 0.11 and an estimated  root mean square deviation (RMSD) of 6.5Å ± 3.9Å 
(Figure 2.0.1) was chosen as an initial model for further study. This model was downloaded in 
PDB format from the online server. System preparation for molecular dynamics was carried out 
using Visual Molecular Dynamics (VMD) and the programs available in version 1.9.3 
(Humphrey, Dalke and Schulten, 1996).  The Mel1a homology model was then uploaded into 
Pymol and the molecular weight was calculated as 34.4 kDA including explicit hydrogen 
atoms. 
A PSF file of the Mel1a GCPR was generated using VMD’s Auto-PSF program for utilizing 
the CHARMM36 forcefield (Huang and MacKerell, 2013) which was sourced from the NamD 
additive forcefield downloads from the university of Maryland  Mackerell lab homepage 
(available at- http://mackerell.umaryland.edu/charmm_ff.shtml). Using the forcefield the PSF 
file contains information regarding atom types, bond types, bond length and angle and dihedral 
and improper angles. The system was then solvated with the TIP3P model available in 
CHARMM36, with 8Å of 𝐻2𝑂 (Hardy et al., 2015). This was applied on all three-dimensional 
axis following a Boltzmann distribution Using VMD 1.9.3’s autosolvate tool. (Dimensions - X-
axis: 62Å, Y-axis: 62Å, Z-axis: 100Å). - using the Mel1a GCPR’s dimensions as a box size 
indicator (Figure 2.0.2). The system was then ionized with a neutralizing concentration of 
0.15mol/L of NaCl with a minimum distance from solute and between individual ions of 5Å 
using VMD 1.9.3’s autoionize tool. The introduction of the ions was also added as a Boltzmann 
distribution (Figure 2.0.3). The system is neutralized to enable Particle Mesh Ewald function 
(Hardy et al., 2015). The solvated and ionized protein was then placed into a 65Å (X + Y axis) 
1-palmitoyl,2-oleoyl-sn-glycero-3-phosphocholine (POPC) bi-lipid membrane compatible with 
the CHARMM36 forcefield (Hardy et al., 2015). The POPC membrane was aligned with the 
Mel1a Protein structure on the Z-axis. TIP3P water and POPC lipid molecules which were 
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closer to the protein or lipid-bilayer than 0.6Å were then removed using the VMD Tk Console. 
A final PDB and PSF set were then saved as the final system for molecular dynamics (Figure 
2.0.4).  
For minimization, heating and equilibration harmonic constraints to the carbon backbone of the 
protein (using the carbon-α atoms in each amino acid), were defined. A constraint was also 
applied to the phosphorus atoms of the bilipid membrane. In this fashion the side chains of the 
protein remain mobile allowing it to reach a converged minimum energy state, while keeping 
the overall orientation of the molecule aligned within the membrane. NAMD harmonic 
constraints limits the amount of kinetic energy that atoms experience thus preserving the 
overall conformation of the initial model until equilibration is complete.  
2.1 Minimization of the Mel1a GCPR System. 
The Mel1a system was subject to conjugate gradient minimization which is an iterative method 
that optimizes the geometry of all atoms within the system and finds the lowest energy 
conformation (Hardy et al., 2015). For all NAMD calculations the CHARMM36 forcefield was 
utilised (Figure 2.1.1). The created system PDB and PSF file types are given to the INP file for 
the simulation to follow (Figure 2.1.2). The molecular system is run as an NPT ensemble (the 
number of particles (N), pressure (P) and temperature (T) are constant) at a pressure of 1.01325 
bar and a temperature of 310 K. 
Group pressure is responsible for allowing NAMD to calculate the pressure of the system using 
the kinetic energy term. Langevinpiston was set to on (Hardy et al., 2015), and the following 
variables were used: langevinPistonTarget set to 200fs piston oscillation period, 
LangevinPistonDecay was set to 50fs (it is intentionally set smaller than the oscillation period 
to allow a larger degree random forces) and LangvinPistonTemp is set to 310 K (Figure.2.1.3). 
Timestep is set to 2 fs, NonbondedFreq is set to 2. (this command specifies how often a full 
electrostatics evaluation is performed), fullElectFrequency command dictates the amount of 
timesteps in fs between a full electrostatics evaluation and is set to 4 fs. stepspercycle 
commands the number of steps between each cycle between atom reassignments 20 steps are 
assigned (Figure 2.1.4). rigidBonds are set to water molecules which ignores the angles and 
bond lengths of the surrounding water molecules. In the CHARMM36 TIP3 model water is 
optimised to have fixed angle and bond lengths. Cutoff informs the system of the maximum 
distance between the furthest interacting surface of the protein and an exogenous molecule 
interaction should be recorded in terms of van der-Waal interaction and electrostatic potential 
(it is set to 12 Å), switchDist specifies the cutoff distance for calculations in Å, and margin 
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discerns the amount of space the system can expand or contract within. Cell origin, and 
cellbasisvectors are information given from a script file which generates the starting points for 
each axis of the system. PMEGridSpacing is set to 1 which activates Particle Mesh Ewald for 
electrostatics calculations in periodic systems (Figure 2.1.5). Langevin Variables are set to on. 
Langevin Dampening is set to 5 (the maximum friction and random forces co-efficient). 
Langevin for hydrogen molecules is off, preventing the system from using the Langevin 
algorithm for those atoms. LangevinTemp set to 310 K.  Hydrogen molecules are set to rigid 
bonding in order to reduce computational load and assist in geometry optimization (Figure 
2.1.6). Minimization steps are set to 2500, however the total steps are 2500 x 2 = 5000 due to 
the record step being every 2 fs. (Figure 2.1.7). All Calculations were performed on a 56 core 
Intel Xeon CPU E7-4850 v3 2.20GHz Linux server. 
 
2.2 Heating of the Previously Minimized Mel1a GCPR system. 
Once minimization was completed the Mel1a GCPR system was heated to bring the 
temperature of the system to 310 K. Initial co-ordinate and extended system files, created in the 
minimization calculation were used, as an input for geometry and call dimensions prior to 
system heating. Input file settings were similar to those used for minimization with a few 
exceptions specific for heating. BinCoordinates were specified as the optimized geometry co-
ordinates derived from minimization. Cellorigin and cellbasisvector 1, 2 and 3 are hashed out 
and replaced with reference to the extended system file which provides this information from 
the minimization step. Cutoff for recorded interactions remain the same as do PME and PME 
gridspacing. Variables WrapAll and Wrapwater signify that water/ion molecules which fall 
outside the periodic boundary are not to be translated to the opposite side of the water box 
during heating. (Figure 2.2.1). Langevin Dampening coefficient was reduced from 5 to 1 1/ps 
(Lowering the friction and random forces co-efficient) the other Langevin parameters remained 
the same. Harmonic constraints were used as before in minimization. Langevinpistonperiod, 
langevindecay and Langevinpistontarget values were maintained identically to the 
minimization simulation. Useflexiblecell is set to “no” preventing the system from creating a 3-
orthogonal dimensional system to fluctuate independently.  Useconstantarea is set to no – 
allowing the system to fluctuate on all 3 axes. If it were enabled it would prevent x and y axis 
fluctuations, while allowing z-axis fluctuations. Usegrouppressure is enabled to allow the 
pressure to be calculated via the SHAKE method. (Figure 2.2.2). The initial temperature of the 
system was set to 0 degrees Kelvin and increased by an increment of 0.001 K per timestep 
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(Figure 2.2.3). The amount of timesteps was set to a total of 310,000.  
 
2.3 Initial Equilibration of the Mel1a GCPR System. 
An input file for equilibration of the Mel1a GCPR system was written with data gathered 
during the heating phase: coor (binary co-ordinates), xsc (extended system) and vel (velocities) 
files were referenced as the starting point for the equilibration step. The temperature of the 
system was set to 310 K (Figure 2.3.1).  Harmonic constraints were also applied as used in the 
previous stages (Figure 2.2.1). Forcefield parameters files remain the same as the prior 
simulations using the CHARMM36 the amount of timesteps was increased to 5,000,000, 
limiting the equilibration time to 10ns (Figure 2.3.2). 
2.4 Alternative Equilibration Simulation – ReassignFreq. 
A second equilibration input file was created with some extra variables to try and refine the 
data to a narrower distribution of temperature. Using the algorithm reassignFreq – this is used 
to reassign the temperature of the entire system to a specified number. The algorithm randomly 
reassigns velocities within the system following a Maxwell distribution to the correct 
temperature. In this case 310 K for every timestep of the simulation. reassigntemp gives the 
temperature to reassign the velocities to which is set to 310K. reassignhold specifies the 
temperature to hold the simulation at (if the system deviates from that temperature in any step, 
It gets set back to 310 degrees Kelvin) reassignincr is set to its default value of 0, this disables 
the simulation from using simulated annealing or other slow cooling and heating methods 
specifying that reassigntemp and reassignhold are absolute values to be operated (Figure 2.4.1). 
The vel (velocity), coor (binary co-ordinates) and xsc (extended system) files from the heating 
run (Section 2.2.) performed before the first equilibration were sourced as initial data in the 
same fashion rather than continuing chronologically from the end of the initial equilibration. 
The same Mel1a GCPR system PDB and PSF files from system setup section 2.0 were sourced 
for this equilibration run. Harmonic constraints were utilized as previously described in figure 
2.2.1. The calculation was run for 5,000,000 steps with a timestep value of 2 fs.  
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2.5 Alternative Equilibration Simulation – RescaleFreq. 
A third equilibration calculation was undertaken using the variables for rescale frequency to 
relate the distribution of energy in the system in comparison to the previous two simulations. 
The equilibration was set to run for the same amount of time (10ns) as the previous 2 
simulations following on from the same heating data obtained prior to the first equilibration run 
(shown in figure 2.2.1). The initial system PDB and PSF were used (section 2.0), and the initial 
harmonic constraints PDB with the Mel1a GCPR residues and bi-lipid phosphorus atoms 
limited in the same way (figure 2.2.1). RescaleFreq is similar to reassignfreq but rather than 
forcing the system to be at a constant temperature of 310 Kelvin, it allows deviation in 
temperature. All the velocities in the system are multiplied by the same value and chosen to 
shift the average kinetic energy so it corresponds to the correct temperature defined in the input 
file. Both algorithms for temperature control are mutually exclusive in their action. 
resecaleFreq determines how often the distribution of energies are rescaled to a specified 
value. rescaletemp defines the temperature to which the system is rescaled to.  
 
2.6 10ns Molecular Dynamics Runs of the Rescale Equilibrated Mel1a GCPR 
system. 
From the equilibration data, the rescale equilibrium data was used as it gave the best fit 
distribution of heat and velocity of the three types of simulation. The Molecular dynamics 
(MD) simulations were set up in 3 new input files. Labelled MD run1, run2, and run3 
respectively (generating a triplicate dataset). The input for the three runs were identical in 
detail. The vel (velocity), coor (binary co-ordinates) and xsc (extended system) data was taken 
from the rescale equilibrium data and referenced as the starting point for the runs, harmonic 
constraints were hashed out to nullify them allowing the simulation freedom to explore 
conformational space. PDB and PSF inputs remained the same as section 2.0 and the variables 
for rescale were removed. The starting temperature was set to 310 degrees Kelvin (Figure 
2.6.1). Timesteps remained totalling 10 nanoseconds duration for the simulation. (5,000,000 x 2 
= 10,000,000) (Figure 2.6.2). langevinDampening was increased to 2 (Figure 2.6.2) following 
issues with simulation start. Some atoms within the simulation were “moving too fast” as stated 
by the CHARMM runtime environment. This is due to the FFT (Fast Fourier Transform) not 
being able to make a logical velocity path interpretation on the movement of atoms. Increasing 
the friction in the system slows these atoms to readable levels by the FFT algorithm as it is only 
recording once every 2 femtoseconds. Rigid bonds are turned off on the protein model allowing 
attached hydrogens to move free of constraint. Constraints persist on the water molecules 
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(TIP3P) in the environment. 
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2.7 CGENFF Melatonin Parameterization and Minimization. 
 
The melatonin ligand was created in Avogadro (Hanwell et al., 2012) using the crystal 
information from (Wakahara, Fujiwara and Tomita, 1972) and saved as a Mol2 file 
(Figure2.7.1). New folders were set up on the server for the ligand file to be placed with the 
appropriate files for parameterization using CHARMM General Forcefield (CGENFF) 
(Vanommeslaeghe et al., 2010). MOL2CRD script (figure 2.7.2). was also placed in the file 
along with an input file written instructing the charm forcefield to use the generated melatonin 
mol2 file (2.7.3) to create parameters. 
The output log file containing structural calculations (dihedrals, bond angles and lengths, atom-
types parameterized by CGENFF) for the creation of melatonin is shown in figures 2.7.4 to 
2.7.10. 
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2.8 Docking of CGenFF Parameterized Melatonin to MTNR1A G-coupled Protein 
Receptor. 
 
The Mel1a GCPR co-ordinates from the final frame of each 30ns molecular dynamics run, 
were extracted from the system as a new PDB set of co-ordinates utilizing VMD 1.9.3. The 
initial homology PDB was also used for docking solutions using Chimera version 1.12 
(Pettersen et al., 2004) with the Autodock Vina (Trott and Olson, 2010) plugin for docking 
surface analysis . 
A 3-dimensional box with dimensions X: 25Å Y: 25Å, by Z: 25Å which is shown as a green 
outline (figure 2.8.1) was placed over the extracellular portion of the protein which was placed 
in a vacuum. The parameters for docking were left at default. With the default options 
hydrogens are added to the structure and charges were merged. Non-polar charges were 
removed. No non-standard residues were present apart from the ligand – ignore non-standard 
residues was set to “false”. The amount of binding modes was specified as 10 (ten docking 
positions) exhaustiveness of search and maximum energy difference were set to maximum 
values (exhaustiveness of search:8, Maximum energy difference 3). Docking was performed on 
the provided Opal Web service (Huang et al., 2014) made available through the Chimera client 
autoDock Vina plugin to produce 10 solutions of the ligand in various combinations of co-
ordinates for each PDB file (run 1,2,3 and homology). This data was saved and compiled into 
one PDBQT file for each of the different final frames of the previously mentioned protein 
simulations. From these solutions the best fitting solution was chosen for all protein frames 
(Figure 2.8.2). The final frame of the 30ns control structure run 2 was chosen for docking, as it 
had the lowest protein backbone RMSD. The co-ordinates of the ligand were then added into 
the final frame of 30ns molecular dynamics run 2. Necessary TIP3P water molecules within 
2.5Å of the ligand were removed using the representation tab in VMD selection tools 
highlighting the entire MEL1a GCPR and bi-lipid membrane system, minus the index numbers 
of the water molecule atoms to be deleted. A new system PDB was saved to once all the 
molecules were removed. 
The QM parameterized ligand geometry optimized PDB for the melatonin molecule were then 
edited to have the same co-ordinates as the docking solution - while keeping the correct 
topology attained through Gaussian16 (section 3.0). The optimized charges PSF and modified 
co-ordinate PDB generated from the quantum parameterization were merged with the system 
using VMD1.9.3’s “Merge Structures”. This compiles the co-ordinates of the Mel1a GCPR bi-
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lipid membrane system PDB and PSF (topology information generated by the CHARMM 
forcefield though the FFtk plugin in VMD 1.9.3) with the ligands PDB and PSF structures 
which results in a complete molecular system ready for minimization.  
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2.9 30ns Molecular Dynamic Simulation of the Mel1a GCPR System. 
Upon review of the data for the 10ns MD simulations, it was decided to extend the runs to 30 
nanoseconds to give the system more time to search conformational space. An attempt to 
extend the simulations using the original 10 nanosecond runs was bid but failed due to atoms 
moving too fast similarly to the rescale and reassign equilibration runs this is due to the 
RATTLE algorithm (Andersen, 1983) which is used under the NPT ensemble to integrate the 
equations of motion in MD calculations. Like the SHAKE (Kräutler, Van Gunsteren and 
Hünenberger, 2001) algorithm it is used to verify the co-ordinates and the velocities of a 
molecule or system follow the constraints of the forcefield at each timestep. Instead, A new set 
of input files were created for fresh 30 nanosecond runs using the rescale equilibration data as a 
starting point (Figure 2.9.1) Allowing NAMD to record every 1 femtosecond of the simulation 
allowing for a larger degree of calculations at each timestep (Figure 2.9.2). 
LangevinDampening was set to 1 due to the change in the timestep variable as the random 
forces and friction co-efficient was increased previously to allow SHAKE and RATTLE to be 
able to calculate velocities and co-ordinates properly. The amount of timesteps was doubled to 
30,000,000 (30ns) as data is now recorded every single femtosecond (Figure 2.9.3). Triplicate 
input files of the 30ns input files were created and placed into respective folders to generate 
triplicate data and was performed on the server identified previously.  
 
2.10 Minimization of the Melatonin-Mel1a GCPR Docking System. 
Due to the removal of water molecules which were closer than 1.5Å to melatonin it was 
necessary to repeat minimisation, heating and equilibration of the system prior to molecular 
dynamic calculations. Conjugant gradient minimization was performed using the NAMD input 
file variables as used for the initial molecular dynamics system without melatonin (Figure 
2.10.1) however the custom parameter file for the melatonin molecule (made in section 3.0) 
with the associated PDB and PSF files defined for the system was used. The melatonin 
parameter file contains a novel set of parameters specifically calculated for melatonin (Section 
3.0). A new set of harmonic constraints were also generated for the system. This was applied to 
the Carbon-α backbone of the Mel1a GPCR and bi-lipid membrane phosphorus atoms in a 
similar fashion to the control simulations (section 2.1 – Minimization of the Mel1a GPCR 
System.). This set of constraint PDB’s is shown in figure 2.10.2, Minimisation was run for 
2500 steps. 
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2.11 Heating of the Docked Mel1a-Melatonin System. 
Similarly to the initial heating of the system minus melatonin, the same timesteps and 
parameters for the simulation were retained (section 2.2). The coor (binary co-ordinates) and 
xsc (extended system) from the conjugant gradient minimization from section 2.10 of the 
Mel1a-melatonin docking system were sourced in the heating input file for NAMD (Figure 
2.11.1). Heating was carried out over 310,000 steps – in order to reach the specified 
temperature, of 310K, by increasing temperature at 0.001 kelvin per timestep (1 kelvin per 
1000 steps). 
 
2.12 Rescale Equilibration of the Mel1a-Melatonin Docking System. 
Heating binary co-ordinates, velocity data and extended system data from the heating phase 
(section 3.2) was entered into a new input file for equilibration with the rescale algorithm 
which was used for the control calculations (Figure 2.12.1) where rescaling frequency was 
performed every timestep at a rescaleTemp of 310º K. This was performed using the same 
variables as the initial rescale equilibration (section 2.5). The docking system harmonic 
constraints mentioned in the previous sections 2.11 and 2.10, were also re-utilized. The only 
difference was the simulation time, which was run for 2,500,000 timesteps (5 ns at 2 fs per 
calculation step). The data was analysed using VMD1.9.3 to check for thermodynamic stability 
of the protein within system by Maxwell-Boltzmann distribution of velocity data and the 
NAMD plot analysis of the log file created in the calculation, before entering triplicate 30 ns 
molecular dynamic simulations. 
 
2.13 30ns molecular dynamics simulation of Mel1a-Melatonin Docking System. 
Three trajectories for the Mel1a/Melatonin docking system were carried out (adhering to the 
original parameters for the 30 ns control calculations). Timestep was set to 1 fs and harmonic 
constraints were disabled for the system. The langevin parameters were identical to the 30ns 
control runs were langevinTemp was set to 310K, LangevinHydrogen was set to off, and 
langevinDampening was set to 1. (Figure 2.13.1). The QM generated parameter file for 
melatonin was for all three MD simulations and rigid bonds were set to water only (Figure 
2.13.2). Triplicate runs were performed with the coor (binary co-ordinates), vel (velocity) and 
xsc (extended system) files created in the rescale equilibration of the Mel1a/melatonin docking. 
 
Figure 2.0.1. Mel1a Homology model generated in 
the I-Tasser online web server. Shown in  Blue, new 
cartoon representation in VMD. 
Figure 2.0.2. Mel1a Homology model solvated in TIP3P wa-
ter molecules. (Dimensions - X-axis: 62Å, Y-axis: 62Å, Z-
axis: 100Å).  Protein shown in VMD - representation New 
Cartoon, Coloured in Cyan. Water is shown in representation 
liquorice.  
Figure 2.0.4, Homology model of protein in POPC bi-lipid 
membrane. Water represented in a Quicksurf transparent 
overlay coloured cyan and internal water represented in liq-
uorice. Lipids represented in liquorice. Protein represented 
new cartoon, coloured in Green. Ions shown in VDW 
(Chlorine blue. Sodium, yellow). Phosphorus atoms shown in 
surf, coloured in Tan. 
Figure 2.0.3. Mel1a Homology model solvated and ion-
ized in TIP3P water molecules. Shown in VMD Protein 
representation New Cartoon in Cyan. TIP3P (water) 
Shown in liquorice, Ions shown in VDW Chlorine in 
blue, Sodium in yellow. 
Figure 2.1.1. The Toppar directory contains molecule specific parameters for the system to follow during geometry  
optimization (Obtained with the NamD 2.12 additive force field files). NamD will not run a simulation unless it has all the 
required parameters for each molecule type. 
Figure 2.1.2.  PDB and PSF structures were referenced in the input file for minimization. The temperature for the minimiza-
tion was set to 310 Kelvin. 
Figure.2.1.3 Group pressure is responsible for allowing NamD to calculate the pressure of the system using the kinetic energy 
taken from the system. useFlexibleCell and useConstantArea were not used for system minimization.  
Langevinpiston is set to on, and the following variables were used, langevinPistonTarget set to 200fs (femtoseconds) as a pis-
ton oscillation period, LangevinPistonDecay was set to 50fs, it is intentionally set smaller than the oscillation period to allow 
a larger degree random forces. LangvinPistonTemp is set to 310 Kelvin, as a base figure to keep the pressure of the system 
adhered to.   
Figure 2.1.4 - timestep is set to 2, this instructs NamD to record data every 2fs of the simulation.  
NonbondedFreq is set to 2. – this command specifies how often a full electrostatics evaluation is performed. fullElectFrequen-
cy this command dictates the amount of timesteps in fs between a full electrostatics evaluation and is set to 4. stepspercycle 
commands the number of steps between each cycle between atom reassignments 20 steps are assigned.  
Figure 2.1.4. - rigidBonds are set to water molecules which tells the program to ignore the angles and bond lengths of the sur-
rounding water molecules (TIP3P). Cutoff informs the system of the maximum distance between the furthest interacting sur-
face of the protein and an exogenous molecule interaction should be recorded in terms of Van der-Waal interaction and elec-
trostatic potential. – it is set to 12 Angstroms. switchDist specifies the cutoff distance for calculations. Margin discerns the 
amount of space the system can expand or contract within. Cell origin, and cellbasisvectors are information given from a 
script file which generates the starting points for each axis of the system. PMEGridSpacing is set to 1 which activates Particle 
Mesh Ewald for electrostatics calculations in periodic systems. 
Figure 2.1.6 – Minimization steps are set to 2500, however the total steps are 2500 x 2 = 5000 due to the record step being 
every 2 femtoseconds. 
Figure 2.1.5 —Langevin Variables are set to on. Langevin Dampening is set to 5—the maximum friction and random forces co-
efficient. Langevin for hydrogen molecules is off, preventing the system from using the Langevin algorithm for those at-
oms.Langevin variables were switched to on. - langevinTemp set to 310 Kelvin.  Hydrogen molecules are set to rigid bonding. 
To reduce computational load and assist in geometry optimization. 
Figure 2.2.1. - .PDB and .PSF files remain the same for the heating phase. binCoordinates are added to the system to give the 
system a new set of optimized geometry co-ordinates. Velocities from the minimization simulation are not carried across and 
are hashed out in the input as they offer no beneficial figures in minimization. Cellorigin and cellbasisvector 1 2 and 3 are also 
hashed out as they are no longer used due to the change in positioning of atoms during the system during minimization. Cutoff 
for recorded interactions remain the same as do PME and PME gridspacing. Variables WrapAll and Wrapwater signify that 
water/ion molecules which fall outside the periodic boundary are not to be translated to the opposite side of the water box dur-
ing heating. 
Figure 2.2.2.— constraints, langevin parameters and output parameters for heating 
Figure 2.2.3  - Temperature parameters . Using a random seed, temperature is started at 0 degrees kelvin and increased by an 
increment of 0.001 Kelvin per timestep. 310,000 steps are required to reach 310 Degrees Kelvin. 
Figure 2.3.1. – Structure and co-ordinate files remain the same using the PDB and PSF files created in VMD. binCoordinates, 
BinVelocities and extendedSystem draw the data created in the heating simulation for use in the equilibration simulation. The 
temperature of the system is set to 310 Kelvin, harmonic constraints are upheld for the equilibration simulation. 
Figure 2.3.2 - Forcefield parameters used for the system in minimization, heating and equilibration rigid bonds for the system 
are set to on, restricting movement of the hydrogen atoms in the simulation. The amount of timesteps in increased to 
5,000,000 to reach 10 nanoseconds of time (2 x 5,000,000 = 10,000,000). 
Figure 2.4.1. - Reassign equilibration input file details. 
Figure 2.5.1. Input file for the rescale equilibration run, variables remain similar to the first two equilibration runs but reassign 
variables are removed and replaced with rescale parameters.  
Figure 2.6.1- Parameters for Molecular dynamics simulations at 10 nanoseconds. 
Figure 2.6.2. - Input variables for 10ns calculation of Mel1a GCPR bi-lipid system. 
Figure 2.7.1 – melatonin created in Avogadro following the crystal structure attained from (reference) saved 
in .mol2 format for use with the CGenFF forcefield for minimization and parameterization. 
Figure 2.7.2. MOL2CRD file contents used to create the parameters through GCenFF. Gives the usage 
command for CGenFF this contains the Melatonin.inp, Melatonin.mol2 file and an output name which is 
specified in the command. 
Figure 2.7.3.  – structure input file used to instruct CGenFF to use the Mel.mol2 file and MOL2CRD file to create parameters. It also uses the CHARMM 
forcefield files top_all36 cgenff.rtf and par_all36_cgenff.prm to create a PDB file for the ligand. It also instructs under the command @resi (in the case of the 
melatonin file, this is known as MEL) it writes a minimized .crd and .pdb file before finishing with the .psf. which is written in XPLOR format. 
Figure 2.7.4 - CGenFF’s output during the minimization and parameterization process. This shows reading of the CHARMM files top_all36_cgenff.rtf and 
par_all36_cgenff.prm. 
Figure 2.7.5 – shows the confirmation of the resname MEL by the script. Topologies being generated by the gen-
eral forcefield is started. 
Figure 2.7.6. – the CGenFF output file reading the atoms, bonds, angles summarising the residue as 1 and giving a measure of dihedral 
and improper angles found by the forcefield before writing a temporary init.CRD, prior to minimization.  
Figure 2.7.7 – writing of an initial PDB before minimization is performed using the resname specified 
(MEL) it measures the spatial dimensions of the ligand and concludes it is larger than 12 angstroms at 
13.54 angstroms. CGenFF states how many bond combinations have been found for the ligands struc-
ture. Minimization is then initiated by the forcefield. 
Figure 2.7.8 – summary table of all Van der-waal, bond angles, dihedrals and impropers during minimi-
zation in CGenFF on melatonin.  
Figure 2.7.9. – After minimization is finished in CGenFF, the new geometry is saved in a file called 
@resi_min.pdb (new co-ordinates after minimization) this creates the file MEL_MIN.PDB. 
Figure 2.7.10 – CgenFF saves a new CRD and PSF file with the pretext @resi_min.CRD, and 
@resi_min.xplor_ext.psf. @resi is MEL, therefore the new filenames are; MEL_MIN.CRD, 
Mel_MIN.xplor_ext.psf.  
 
These files are now ready with topology and co-ordinate information for a docking simulation. 
Figure 2.8.1 – Docking was performed on the provided Opal Web service made available through the 
Chimera client. 
Figure 2.8.2 – Docking solutions shown in Chimera 1.12 using sticks for the 10 Melatonin results and 
cartoon for the protein. 
Figure 2.9.1 - input file for the 30 nanosecond (ns) input files for pdb and psf remain the same, rescale 
equilibration data is used for initial starting point for the simulation identical to the 10ns simulations. 
Harmonic constraints are disabled. 
Figure 2.9.2 - Timestep is changed to 1, so the FFT algorithm records data for every step instead of every 
2 steps as to compensate for the atoms which are moving too fast for FFT to make a logical velocity and 
c-ordinate trajectory. Langevin Dampening was lowered back to 1 decreasing the amount of friction ex-
perienced by the system. As this is the case timesteps will also have to be doubled to 30,000,000 as there 
is no longer the need to divide the timesteps by 2. 
Figure 2.8.3 - in identical fashion to the 10 nanosecond molecular dynamics runs, the force field parame-
ters remain the same since the FFT algorithm is now recording every 1 femtosecond, the number of run 
steps is doubled to compensate for the recording of data being doubled. 
Figure 2.10.1 -The gradient descent model was used for 2500 timesteps with a LangevinDampening co-efficient of 5. Due to 
the removal of water molecules and the addition of the Melatonin ligand in the new PDB and PSF files, it is necessary to re-
minimize and heat the system before equilibration, as distribution of potential energy, heat and velocity has changed as a re-
sult. 
Figure 2.10.2 - A new constraints file which limits the energy of carbon alphas in the protein and the phosphorus atoms of the 
membrane were created due to the altered/removed atoms within the system mentioned previously to uphold the same envi-
ronment in minimization. 
Figure 2.11.1 –Heating input file phase. Langevin Dampening is set to 1 down from 5 in minimization. New docking .pdb 
and .psf files are also sourced. 
Figure 2.12.1 – Equilibration input file. the system crashed reporting periodic cell boundary limits being 
exceeded. As a result. The margin of the simulation was increased from 1.5 to 5 to counteract the issues 
seen. The Langevin Dampening coefficient was also increased to 2, to give the system a larger friction 
and random forces variable.  
Figure 2.13.1 – Input file for molecular dynamics on the docking system.  
Figure 2.13.2 – Parameters for docking MD simulation, mel1_final.par was added to the parameters section. 
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3.0. Quantum Mechanical (QM) Parameterization of Melatonin. 
 
The PDB file previously created in Avogadro for melatonin was used as an initial co-ordinate 
file for the forcefield toolkit (FFTK) in VMD. Using VMD’s built in Force Field Tool Kit 
(FFtk) an initial PSF was generated which was entered into the buildpar section of FFTK for 
Gaussian16. Atom types were defined using the CGenFF forcefield and the protein datafile for 
CHARMM36. Properties for the ligand were viewed/edited in Molfacture, also available 
through VMD1.9.3.  Once this step is completed it is turned into new PDB and PSF files. The 
basis set used for parameterization was MP2/6-31G* (Jurečka et al., 2006). 
 
3.0.1 Geometry Optimization. 
An initial parameter file was generated in FFTK (Jurečka et al., 2006). and an input Gaussian 
16 geometry file was generated under the opt.geometry tab in FFtk. This generates a new set of 
optimized co-ordinates and low energy geometry conformation of the molecule.  
 
3.0.2 Water Interaction Properties of Melatonin. 
Water interaction sites were then calculated for the molecule in FFtk. This builds parameters 
for the donor (interaction of oxygen in water) and acceptor (interactors with hydrogen in water) 
sites of the ligand for hydrogen bonding atoms/interactions. The base name is taken from the 
original topology data (.psf) and geometry optimized .pdb.  The QM water interaction data was 
then utilised in charge optimisation of the molecule. The water interaction section utilized basis 
sets HF/6-31G* for water interaction, HF single point used the HF/6-31G* basis set, and MP2 
single point utilized MP2/6-31G*.   
3.0.3 Charge optimization of Melatonin. 
The water interaction data was then used in the charge optimisation of melatonin and an output 
log was specified to write new charge parameters to. Initial charges under the constraints tab 
were set to -0.1 as they cannot be 0. Aliphatic hydrogens were set to +0.09 as an initial charge 
in accordance with the CHARMM rules. A charge sum for the molecule was calculated based 
on the initial charge input (low bounds are set to -1.0, while high bounds are set to 1.0 to give a 
range of charge distribution for each atom type as a scaffold for optimisation). The Gaussian 
log files containing the water interaction results were then loaded as QM target data. In addition 
to each water interaction HF single point energy (at the theory level of all water interactions) 
and MP2 single point energy (a higher level of theory) was supplied. As such, the MP2 single 
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point data also provided dipole information for the molecule. Optimisations were performed 
using the simulated annealing. After the optimization of the charges the data was saved as an 
updated .psf which includes the optimized charge data along with all previously attained water 
interaction data prepared using the HF and MP2 basis sets.   
 
3.0.4 Hessian Bond Calculations for the Melatonin molecule and bond 
optimization using basis set MP2/6-31G*. 
Data calculated during geometry optimization, the in-progress parameter file and Gaussian16 
checkpoint files were utilised in order to calculate the Hessian for bonds and angles. Bond 
lengths, angles and force constants were then optimised via molecular mechanics algorithms 
against the Hessian QM target data. Hessian data is generated using the excited and ground 
state of bonds through convergence of the results attained.  
3.0.5 Scanning of torsion bonds and atoms to generate QM target data. 
Data from the previous steps (charge optimized .psf, geometry optimized .pdb) is loaded into 
the scan torsions tab of FFtk. Along with the hessian data generated in the previous step which 
was saved into the parameter (.par) file. This data is utilized to identify the dihedral angles 
present in the molecule. No equivalent dihedrals (based upon molecular symmetry) are present 
in the molecular structure of melatonin, so none were removed. Scan radius is assigned in 
increments of +/-90 o to provide 180 degrees of data per dihedral calculation with a 10o window 
size. Two exceptions to this were applied for the CT2 molecules found in the structure which 
were additionally scanned across +/-180-o. This was done to account for the greater molecular 
flexibility in this region which produced a greater range of the dihedral angles.  
3.0.6 Optimization of torsional angles and phase shift. 
Optimization of dihedral angles was then performed using the data generated and saved in the 
optimized charges PSF, optimized bonds PSF, and files optimized previously. Scan torsions 
data was also sourced - to the QM target data section to identify dihedrals for torsional 
refinement.  Parameter files were sourced from the CHARMM forcefield for proteins and 
general forcefield (CGenFF) also included is the in-progress PAR file for the ligand. Once the 
dihedrals had been optimized. The file is saved and merged into the PAR file ready to be used. 
Dihedral angles were optimised initially without an energy cut off, force constants were reset 
(kmax equal to 3) and then a cut off of 20 kcal/mol was applied to all further calculations. All 
calculations were performed as simulated annealing and melatonin conformations greater than 
20Kcal/mol received a weighting of zero. The MM calculations were then compared to the QM 
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Hamiltonian in order to assess the progress of the optimisation where the lowest possible 
RMSE was obtained. In addition, reference was made to analogous force constants and phase 
shifts from CHARMM while periodicities were set in accordance with the known molecular 
nature (i.e. 2 for planar rings).  
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Results. 
 
4.1 Characterization of the I-Tasser Homology model of the Mel1a G-Protein 
Coupled Receptor. 
 
The I-tasser Generated Mel1a GCPR homology model was characterised and coloured based 
on secondary structure identification for ease of understanding the overall structure in 
VMD1.9.3. (Figures 4.1.1, 4.1.2, 4.1.3). Characterization of the GCPR will allow comparison 
with known structures of the same family Rhodopsin and β2 adrenergic GCPR’s which have 
been solved via X-ray crystallography.  Initial characterization is also used as a backwards 
reference to any changes which may happen under molecular dynamic simulation. 
 
The seven alpha helix sections of the I-Tasser homology model for Mel1a are shown in 
Figure 4.1.1. 
 
Alpha Helix A, Asp19 – Asn55.  
Comprised of 37 residues, a  singular 180-degree helical structure is formed between Asp19 to 
Ala21 leading to a short loop section which contains pro23. this continues as an alpha-helix 
until residue Asn55. Cys32 a residue responsible for disulphide bonds has no partner cysteine 
in close proximity- the nearest being Cys289 in alpha helix-turn-helix G. 
 
Alpha Helix B, Asn63 - Asn90. 
An alpha helix shape is maintained in the first 12 residues until reaching Leu74, where the helix 
takes a larger radius of Å for the next 10 residues and has a pi-helix appearance. Included in the 
residues are a double-barrel Val75 and Val76. This gives the helix A slight angular turn 
between approximately Ile78 and Tyr79. The new angle is followed from this point where a 
more typical alpha helical conformation returns continuing until residue Asn90.  
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Alpha Helix C,  Tyr97 - Ser132.  
Cys100 is pointed inward towards the core of the protein and forms a disulphide bond with 
Cys177, this would make the section very stable and infer that it is kept in a tight conformation 
for a biological purpose.  Cys127 faces outward into what would be the membrane. The closest 
cysteine residues sit on alpha helix E - at Cys146 which is more than 15Å away and alpha helix 
D at Cys206 which is separated by A minimum of 7Å from the cysteine residues on alpha helix 
B. The cysteine residues suggest that alpha helix C is less conformationally flexible than that of 
the other helixes. 
 
Alpha Helix D,  Lys142 - Arg164.  
Leading from Lys142 the alpha helix follows a uniform 3 10 helix shape. Having a cysteine 
molecule (Cys146) with no disulphide bond, although it has the potential to create a bond with 
Cys127 following molecular dynamics of the protein. At Leu156, the helix exhibits a slight turn 
towards alpha helix C. This is further perpetuated by Pro161 a residue known for inducting 
turns in secondary structure, towards the end of the helix prior to the structure changing into a 
loop section (Beta Loop E).  
 
Alpha Helix E, Ser185 - Leu215.  
After the first 4 residues Ser185 to Ile189 the helical shape widens and there is an angular turn 
which leads the remaining helix away from the core of the protein. After Pro199 the helix 
returns to the classic alpha helix conformation. Which extends all the way to Leu215. Met200 
sits outside the core of the protein in the bi-lipid cell environment. Which may show incorrect 
orientation of the helix. Furthermore, Cys206 does not have a nearby partner cystine in any 
other section of the secondary structure. Its closest cysteine neighbour is over 7Å away on 
alpha helix C. 
 
 
Alpha Helix F, Leu229 - Val261.  
An alpha helical structure is evident until residue Phe247 where a 90-degree bend is observed. 
This kink is 6 residues long ending in Pro253 before returning to an alpha helical conformation 
between residues Leu254 to Val261. No interactions are present with surrounding parts of the 
protein, so the kink is a property of the primary sequence. 
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Alpha Helix-Turn-Helix G, Asn274 - Ile309. 
 
A typical helix structure is seen for the first 13 residues (Asn274 to Asn287). A slight bend is 
promoted towards helix A at which Cys289 appears to be at the closest point. This leads to the 
impression that it is closer to Cys32 in orientation. However, this may be due to the current 
orientation of the helix which will change under simulation conditions. The helix-turn-helix 
portion is seen between the two isoleucine residues (Ile 293 and 294) which are followed by 
Tyr295 and Gly296. Residues Leu297 and 298 are seated before the final turn begins. Asn299 
sits at the centre turning between the helix sections. After the turn the remaining amino acids 
follow a standard alpha helical conformation from asn299 to Ile309. 
 
Loop sections A to E and beta Turn A in the Mel1a GPCR are seen in Figure 4.1.2, these 
sections are highly mobile at the end of either side of the protein (extracellular and 
intracellular). Mapping of the loop regions is important as it is going to change significantly in 
molecular dynamic (MD) simulation. Hydrophobic parts of the loop sections are likely to pack 
into conformations after calculations have been performed. 
 
Beta Loop A. Met1-Gly18.  
The extracellular Beta loop A spans 18 residues and at Leu8 and Pro9 there is a turn that 
corresponds to the uppermost point of the entire protein on the extracellular side of the 
membrane. The loop then traverses towards the core of the protein until residue Pro14. where a 
beta-turn-like conformation follows on to Val15. 
Beta Loop B, Lys56-Gly62.  
 
The loop contains 6 residues. It sits on the intracellular side of the Mel1a GCPR. It provides 
transition between alpha helix A, and alpha helix B. 
 
Beta Loop C – Asn91-Gly96.  
The extracellular loop is a transitional structure between alpha helix B and alpha helix C. 
Containing 5 residues. Asn91 transitions from alpha helix to loop section, Gly96 sits before the 
start of alpha helix D. 
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Beta Loop D Leu133 – Ser141.  
 
Initiated at Leu 133, the loop transitions between alpha Helix D and alpha Helix E completing 
at residue Ser141 on the intracellular side of the protein. The centre section of the loop takes on 
a circular conformation. Starting at Lys134 and progressing in a circular motion until Tyr139. 
Before straightening out prior to alpha helix E with double Ser140 and 141 residues.  
 
Beta Loop E Ala165 - Thrrr167.  
This extracellular loop transitions between alpha helix E and beta turn A, consisting of 3 
residues Ala165, Gly166 and Thr167.  
 
Beta Turn A 168 – 179.  
Beta turn A is a beta sheet on the extracellular side, between residues Leu168 and Ala171 after 
which Pro172 induces a turn. This is followed by a short loop section which includes 2 residues 
(Arg173, Ile174) before returning to a beta sheet conformation at Tyr175. This sheet contains a 
cysteine (Cys177) residue which has formed a disulphide bond with Cys100 on alpha helix C, 
inferring a restaint in positioning for the beta turn in this area. The second sheet ends at Phe179. 
Hydrogen bond interactions are present between the two sheet sections between Gln169 
oxygen (O) and Thr178’s HG1, Asp171’s oxygen atom(O) and Ile174’s (HN) interact. Pro179 
has a hydrogen bond interaction with the HN atom on the Ile174 residue - likely inducing the 
turn between the beta sheets. 
 
Figure 4.1.3 shows the remaining secondary structure loop sections from the I-Tasser 
Mel1a GCPR structure. 
 
Beta Loop F Ala180-Ser184.  
Beta loop F contains 4 residues(Ala180 -Ser184). It transitions between Beta turn A and alpha 
helix F on the extracellular side of the Mel1a GCPR. 
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Beta Loop G – 216 – 228. 
Formed of 12 residues, loop G resides on the intracellular portion of the protein. The structure 
contains 2 Proline residues, Pro223 and Pro227 which seem to cause a bend between this length 
of loop.  Lys226 is held in place by a hydrogen bond between Pro223’s O atom, and Lys226’s 
HD1 atom. 
 
Beta Loop H – Ala262 – Pro273.  
Containing 11 residues, beta loop H starts at Ala 262 on the end of alpha helix F. Pro265 
induces a turn. Molecular dynamics simulation would likely cause a more packed 
conformation. Leading to a less exposed methionine residue.  Furthering on from Met268, 
Pro270 this causes another fold in the loop section. The remaining 3 residues follow the 
modified direction by Proline towards helix-turn-helix G, the final alpha helix in the proteins 
structure. 
  
Beta Loop I – Ile310 toVal350.  
Loop I resides on the intracellular side of the Mel1a GCPR and is comprised of 40 residues. It 
begins at the end of helix turn helix G starting at Ile310. Four residues after the initial residue, 
Cys314 is exposed and has no obvious di-sulphide bonding partner. it is possibly related to 
protein-protein interaction in which a di-sulphide bond is formed between another molecule 
and MEL1A. Due to Cysteine molecules being on the intracellular side of the protein, it is more 
likely it is involved in protein-protein interaction with another sulphur containing Cysteine 
residue on an exogenous molecule. Further along the loop Pro335 and Pro337 inferring the 
latter half of the loop may be more tightly packed. Two residues further along the loop Met339 
is present. Hydrophobic in nature is also presents the assumption that this section of loop is 
packed towards the centre of the intracellular side of the protein.  
 
The I-Tasser model appears to have a general rhodopsin like GPCR family shape, there are 
clear intracellular and extracellular loop sections, and the central core is comprised of Alpha 
helix sections. A structural alignment with known X-ray diffracted structures of GPCR’s will 
give a general comparison between a confirmed crystal structure and the homology model. 
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4.2 Structural Alignment with X-ray Structures of Human Rhodopsin and β2-
adregernic receptor. 
The homology model for Mel1a was aligned with the X-ray crystal structures for the 
Rhodopsin and β2-adregernic GCPR’s for comparative analysis after removing all other 
molecules and residues not related to the structures. This was performed in Pymol 2.1.1 
(Delano, 2002)(Figure 4.2.1). RMSD of the alignment is given in angstroms and provides a 
measure of structural variation between the crystal structures and the prediction of Mel1a made 
by the i-Tasser server, the GCPR’s are shown in carton. RMSD between Mel1a and β2 
Adrenergic receptors is 1.006Å. RMSD between Mel1a and Rhodopsin receptors is 2.170Å. 
The I-tasser structure resembles both the B2 adrenergic and rhodopsin families, the loop 
sections on the extracellular side more closely follow the profile of the rhodopsin crystal 
structure, but share similar architecture in the core helix sections of the protein, the lower 
RMSD figure for the adrenergic receptor is likely due to the missing sections of loop secondary 
structure, which should me located on the intracellular side, but are not present - due to the T4 
lysosome fusion which was required for crystallization of the structure. This fusion replaced the 
loop sections between TM4, TM5, and TM6 on the receptor. The final loop section on the 
intracellular side of rhodopsin is also missing due to the crystallization process, which would be 
comparative to loop I. Alpha Helixes E and F sit differently to the rhodopsin model. Which 
explains the higher RMSD between the structures. 
 
4.3 Electrostatic Analysis of the Initial I-Tasser Homology Model. 
The homology model for Mel1a was studied using Pymol for electrostatic surface map analysis 
by converting the provided .PDB file downloaded from the I-Tasser server. The .PDB was 
converted to a PQR file using the Pymol plugin for APBS electrostatics (Dolinsky et al., 2004). 
Grid spacing was set to 0.5, electrostatics were rendered as a Connolly surface using the Non-
Linear Poisson-Boltzmann equation, Utilising a protein dielectric of 2.0 and a solvent dielectric 
of 78.0. At a Temperature 310K using an ion concentration of 150mM. The charge map which 
was set to -/+ 10 (default is 5) the charge information is created using the AMBER forcefield 
(Figure 4.3.1) (Rodríguez-Acosta et al., 2016). 
 
The extracellular side of the protein shows an electronegative pocket which may be a potential 
active site for melatonin. The extracellular side is mostly positive/neutral in charge on the 
surface with a small pocket. Which appears to be mostly negatively charged for the 
conformation predicted by I-Tasser. The side cut view of the protein displays the depth of both 
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pockets in a cut away section. Showing neither pockets are connected from the intracellular to 
extracellular side. The intracellular side of Mel1a is mostly electropositive. This could be a 
potential site for interaction with intracellular proteins. This is supported by electrostatic 
analysis of the β2 adrenergic and rhodopsin GPCR’s (data not shown). which have a similar 
electrostatic distribution of charge which supports the electrostatics of the I-Tasser model of the 
Mel1a GPCR, where it is seen in both models that the extracellular side has an electronegative 
pocket, and the intracellular side has a large electropositive surface. The electrostatic surface of 
GNAi3 – a G-protein believed to interact with all three of the proteins, Mel1a, Rhopdopsin and 
the β2 adrenergic, is electronegative on a large proportion the surface. (data not shown). 
 
Summary. 
The I-Tasser model for the Mel1a GCPR shows high similarity to both the rhodopsin and β2 
adrenergic GPCR’s, with close architectural similarity in the trans-membrane core. It also has a 
similar electrostatic charge distribution. The characterization also confirms that the model has 
7-Transmembrane sections which traverse the bi-lipid membrane as a GPCR is described.  
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Figure 4.1.1. 
MEL1A G-CPR Homology Model.  
 
Displayed in VMD 1.9.3 - Drawing Method 
“New Cartoon”,   Material “AOChalky” and 
under the Colouring Method “ColorID” in 
various colours to segregate each section of 
the structure.  
Characterization of the I-Tasser  Homology Model 
Colour Map and Alpha Helix sections of the MEL1A 
GCPR . 
Beta Loop A,  
Met1 - Gly18. 
Beta Turn A, 
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Beta Loop E, 
Ala165 - Thr167. 
Beta Loop D, 
Leu133 - Ser141. 
Beta Loop C,  
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Figure 4.1.2 MEL1A Characterization, Beta Loop and Turns Part 1. 
Loop F, Ala180 - Ser184 Loop G, Glu216 - Lys228 Loop H, Ala262 - Pro273 
Figure 4.1.3 MEL1A Loop Sections Part 2 
Loop I, Ile310 - Val350 
Initial I-Tasser Homology model of the Mel1a 
and β2 Adrenergic receptors. 
Initial I-Tasser Homology model of the 
Mel1a and Rhodopsin Receptors. 
Figure 4.2.1 Structural alignment to X-ray Crystal Structures of β2-Adregernic Receptor and Rhodopsin G-Coupled Protein Receptors. 
1. Mel1a GCPR shown in Green,  X-ray crystal structure 
of β2-adregernic GCPR shown in Cyan.  RMSD between 
the structures is 1.006Å. Models are shown in representa-
tion : cartoon 
2. Mel1a GCPR shown in Green, Rhodopsin 
GCPR shown in Magenta. RMSD between the 
structures is 2.170Å Models are shown in represen-
tation : cartoon 
Figure 4.3.1. - Electrostatic analysis of the Initial I-Tasser Homology Model of the Mel1A GPCR. 
Extracellular View and  
Electronegative Pocket. 
Intracellular view. 
Side View (membrane portion). 
Side Slice of Mel1A to show 
intracellular and extracellular pockets. (blue 
intracellular, red extracellular) 
(Above) Electronegative pocket which 
could potentially be a binding site for 
small molecules. 
 
Pocket image taken at 45 degree angle 
from original image (left). 
Electrostatics images rendered in Pymol using the APBS  
electrostatics plugin utilizing the AMBER forcefield—to assess 
the surface interaction properties of Mel1a. Areas displayed in 
red are electronegative, Areas shown in blue are positive. Neutral 
areas have a white appearance. 
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5.0 Minimization of Mel1a GPCR System by Conjugant Gradient. 
Data extracted from the NAMD log file and was analysed using VMD 1.9.3 NAMD plot 
module with a stride of 1, incorporating the entire dataset for the minimization calculation 
(frames 0 to 2,500). 
Bond energy for the entire system had an average over the 2500 timesteps of 680.21 
Kcal/mol with an initial starting energy of 4457.61 Kcal/mol followed by an initial spike in 
energy to 14,046 Kcal/mol between timeframes 15 and 20 within the initial 50 timesteps), 
and a final bond energy of 658.76 Kcal/mol in frame 126 (or timestep 2500). The calculated 
RMSD for the protein backbone was as follows: average of 0.134Å, a minimum of 0.046Å, a 
maximum of 0.154Å and a standard deviation of 0.013Å.  The RMSD visualiser tool was also 
used to plot a chart over time showing convergence at the 50th frame for the selection 
‘protein’ (Figure 5.0.1). Bond angles have an average of 3,126.17 Kcal/mol with an initial 
value of 8,739.38 Kcal/mol and a final value of 3,822.01 Kcal/mol. Dihedral angles show an 
average of 7,510.41 Kcal/mol, an initial of 8,523.76 Kcal/mol and a final frame figure of 
8,115.71 Kcal/mol. Improper data shows an average value of 77.35 Kcal/mol, an initial value 
of 121.62 Kcal/mol and a final frame value of 90.89167 Kcal/mol Figure. Potential energy of 
the entire system has an average value of 25,856,661.43 Kcal/mol which reduces 
significantly from its initial value of 99,999,999,999.99 Kcal/mol and results in a final value 
of -82,206.3318 Kcal/mol (Figure 5.0.2).  
 
Summary. 
The data suggests that the addition of the POPC membrane, ligands and solvent, the system 
needed minimization to conform, as the potential energy was high. It has minimized all 
energy variables in the system and given the POPC membrane a degree of randomization. As 
Van Der Waal (VDW) interaction forces from the GPCR structure and the POPC membrane 
rebalance, the potential energy decreases and becomes negative. This is due to the way the 
system was built in VMD, the POPC membrane is placed over the protein and lipids were 
removed that were closer than 0.6Å. 
 
 
 
36 
 
5.1. Heating of the Mel1a GCPR Control System to 310K. 
Data was extracted from the NAMD log file and was analysed using VMD 1.9.3’s NAMD 
plot module with a stride of 1, incorporating the entire dataset for heating (steps 0 to 
310,000). RMSD for the protein backbone was calculated using the RMSD trajectory tool 
module in VMD 1.9.3 and has the following values:  an average of 0.128Å, minimum 
0.015Å, maximum 0.189Å and a standard deviation of 0.041Å. Bond energy data over the 
simulation of the Mel1a GCPR system gives an average figure of 1,463.64 Kcal/mol, with an 
initial of 472.1 Kcal/mol and a final figure of 2,529.75 Kcal/mol (Figure 5.1.1). Potential 
energy shows an average figure of -99,921.81 Kcal/mol with an initial reading of -113,045.54 
Kcal/mol and a final figure of -82,061.99 Kcal/mol. Van Der-Waal shows an average 
interaction energy of 8,065.20 Kcal/mol, an initial of 9,321.47 Kcal/mol and a final of 
4,656.60 Kcal/mol (Figure 5.1.2) for the entire system.  
Summary. 
Temperature data shows the increase in degrees Kelvin over the timesteps, starting with the 
initial timestep at 0 K, and finishing at 307.74 K as an average figure for the entire system 
(Figure 5.1.3). This shows that the protein system is ready for equilibration at 310 K  
 
5.2 Rescale Equilibration of the Mel1a Bi-Lipid Membrane System Analysis. 
After equilibration was completed an RMSD trajectory analysis was performed on the data 
accrued. The average RMSD of the protein backbone was 0.255Å with a standard deviation of 
0.004Å over 2500 timesteps. (minimum 0.243Å maximum 0.267Å). Using the timeline plugin 
in the VMD 1.9.3 the protein was coloured by RMSD (Figure 5.2.1) visually combining the 
data of the atom trajectories of residues over the course of the calculation. Maximum 
movement of the protein is evenly distributed since the use of harmonic constraints preserves 
the structural integrity of the model during equilibration. This is evident in that fact that the 
greatest RMSD is 0.91Å. Regions in the protein of high RMSD areas are shown in red, while 
regions of low RMSD in drawn in blue. A Maxwell-Boltzmann temperature distribution of the 
Mel1a System was also performed in order to assess the velocity distribution of the system 
(Figure 5.2.2). From this the temperature can then be derived using the sum of all kinetic 
energy within the data. The velocity data was compiled into a graph and then normalized. The 
temperature of the system following the equation showed a system temperature of 310.023º K 
with a narrow distribution of temperature.   
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NAMD log file data was also analysed to check system stability using the NAMD plot module 
available in VMD 1.9.3. Average Kinetic energy in the system was 28,376.06 Kcal/mol with an 
initial value of 28,171.63 Kcal/mol and a final value of 28,490.36 Kcal/mol. The temperature in 
K of the system shows an average value of 309.99 K, with an initial temperature of 307.73 
degrees Kelvin, and a final temperature of 311.21 K (Figure 5.2.3). Potential energy in the 
system is on average -86,395.81 Kcal/mol. Average Van der Wall interaction energy is 
3,304.05 Kcal/mol with an initial value of 4,656.6 Kcal/mol and a final value of 3,197.06 
Kcal/mol (Figure 5.2.4). Bond energy of the entire system through equilibration shows an 
average figure of 2,457.94 Kcal/mol with an initial figure of 2,529.75 Kcal/mol and a final 
figure of 2,461.34 Kcal/mol (Figure 5.2.5). 
Summary. 
Limited deviation in the above variables suggest that the system has reached relative 
equilibration at the desired temperature of 310 Kelvin within the confines of the simulations 
timesteps. The RMSD overlay suggests there are no visible heat spots in the system, while the 
data involving kinetic and potential energy, Van der Waal interactions and bond energy support 
the previously shown Maxwell-Boltzmann data and that the temperature stays stable for the 
duration of the calculation. 
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5.3 Analysis of the Mel1a 10ns Trajectories. 
The final frame from each set of trajectory data was analysed using Pymol 2.1.1 for 
electrostatic analysis and structural alignment. RMSD trajectory data was obtained using VMD 
version 1.9.3 and visual inspection of the trajectories was also undertaken using VMD to note 
any zones in the structure where consistent conformational change was observed. The beta2 
adrenergic and rhodopsin X-ray models were also used as reference for structural comparison. 
Mel1a 10 ns trajectory data was uploaded into VMD 1.9.3 for interpretation. Using the 
trajectory analysis tool, the trajectory data was aligned (As the subject to be analysed is the 
protein structure alone, which in MD conditions moves in the respective X, Y and Z co-
ordinates independently) to the protein reference frame (frame 0).  Run 1 showed an average 
RMSD of 4.613Å with a minimum of 0.942Å a maximum of 5.663Å, and a standard deviation 
of 0.799Å. Run 2 gave an average RMSD of 4.417Å, a minimum RMSD of 0.925Å a 
maximum at 5.326Å, with a standard deviation of 0.766Å. Run 3 exhibited an average RMSD 
of 4.674Å a minimum of 0.948Å and maximum of 6.361Å with a standard deviation of 1.08Å. 
The VMD timeline plugin was used to analyse RMSD of the protein within the system and the 
output data was used to colour the protein in each of the three MD runs by RMSD (Figure 
5.3.1). Areas in red represent high deviation in the proteins residue positioning. Blue areas 
show residues which do not deviate far from their initial positioning and are mostly seen in the 
of the core of the protein in all three calculation datasets. The data suggests the core of the 
protein is stable (alpha helix sections). Most movement is seen in the loop sections which are 
exposed to solute. Although the maximum RMSD is similar to the previous two runs, it appears 
the core of the protein is searching conformational space to a higher degree than the previous 
runs on the end portions of a few alpha helix sections. Although most of the high RMSD 
remains in the loops the RMSD in the helix sections suggesting a higher degree of deviation 
from the initial conformation. This suggests it needs more time to search conformational space. 
Run 3 shows conformational change in the helix-turn-helix G (Figure 4.1.1) in comparison to 
the previous two 10ns runs (runs 1 and 2). Although the RMSD of the entire protein is not 
significantly different to the other sets of trajectory data (Run 1: 4.613Å, run 2: 4.417Å, run 3: 
4.674Å) most of the conformational motion is observed in the loop sections before, in between 
and after the 7 helix trans-membrane portions of the protein on the intracellular and 
extracellular sides. These sections are exposed to solvent and therefore it is expected that 
movement would be greater in these regions as loop sections are intrinsically flexible.  
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RMSD data against simulation frame (Figure 5.3.2) is also presented for each trajectory and the 
data shows three similar profiles. A deviation in RMSD is observed in run 3 where a RMSD of 
2Å is evident between frames 1500 to 2500, compared to runs 1 and 2.  
The log files from the three 10 ns Mel1a trajectory datasets were analysed using the NamdPlot 
module available in Vmd 1.9.3 and representative charts of the data were generated. The 
resultant figures from all three trajectories are shown in the table below (Table 5.3.1) data can 
also be viewed in graph form in figures 5.5.1 and 5.5.2 for 10ns for run 1, 5.10.1, 5.10.2 for 10 
ns run 2 and 5.15.1 and 5.15.2 for 10 ns run 3; 
 Table 5.3.1 Initial. Average. Final. 
Kinetic energy (10ns run 1). 28,433.70 
Kcal/mol 
31,180.79 
Kcal/mol 
31,102.7 
Kcal/mol 
Kinetic energy (10ns run 2). 28,433.59 
Kcal/mol  
31,361.43 
Kcal/mol 
31,419.24 
Kcal/mol 
Kinetic energy (10ns run 3). 28,433.7 
Kcal/mol 
31,183.43 
Kcal/mol 
31,343.69 
Kcal/mol 
Potential energy (10ns Run 1). -87,607.42 
Kcal/mol 
-84,993.63 
Kcal/mol 
-84,909.59 
Kcal/mol 
Potential energy (10ns Run 2). -87,607.42 
Kcal/mol 
-86,178.61 
Kcal/mol 
-87,607.42 
Kcal/mol 
Potential energy (10ns Run 3). -87,607.42 
Kcal/mol 
-84,990.66 
Kcal/mol 
-85,119.47 
Kcal/mol 
Bond energy (10ns Run 1). 2,553.98 
Kcal/mol 
6,335.65 
Kcal/mol 
6,481.68 
Kcal/mol 
Bond energy (10ns Run 2). 2,553.98 
Kcal/mol 
5,516.88 
Kcal/mol 
5,569.43 
Kcal/mol 
Bond energy (10ns Run 3). 2,553.98 
Kcal/mol 
6,333.26 
Kcal/mol 
6,353.42 
Kcal/mol 
Temperature in Kelvin (10ns Run 1) 280.16 K 307.2 K 306.46 K 
Temperature in Kelvin (10ns Run 2) 280.16 K 309.01 K 309.58 K 
Temperature in Kelvin (10ns Run 3) 280.16 K 307.23 K 308.83 K 
*Table 5.3.1 – A summary of the data collected from all 10 ns molecular dynamics runs. 
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5.4 Mel1a 10ns Run 1. 
5.6 Visual analysis of the Mel1a protein structure in 10ns Run 1. 
Upon visual analysis of the protein in MD run 1 (Figure 5.6.1), the following 
characteristics were observed. Mel1A loop A (on the extracellular side of the 
membrane) moves closer to the core of the protein as the simulation progresses, 
resulting in a packed conformation at the end of the trajectory. Cys100 and Cys177 
form a disulphide bridge between beta loop turn A and alpha helix C limiting the 
movement of this loop section throughout the calculation. Helix-turn-helix G bends on 
the upper residues between Tyr285 and Leu290 in the final frame of the simulation. On 
the intracellular side of the membrane loop I (the longest loop section on the 
intracellular side) residue Cys314 seems to be traversing the membrane layer in an 
outwards direction from the protein core. Met339 is in an unfavourable position (due to 
being hydrophobic) in solute for the entire duration of the run and extends further from 
the core as the simulation continues initially 16.70Å distance from Asn55 on alpha helix 
A, and a final frame distance of 24.21Å from the same residue. In conjunction with this 
conduct, loop G moves away from the core of the protein on the intracellular side. 
Lys222 which moves away from the core, measured from Val214 on alpha helix E: start 
distance of 13.25Å and a final frame distance of 18.01Å.  
5.7 Structural Alignment Analysis of Trajectory 1. 
Structural alignments with the original homology model for the first trajectory can be seen in 
Figure 5.7.1. The align command was used in Pymol 2.1.1 to structurally align the initial Mel1a 
homology model (from I-Tassier) shown in green, with the final frame of the 10ns Mel1a 
trajectory 1data set shown in red (Part A). The RMSD between the structures is 3.03Å with 
most of the change being observed in the loop sections of the Mel1a protein. This suggests that 
the proteins loop sections (post homology modelling) were not in a favourable conformation 
and that the 10ns data set has allowed the structure to dynamically search for more appropriate 
loop conformers. Part B of figure 4.7.5 shows the structural alignment between the β2-
adrenergic GCPR (cyan) and the first 10ns run of Mel1a (red). the RMSD between the 
structures is 2.626Å which is comparatively smaller between part A and part B. However, the 
loop sections of the protein are still largely very divergent. In the crystal structure of the β2 
adrenergic GCPR many of the loop domains were not resolved most likely due to their 
conformational flexibility. Therefore, the lack of loop data in this X-ray structure may account 
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for the lower RMSD between it and the Mel1a since the calculation is now focused on the 
transmembrane helices. Part 3 shows the structural alignment between the rhodopsin receptor 
(shown in blue) and the final frame of Mel1a run 1 (red). With an alignment RMSD of 3.517Å 
similarly most of the difference seen in the structures is within the loop domains of these 
structures and like the crystal structure of β2 – sections of loop structures are missing on the 
intracellular domain of the model.  
Since crystal data for the GCPR superfamily is limited it is possible that the homology model 
was created using data of both the rhodopsin and β2 adrenergic GCPR’s. Both receptors also sit 
within the Rhodopsin-like receptor family (Mel1a within subfamily A9, β2 in subfamily A17).  
And may account for the low RMSD figures, and the high similarity in the core sections of the 
GCPR’s 
5.8 Electrostatic Analysis of Mel1a 10ns Run 1. 
Electrostatic surface analysis was performed using Pymol. The .PDB was converted to a PQR 
file using the Pymol plugin for APBS electrostatics. Grid spacing was set to 0.5, electrostatics 
were rendered as a Connolly surface using the Non-Linear Poisson-Boltzmann equation, 
Utilising a protein dielectric of 2.0 and a solvent dielectric of 78.0. At a Temperature 310K 
using an ion concentration of 150mM. Molecular surface visualisation was altered to show 
electrostatic charge potential of -/+ 10 (from the default value of 5). Areas shown in red are 
electronegative. Areas shown in white are neutral while blue areas of the surface are positive.  
Dimensions of the electrostatic surface are shown in figure 5.8.1. The extracellular portion of 
the protein shows a hue of small electro negative and positive charges but is mostly neutral 
except for an electronegative pocket which traverses through the core of the protein to the 
intracellular side where it finishes.  The side profile of the protein which is situated within the 
POPC membrane of the simulation is predominantly neutral. Both the extracellular and 
intracellular portions of the protein can be seen in the side view and positive charge is more 
visible on the intracellular side.   
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5.9 Mel1a 10ns Run 2. 
5.11 Visual analysis of the Mel1a protein structure in 10ns Run 2. 
Visual inspection of the Mel1a GCPR was undertaken using VMD to note any key 
characteristic conformations similar to the first 10ns run (Figure 5.11.1). Both the intracellular 
and extracellular loops seemed better packed overall than the initial calculation (run 1). The di-
sulphide bond seen in the initial calculation is present in the second simulation between loop A 
and helix C (Cys100 and Cys177). Met339 on the intracellular loop I, is still exposed to solute 
in the same fashion as the previous run. Cys314 also located on loop I, remains unpaired and 
searching the surface of the membrane showing similar behaviour to the first run moving away 
from the core of the protein. There is a large pocket on the extracellular side of the protein 
which is very clearly visible. Loop D has conformed into an alpha helical structure and no 
longer resembles a loop. On the extracellular side Met1 on loop A and Met268 on loop H are 
exposed to solvent. 
 
5.12 Structural Alignment Analysis Run 2. 
Following the same analysis pattern in Pymol performed for Run 1 (section 5.7), Mel1a 10ns 
run2 was structurally aligned with the homology model, β2 adrenergic and rhodopsin GCPR’s 
(figure 5.12.1). Part A shows the 10ns Run2 in red, and the homology model of Mel1a in green. 
The RMSD between the structures is 3.203Å. in comparison to 10ns run 1, a lot of the 
deviation is seen in the loop portions of the protein which is expected for the same previously 
stated reasons in section 5.7. while the core sees little conformational movement there are some 
visible areas in the core alpha helix sections conformational change has occurred. Part B shows 
the structural alignment between Mel1a run2’s final frame which is shown in red and the β2 
adrenergic GCPR shown in cyan. The deviation between the structures is 2.626Å. Although the 
RMSD is lower than the structural alignment with the homology model of the same protein 
(part A), the crystallised 2 adrenergic GCPR is missing loops as previously mentioned and 
likely accounts for the lower figure (section 5.7). Part 3 shows the structural alignment of 
Mel1a Run2’s final frame and the x-ray crystal structure of Rhodopsin. The RMSD between 
the structures is 3.517Å which is slightly higher than parts A and B. Loop D of Mel1a shows a 
similar conformation to the rhodopsin loop of the same orientation. Pymol chooses to define 
the Mel1a loop d structure as a loop rather than helical but has a very similar conformation to 
the rhodopsin helix which it is aligned to. Loop variation is again similarly to the other 
structural alignments and higher in comparison to the central core of the protein except for loop 
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D. This implies that the Mel1a GCPR is in the same family as the crystallised structures as it 
has little deviation in the central core. 
 
5.13 Electrostatic Analysis of Mel1a 10ns Run 2. 
From the final frame of the 2nd 10ns calculation, the Mel1a GCPR was removed from the 
system and saved as a new PDB for electrostatic surface analysis in Pymol using the APBS 
electrostatics plugin. The .PDB was converted to a PQR file for APBS electrostatics. Grid 
spacing was set to 0.5, electrostatics were rendered as a Connolly surface using the Non-Linear 
Poisson-Boltzmann equation, Utilising a protein dielectric of 2.0 and a solvent dielectric of 
78.0. At a Temperature 310K using an ion concentration of 150mM. The charge for the overlay 
was set to +/- 10 as done previously in all electrostatic surface maps. The resultant model is 
shown in figure 5.13.1. a large electronegative cavity is visible on the external side of the cell 
wall. Much larger than seen in the homology model electrostatics model (Figure 4.3.1) and the 
first 10ns run (Figure 5.8.1). the central channel which traverses through the core of the protein 
in the final frame of 10ns run 1 is not correlative with the final frame of run 2, suggesting a 
second conformation. As seen in the first run and the homology electrostatics analysis, the 
membrane portions of the core are persistently neutral in charge.  
5.14 Mel1a 10ns Run 3. 
5.16 Visual Analysis of the Mel1a Protein Structure in 10ns Run 3. 
Visual inspection of the Mel1a GCPR was undertaken using VMD to note any key 
characteristic conformations similar to the first and second 10ns runs (Figure 5.16.1). Cys314 
on the intracellular side of the GCPR consistently moves away from the core of the protein 
traversing the POPC membrane in the third dataset in the same fashion as the first two 10ns 
runs. Similarly, Met339 is exposed to solute on Loop I but the rest of the loop seems to be 
closer packed to the core of the protein. Loop G exhibits similar behaviour to 10ns Run 1 
extending away from the core of the protein but to a lesser extent (initial distance between 
VAL214 on loop G and Leu222 on helix E of 11.82Å) at a final distance of 15.43Å. on the 
extracellular side, Met1 and Met268 sit exposed to solvent. The initial loop (loop A) Met1 (N-
terminus of the protein) packs into the central core of the GCPR by the end of the simulation. 
Helix-Turn -Helix G condenses on the Z-axis at Asn299 to Ile309 and it moves closer to the 
previous part of the helix (Cys289 to Leu298) and folds in on itself. The benzene portions of 
Tyr295, Phe302, and Tyr306 stack by the end of the simulation in a diagonal conformation. 
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5.17 Structural Alignment Analysis Run 3. 
The final frame of the 3rd Mel1a GCPR calculation was saved as a new PDB file with the 
solvent and bi-lipid membrane POPC layer removed in VMD. Pymol was then used to 
structurally align the initial homology model, the β2 adrenergic and rhodopsin GCPR’s. the 
structural alignments are shown in figure 5.17.1. Part A shows the structural alignment between 
the initial homology model of Mel1a shown in green with the 10ns MD model being shown in 
red. The RMSD between the structures is 3.612Å. the overlay suggests that for the most part. 
Dynamic change is again similarly to the data from runs 1 and 2, most of the variation resides 
in the loop sections on both sides of the 7TM trans-membrane portion of the protein showing 
little deviation in the core of the protein. The alignment Part B shows the β2 adrenergic GCPR 
in cyan. RMSD between the aligned protein structures is 3.340Å. The core of the aligned 
structures shows a similar conformation. The loop sections are varied and Loop D on the Mel1a 
structure is represented as a Helix structure which is absent from the β2 structure and still 
appears as a loop. On the extracellular side (top half of the structure) the β2 adrenergic receptor 
has a horizontal Helix section within the loops which does not exist within the Mel1a structure. 
Part C shows the alignment of the Rhodopsin crystal structure in Blue with the 3rd 10ns MD 
run. The RMSD between the aligned structures is 4.449Å. Loop sections with the exception of 
Loop D show large variation in the structural alignment. Rhodopsin and the Mel1a structure 
share the helix-like loop section. the helix turn helix G in Mel1a is spun on its axis with the end 
of the final turn in the helix facing away from the proteins core, unlike rhodopsin which sits 
closer to the core. 
 
5.18 Electrostatic Analysis of Mel1a 10ns Run 3. 
The final frame of the 3rd 10ns MD run was saved as a new PDB file with the membrane, ions 
and solvent removed. Using Pymol, the APBS electrostatics plugin was used to make a surface 
map of electrostatic potential. The .PDB was converted to a PQR file for APBS electrostatics. 
Grid spacing was set to 0.5, electrostatics were rendered as a Connolly surface using the Non-
Linear Poisson-Boltzmann equation, Utilising a protein dielectric of 2.0 and a solvent dielectric 
of 78.0. At a Temperature 310K using an ion concentration of 150mM (Figure 5.18.1). The 
extracellular side of Mel1a has no obvious electronegative pockets and is predominantly neutral 
in charge unlike 10ns runs 1 and 2 which had electronegative pockets of different sizes. This 
may be due to the N-terminus of the protein conforming inside the protein’s central core as 
mentioned in the visual analysis. There is however an electronegative channel present in the 
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core of the protein similarly to 10ns run 1 (Figure 5.8.1).  The intracellular portion of the Mel1a 
GCPR shows the cavity leading to the central electronegative channel and is mostly positive in 
charge on the side view harbours a slight negative charge compared to runs 1 and 2 which had 
neutral charge suggesting a different type of conformational change which exhibits negative 
potential in the core of the protein, possibly describing a function. It is likely a second 
conformation is being shown in 10ns run 3. 
 
Summary. 
After analysis of the structural characteristics of Mel1a post 10ns MD calculation. The largest 
change in conformation was seen in the intracellular and extracellular loop sections of the 
protein structure. It was decided to extend in triplicate the Molecular Dynamics simulations to 
30 nanoseconds to allow the system to explore conformational space for longer (10ns to 30ns). 
Increasing the length of the simulation gives the system longer to find new conformations. The 
second 10 ns MD run displayed a second conformation. The extracellular side of Mel1a 
conformed presenting a large electronegative cavity, along with a distinct difference in bond 
energy of approximately 1000 Kcal/mol. However, all other variables remained within relative 
range of each other, supporting the need for a longer runtime of the system. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.0.1– The above graphs show bond energy of the entire system (left) and root mean square deviation (RMSD) during the minimi-
zation simulation fopr the protein residues selected in the VMD RMSD visualization tool. 
Figure 5.0.2 - Bond angle, Dihedral and Improper data from the minimization (left graph) and potential energy of the entire system (right 
graph). 
Figure 5.1.1-  Bond energy over the timesteps of the heating phase for the entire Mel1a system (left) . The right graph displays to constant 
pressure variable attained through the NPT ensemble for which pressure should be constant the graph shows an average constant pressure 
as the ensemble describes.  
Figure 5.1.2 - Potential energy (left) throughout the heating phase. (Right) Van der Waal interaction data. 
Figure 5.1.3 - Temperature in kelvin over 310,000 timesteps. 
Figure 5.2.1 - Mel1a Coloured by RMSD achieved with the created DCD file of the simulation, drawing method New Cartoon. The scale 
bar represents the minimum and maximum RMSD in the structure.  
Figure 5.2.2—Temperature distribution in the Mel1a GCPR bi-lipid membrane system. The y-axis describes the frequency of 
temperature distribution. The X-axis shows the temperature in Kelvin (K). 
Figure 5.2.3 - Kinetic energy data from the entire Mel1a GCPR Bi-Lipid Membrane System (left)  Average temperature of the system 
through out the calculation of the entire system (right). 
Figure 5.2.4 - Potential energy chart for the equilibration of the Mel1a GCPR bi-lipid membrane systes (left graph). Van Der Waal inter-
action energy plot for the previously mentioned system(right graph) 
Figure 5.2.5 - Bond energy over the duration of the simulation for 
the previously mentioned system (left). 
Run 1 10ns RMSD (root mean square deviation) 
trajectory by colour of Molecular Dynamics. 
Red resembles high areas of movement Max 21.26 
Å, blue resembles low areas of movement min of 
0.00Å. 
Protein is shown in Colouring Method: Trajectory > 
User, Representation: New Cartoon.   
Figure 5.3.1– 10ns MD of MEL1A -  Coloured by Trajectory RMSD. 
Run2 10ns RMSD (root mean square deviation) trajec-
tory by colour. 
High RMSD is seen in loop sections similarly to run 1, sta-
bility is seen in the core of the protein within the alpha  
helix sections. Most deviation in conformation is seen in 
the loop sections of the protein (maximum of 23.38Å). 
Protein is shown in Colouring Method: Trajectory > User, 
Representation: New Cartoon. 
 
Run 3 10ns RMSD (Root Mean Square Deviation) tra-
jectory by colour overlay. 
Red resembles high RMSD, blue represents low RMSD. 
Maximum RMSD seen is 21.26Å.  
Protein is shown in Colouring Method: Trajectory > User, 
Representation: New Cartoon. 
Figure 5.3.2 – RMSD plot for the 10 nanosecond runs or Mel1a. Each colour represents an different RMSD 
plot for the three simulations. The data impresses a need for longer simulations as the system appears to 
still be searching conformational space. 
5.5.1 Bond energy (left) and temperature data for the Mel1a system (Run1). 
5.5.2 —Kinetic energy data  (left) and Potential energy data (right) from the Mel1a system (run1). 
Disulphide bond between Cys100 and Cys177 on the 
extracellular side of  Mel1a GCPR, in 10ns Trajecto-
ry 1. 
Cys100 
Cys177 
Leu90 
Tyr285. 
The bend in Helix-turn-helix G in 10ns trajectory 1 
in the final frame. 
Asn55 
Met339 
Met339 
Val214 
16.70Å 
24.21Å 
Met339 and Cys314 exposed to solvent on the intracellular side of the membrane 
(above). 
Asn55 
Leu222 
Leu222 
18.01Å 
Val214 
13.25Å 
Met339 moves away from Helix A from 
an initial figure of 16.70Å to 24.21Å by 
calculation end (above). 
Leu222 moves from an initial distance of 13.25 to 18.01 by calculation 
end. 
Cys314 
Met339 
Figure 5.6.1—Visual analysis of Mel1a 10ns Trajectory 1. 
MD 10ns Run 1 Mel1a and initial I-tasser 
Homology model of Mel1a GCPR. 
MD 10ns Run 1 Mel1a and X-ray β2  
Adrenergic GCPR’. 
MD 10ns Run 1 Mel1a and Rhodopsin 
GCPR. 
Part A. The initial I-Tasser Mel1a GPCR Ho-
mology shown in green overlaid with the final 
frame of the 10ns Mel1a GPCR, run 1 shown in 
red. The deviation (RMSD) between the struc-
tures is 3.203Å 
Part B. The β2 adrenergic GPCR shown in cy-
an structurally aligned the with 10ns Mel1a MD 
run 1, shown in red. deviation between the 
structures is 2.626Å 
Part C. Structural alignment between the Rho-
dopsin GPCR and the final frame of the 10ns 
MD Mel1a GPCR, run 1. the structures have an 
RMSD of  3.517Å 
Figure 5.7.1 - Mel1a 10ns MD Run 1 Structural Alignment with the Initial Homology model of Mel1a, 2-adrenergic and rhodopsin GPCR’s. 
Extracellular Side (and pocket). Intracellular Side. 
Side View (membrane portion). 
Side slice of the protein showing interior electronegative 
channel which runs from the external to internal sides of 
the membrane. 
Figure 5.8.1 - Electrostatics of Mel1a GCPR final frame 10ns MD Run 1. 
Electrostatic surface analysis was generated 
using Pymol and the APBS electrostatics plugin. 
Red areas are electronegative, blue are positive, 
white are zones with neutral charge. The final 
frame of the Mel1a GCPR 10ns Molecular dy-
namics simulation was utilized for analysis.  
Electronegative pocket seen on 
the extracellular side of the pro-
tein (left, above). Which traverses 
to the intracellular side of the 
membrane (right). The channel is 
also shown in a side slice below. 
Figure 5.11.1—Visual analysis of 10ns Trajectory 2 of Mel1a 
Cys177 
Cys100 
The Disulphide Bond between Cys100 on helix C and Cys177 on beta turn A on the 
extracellular side of the membrane. 
Met339 exposed to solute and Cys314 on the intracellular side moving away from the 
core of the protein along the membrane surface.  
Extracellular Cavity of the Mel1a GPCR, on the external side of the membrane 
Loop D takes a Helix-like Form (left). 
Met1 (the C-terminus) on loop A and 
Met268 on Loop H are exposed to solvent.  
(right) 
Met339 
Cys314 
Met1 
Met268 
MD 10ns Run 2 Mel1a and initial I-tasser 
Homology model of Mel1a GCPR. 
MD 10ns Run 2 Mel1a and X-ray β2  
Adrenergic GCPR’. 
MD 10ns Run 2 Mel1a and Rhodopsin 
GCPR. 
Part C. Structural alignment between the Rhodopsin 
GPCR and the final frame of the 10ns MD Mel1a 
GPCR, run 2. the structures have an RMSD of  3.375Å 
Part B. The β2 adrenergic GPCR shown in cyan 
structurally aligned the with 10ns Mel1a MD run 2, 
shown in red. deviation between the structures is 
2.678Å 
Part A. The initial I-Tasser Mel1a GPCR Homolo-
gy shown in green overlaid with the final frame of 
the 10ns Mel1a GPCR run 2, shown in red. The de-
viation (RMSD) between the structures is 3.197Å 
Figure 5.12.1 - Mel1a 10ns MD Run 2 Structural Alignment with the Initial Homology model of Mel1a, β2-adrenergic and rhodopsin 
GPCR’s. 
Extracellular Side.  Intracellular Side. 
Cropped picture of extracellular 
cavity (left). 
Unlike 10ns Run1, 10ns Run 2 has no channel which traverses 
from the intracellular to the extracellular, although electroneg-
ativity is still seen. 
Electrostatic surface analysis was generated using 
Pymol and the APBS electrostatics plugin. Red 
areas are electronegative, blue are positive. White 
are zones with neutral charge. The final frame of 
the second Mel1a GCPR 10ns Molecular dynam-
ics simulation was utilized for analysis after be-
ing separated from the bi-lipid membrane and 
solvent in the system.  
Figure 5.13.1 - Electrostatics of Mel1a GCPR final frame 10ns MD Run 2. 
Side View (membrane portion) 
Figure 5.15.1—bond energy data in the Mel1a GCPR membrane system (left), temperature of the previously men-
tioned system in Kelvin (right). 
5.15.2 —Kinetic energy in the Mel1a GCPR system (left) negative potential energy in the MEl1a GCPR system 
(right). 
Figure 5.16.1—Visual Analysis of 10ns trajectory 3 of the Mel1a GPCR. 
Cys177 
Cys100 
The Di-sulphide bond between Cys100 on Helix C and Cys177 on beta loop A. 
Met1 (C-terminus) on loop A and Met268 on the extracellular side of 
Mel1a, on loop H.— exposed to solvent. 
Met1 (C-terminus) on loop A compacted into the core of the Mel1a GCPR 
by the final frame. 
Leu222 on loop G extends towards solute from the core of the pro-
tein. (measured from Val214) 
Figure 5.17.1- Mel1a 10ns MD Run 3 Structural Alignment with the Initial Homology model of Mel1a, 2-adrenergic and rhodopsin GPCR’s. 
MD 10ns Run 3 Mel1a and initial I-tasser 
Homology model of Mel1a GCPR. 
MD 10ns Run 3 Mel1a and X-ray β2  
Adrenergic GCPR’. 
MD 10ns Run 3 Mel1a and Rhodopsin 
GCPR. 
Part A. The initial I-Tasser Mel1a GPCR Ho-
mology shown in green overlaid with the final 
frame of the 10ns Mel1a GPCR, run 3 shown in 
red. The deviation (RMSD) between the struc-
tures is 3.612Å 
Part B. The β2 adrenergic GPCR shown in cy-
an structurally aligned the with 10ns Mel1a MD 
run 3, shown in red. deviation between the 
structures is 3.348Å 
Part C. Structural alignment between the Rho-
dopsin GPCR and the final frame of the 10ns 
MD Mel1a GPCR, run 3. the structures have an 
RMSD of  4.449Å 
Extracellular side Intracellular Side 
Side View (membrane portion) 
Side slice view of Mel1a, shows the electronega-
tive channel which traverses through the central 
core of the protein. Also seen in 10ns Run 1. 
Figure 5.18.1 - Electrostatics of Mel1a GCPR final frame 10ns MD Run 3. 
Electrostatic surface analysis was generated using Pymol 
and the APBS electrostatics plugin. Red areas are elec-
tronegative, blue are positive, white are zones with neu-
tral charge. The final frame of the Mel1a GCPR 10ns 
Molecular dynamics simulation run 3 was utilized for 
analysis after removing it from the membrane system in 
VMD 1.9.3.  
No noticeably obvious electronegative pocket is seen in the 
extracellular portion  of the protein and most of the extracellular 
portion seems to be neutral due to conformational differences 
compared to runs 1 and 2 of the Mel1a system at 10ns. This 
may be due to the MET1 residue of loop A conforming to the 
inside of the 7TM core of the GCPR causing a different charge 
distribution on the extracellular side. 
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6.0 - 30 Nanosecond Molecular Dynamic Analysis of the Mel1a GPCR Bi-lipid Cell 
Membrane System. 
 
Data from the triplicate 30 nanosecond trajectories was individually uploaded into VMD 1.9.3 
for analysis. The trajectory data was coloured by RMSD for all three set of trajectory data. In 
addition, the log file was also analysed using the NamD plot plugin available in VMD to check 
the potential energy components of the systems throughout the simulations. Ramachandran 
plots were also generated for the final frame of each triplicate run to assess the secondary 
structure of the protein, and whether the residues were in typical conformations for the type of 
secondary structure. Structural alignment figures were made using Pymol comparing the final 
frame of the simulations of all 3 runs with the I-Tasser homology model of Mel1a, X-ray 
crystal structures of Rhodopsin and β2-adregenic GPCR’s. Electrostatic surface analysis of 
each dataset was also performed using Pymol and the APBS plugin. These steps were followed 
in order to establish a detailed analysis of the protein as a representative model system. 
Using the VMD RMSD trajectory tool the frames were aligned to the initial frame (frame 0) of 
the calculation, and the protein backbone was used to analyse the RMSD of the structure. 30ns 
trajectory 1 had an average RMSD of 5.609Å,  a standard deviation of 0.892Å,  a minimum 
RMSD of 0.832Å and a maximum RMSD of 7.012Å. 30ns trajectory 2 had an average RMSD 
of 5.412Å , a standard deviation of 0.833Å, a minimum RMSD of 0.820Å and a maximum 
RMSD of 6.913Å. 30ns trajectory 3 had an average RMSD of 6.137Å, a standard deviation of 
1.408Å, a minimum RMSD of 0.839Å and a maximum RMSD of 8.393Å. 
The timeline plugin available in VMD 1.9.3 was used to analyse the RMSD data over the 
duration of the 30ns calculation. The trajectory was loaded into VMD with a stride of 15 
allowing for 1000 frames of the simulation to be loaded into the program. This process was 
performed for all three 30ns trajectories and made into a figure showing trajectory data 
coloured by RMSD (Figure 6.0.1). The high RMSD values shown in red are seen in the loop 
sections of the Mel1a GPCR (seen previously in the 10ns simulations figure 5.3.1). The overall 
RMSD of the protein is higher with certain areas reaching a value of 33.14Å in 30ns trajectory 
1 which is primarily observed at the Met1 N-terminus residue which is loose in solute on the 
extracellular side of the protein. A maximum RMSD of 36.50Å in 30ns trajectory 2 is observed 
primarily on the intracellular side of the GPCR however this region of the protein appears to be 
the most conformationally stable in terms of RMSD according to the colour of the region in the 
figure. A maximum RMSD of 43.46Å is observed in the 30ns trajectory 3 which is again 
predominately on the intracellular side of the GPCR and represents the highest maximum 
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RMSD of the triplicate 30ns trajectories. Trajectory 3’s Notable areas of RMSD are in the 
Helix F towards the intracellular side and towards the C-terminus of Loop I which has the 
highest RMSD of the entire structure according to the trajectory colourization. This data is 
expected since the time of the calculation has been increased to 30 ns (from the initial 10ns) 
which should allow the system to more fully explore conformational space. The helical 
transmembrane core of Mel1a, in all three trajectories, remains extremely stable with only 
small relative movement (RMSD) located at the ends of some of the 7TM regions.  
Ramachandran plots were generated using the final frame of each MD trajectory (Figure 6.0.2) 
and show that the majority of the protein residues are found within expected secondary 
structure areas of the chart. A small portion of residues were observed outside the loop section 
of the Ramachandran’s in all trajectories. This is likely due to the highly mobile character of 
the loop domains. Transition residues are also likely in the sections of the plot which do not 
conform to secondary structure types as they transition between one type of secondary structure 
to the next (Ie. alpha helix to loop section). 
Analysis of the Mel1a 30 ns Trajectories. 
The log files from the three 30 ns Mel1a trajectory datasets were analysed using the NamdPlot 
module available in Vmd 1.9.3 and representative charts of the data were generated. The 
resultant figures from all three trajectories are shown in the table below (Table 6.0.1). Data can 
also be viewed in graph form in figures 6.1.1, 6.1.2 and 6.1.3 for 30ns for run 1,  6.5.1, 6.5.2 
and 6.5.3 for 30 ns run 2 and 6.10.1, 6.10.2 and 6.10.3 for 30 ns run 3; 
Table 6.1.1 Initial. Average. Final. 
Kinetic energy (30ns run 1). 28,433.59 
Kcal/mol 
31,331.96 
Kcal/mol 
31,355.04 
Kcal/mol 
Kinetic energy (30ns run 2). 28,433.59 
Kcal/mol 
31,347.03 
Kcal/mol 
31,515.34 
Kcal/mol 
Kinetic energy (30ns run 3). 28,433.59 
Kcal/mol 
31,349.74 
Kcal/mol 
31,482.67 
Kcal/mol 
Potential energy (30ns Run 1). -87,607.43 
Kcal/mol 
-86,286.507 
Kcal/mol 
-86,232.59 
Kcal/mol 
Potential energy (30ns Run 2). -87,607.42 
Kcal/mol 
-86,197.92 
Kcal/mol 
-86,208.45 
Kcal/mol 
Potential energy (30ns Run 3). -87,607.42 
Kcal/mol 
-86,213.9 
Kcal/mol 
-86,349.28 
Kcal/mol 
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Bond energy (30ns Run 1). 2,553.98 
Kcal/mol 
5,497.81 
Kcal/mol 
5,484.58 
Kcal/mol 
Bond energy (30ns Run 2). 2,553.98 
Kcal/mol 
5,496.59 
Kcal/mol 
5,530.10 
Kcal/mol 
Bond energy (30ns Run 3). 2,553.98 
Kcal/mol 
5,496.75 
Kcal/mol 
5,519.9 
Kcal/mol 
Temperature in Kelvin (30ns Run 1) 280.16 K 308.71 K 308.94 K 
Temperature in Kelvin (30ns Run 2) 280.16 K 308.87 K 310.53 K 
Temperature in Kelvin (30ns Run 3) 280.16 K 308.89 K 310.2 K 
Van der Waal interaction energy (30ns 
run 1) 
3,309.59 
Kcal/mol 
2,726.01 
Kcal/mol 
2,783 
Kcal/mol 
Van der Waal interaction energy (30ns 
run 2) 
3,309.59 
Kcal/mol 
2,710.42 
Kcal/mol 
2,631.01 
Kcal/mol 
Van der Waal interaction energy (30ns 
run 3) 
3,309.59 
Kcal/mol 
2,714.37 
Kcal/mol 
2,591.42 
Kcal/mol 
*Table 6.0.1 – A summary of the data collected from all 30 ns molecular dynamics runs. 
 
6.2 Visual Analysis of the Mel1a Protein Structure in 30ns Trajectory 1. 
The DCD file for the MD calculation was loaded into VMD 1.9.3 with a stride of 1 and 
therefore incorporated all 15,000 frames of the simulation (Figure 6.2.1). In a similar fashion to 
the 10ns simulations of Mel1a, the disulphide bond between CYS100 on Helix C and CYS177 
on beta turn A is present. Loop D behaves as a loop throughout the simulation, unlike 10ns run 
2 (section 5.11). CYS314 shows similar behaviour to all the previous 10ns MD runs traversing 
away from the core of the protein in Loop I whilst staying close to the POPC membrane. The 
sulphur atom is oriented towards the lipid bi-layer to avoid contact with solvent (water and 
ions). MET339 remains exposed to solute in the same fashion as the previous runs. Met 1 
initially sits close to the centre of the core, but as the simulation continues it breaks away from 
the core and reconfirms above Helix A by the end of the calculation. 
 
6.3 Structural Alignment Analysis of Mel1a from 30ns trajectory 1. 
The final frame of trajectory 1 was saved in VMD (as a pdb file) with the solvent, ions and 
lipid bilayer removed. It was then loaded into Pymol where structural alignment with the 
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original I-Tasser model, Beta 2 Adrenergic and Rhodopsin was carried out (Figure 6.3.1) . For 
the I-Tasser model, part A, The RMSD between the structures is 3.813Å. Most of the deviation 
seen between the aligned structures is observed in the loop sections of the GPCR’s. There are 
differences in the orientation of some of the helix sections of the protein. Most notedly in the 
Helix-turn-helix G where both the final helix section before loop I is facing away from the 
protein at a different angle and further into the core at the upper half (before loop H) of the 
helix in comparison to the homology model in part A.  All the other alpha helix sections have 
slightly different angular orientations but follow a similar path. Alpha helix F sits further from 
the core of the Mel1a GPCR, Helix A is more tilted towards Helix-Turn-Helix G. which via 
molecular dynamics simulation has conformationally changed. In Figure 6.3.1, Part B the 
structural alignment with the β2 adrenergic GPCR X-ray crystal structure is shown. The RMSD 
between the structures is 3.119Å. This is slightly less than the difference between the alignment 
with the homology model (Part A) and may be because the β2 adrenergic receptor is missing 
intracellular loop sections. The helix-turn-helix G domain tilts inwards on the upper 
extracellular side, and as a result the intracellular side tilts away from the core of Mel1a. As 
seen in all structural alignments part B has high RMSD in the loop domains of both GPCR’s. 
There is also no structural similarity between the upper short extracellular helix observed on the 
β2 adrenergic receptor and Mel1a’s extracellular loops where no helix exists at this location. 
Part C in figure 6.3.1 shows the structural alignment of trajectory 1 final frame with the 
Rhodopsin GPCR. The RMSD between the protein structures is 3.234Å. The loop domains of 
the aligned GPCR’s are again different in conformation but are more similar than that of the 
structurally alignment observed with the β2 adrenergic receptor (Part B, figure 6.3.1). Helix-
Turn-Helix G is still pointed away from the protein core in comparison to Rhodopsin on the 
‘Loop I’ end, and more buried in the core at the ‘Loop H’ end. This shows that the Mel1 GPCR 
is conformationally different from the β2 adrenergic and rhodopsin GPCRs’ but shares the 
family resemblance as a GPCR. The stability in the core also shows the Mel1a GPCR under 
simulation conditions does not deviate significantly inside the bi-lipid membrane.  
 
 
6.4 Electrostatic Surface analysis of Mel1a - 30ns Run 1. 
The final frame of 30ns MD on run 1 was saved as a new PDB file through VMD 1.9.3 and 
input into Pymol. The .PDB was converted to a PQR file using the Pymol plugin for APBS 
electrostatics. Grid spacing was set to 0.5, electrostatics were rendered as a Connolly surface 
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using the Non-Linear Poisson-Boltzmann equation, Utilising a protein dielectric of 2.0 and a 
solvent dielectric of 78.0. At a Temperature 310K using an ion concentration of 150mM. Using 
(Figure 6.4.1), an electrostatic surface map was created with a charge distribution map +/- 10 . 
Red areas of the surface map show electronegative regions of the protein while blue indicates 
electropositive regions. White colouring represents neutral areas in the protein.  The 
extracellular side of the protein has no obvious electronegative cavity in comparison to the 
Mel1a GPCR 10 ns trajectory 1 (Figure 5.8.1), 2 (Figure 5.13.1), and the I-tasser homology 
model (Figure 4.3.1). However, there are electronegative patches observed on the extracellular 
surface. The intracellular side of Mel1a has a large central electronegative cavity which is not 
directly connected to the extracellular side as was observed in the earlier 10ns trajectories 
(Figures 5.8.1 and 5.13.1). Of note, this electronegative cavity is surrounded by an 
electropositive “shroud” provided by the loop sections of the protein. A membrane positioned 
side view of Mel1a shows that it is electronically neutral (white).  
 
6.6 Visual Analysis of the Mel1a Protein Structure in 30ns Run 2. 
The DCD file was loaded into VMD 1.93 with a stride of 1 incorporating all 15,000 frames for 
visual analysis (Figure 6.6.1 and 6.6.2). The CYS100-CYS177 di-sulphide bond persists in 
30ns trajectory 2 as with all previous runs. MET 1 is initially buried towards the core of the 
GPCR however, as the simulation progresses it moves out into solute before returning to a 
similar conformation. MET268 moves from the outside of the protein to the inside core of the 
protein as MET1 and returns to its initial conformation. As the simulation progresses and 
between THR37 and VAL40 on alpha helix A the structure changes conformation, producing a 
short loop section between the alpha helix A domain. Similar phenomena are seen in the 
VAL84 and MET86 portion of alpha helix B before it transitions into Loop C where the 
residues are almost uncoiled but hold a pi helix-like conformation from Pro80 and after the turn 
in Helix B ending at Phe89. Between LEU133 and SER140 on loop D the beta loop has 
changed form to a helix-like conformation before transitioning into alpha Helix D (Unlike the 
previous trajectory in Section 6.2). Conformational change is seen on loop E between GLN219 
and LYS226 before transitioning into alpha helix F where it has an almost helical form. Helix-
Turn-Helix collapses on the Z-axis - This is observed at Asn299 where the helix bends in 
another direction and continues to residue ILE309. The conformation of Helix-turn-helix G 
collapses on the Z-axis of the display from 42.93Å to 38.48Å (distance measured from residue 
GLU274:HG2 at the beginning of the helix-turn-helix measured in relative distance from 
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ILE309:O) causing significant conformational deviation as the trajectory progresses to the final 
frame. Similarly, as observed in all trajectories, the intracellular residue on loop I - CYS314 is 
moving away from the core of the protein and the sulphur atom is oriented towards the POPC 
membrane away from solvent. Met 339 is similarly still exposed to solvent on the intracellular 
side. This seems to ‘spread’ the entirely to loop I across the POPC membrane away from the 
core of the protein. 
6.7 Structural Alignment Analysis of Mel1a from 30ns Run 2. 
The final frame of the Mel1a bilipid cell membrane system (30ns trajectory 2) was saved in 
VMD as a pdb file with the solvent, ions and lipid bilayer removed (Figure 6.7.1). It was then 
loaded into Pymol and structurally aligned with the initial I-Tasser homology model of Mel1a 
(Orange) shown in Part A. The RMSD between the aligned structures is 4.194Å. In addition to 
the previously seen variation in the loop sections, large parts of the alpha helix core deviate in 
conformation. Most notably Helix A which has a central loop section and Helix-turn-helix G 
which has a sharper ‘Z’ shape conformation reducing its size on the Z-axis. Most of the helix 
does not structurally align as it has done in the previous 10ns calculations nor the homology 
structural alignments. (Section 4.1 and section 4.7). Part B in figure 6.7.1 shows the structural 
alignment of the β2 adrenergic GPCR (shown in Cyan) with the final frame of 30ns run 2 
(shown in green). The RMSD between the structures is 3.563Å, which is comparatively lower 
than the RMSD between the initial homology model and 30ns Run 2’s final frame. But as noted 
previously loop sections are missing from the crystal structure for the β2 adrenergic GPCR. 
Most of the helix sections follow a similar pattern except for alpha helix A which bends 
significantly at the centre loop between residues THR37 and VAL40 towards helix-turn-helix 
G. The helix-turn-helix G sections of the core which vary considerably compared to previous 
structural alignments the Asn299 to Ile309 section sits above the similar helix shape seen in the 
β2 adrenergic GPCR. Loop D has a helical representation in Pymol which is not shared by the 
β2-adrenergic GPCR. Part C in figure 6.7.1 shows the structural alignment with the rhodopsin 
GPCR X-ray crystal structure. RMSD between the aligned structures is 3.885Å. The structure 
of rhodopsin seems to be more like the final product of the 30ns simulation. Alpha helixes E 
and F bend inwards towards the core of Mel1a on the extracellular side more so than 
rhodopsin’s structure. Helix A is very different as in part A and part B with a loop section 
splitting it into two separate helixes. The extracellular side of Helix B also shows a large degree 
of conformational difference as the upper half bends in towards the core. 
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6.8 Electrostatic Surface analysis of Mel1a - 30ns Run 2. 
The final frame of 30ns MD on run 2 was saved as a new PDB file through VMD 1.9.3 and 
input into Pymol. The .PDB was converted to a PQR file using the Pymol plugin for APBS 
electrostatics. Grid spacing was set to 0.5, electrostatics were rendered as a Connolly surface 
using the Non-Linear Poisson-Boltzmann equation, Utilising a protein dielectric of 2.0 and a 
solvent dielectric of 78.0. At a Temperature 310K using an ion concentration of 150mM 
(Figure 6.8.1) an electrostatic surface map was created with a charge distribution map +/- 10. 
The extracellular side of the Mel1a GPCR has a shallow electronegative pocket visible. The 
intracellular side shows a large electropositive surface and an electronegative cavity which is 
covered by loop sections this cavity traverses to the central core of the protein structure but 
does not connect with the intracellular side similarly to both figures 4.7.11 and the initial 
homology model  in figure 4.1.5, which have a central channel which is not connected from the 
intracellular side to the extracellular side. The side view shows a mostly neutral (white) 
extracellular profile. The intracellular is more electropositive. This is also seen in the side slice 
of Mel1a which shows the disconnected channel.  
 
 
6.11 Visual Analysis of the Mel1a Protein Structure in 30ns Trajectory 3. 
The DCD file for the third 30ns run of Mel1a was loaded into VMD 1.9.3 with a stride of one 
incorporating all 15,000 frames for visual analysis (Figures 6.11.1 and 6.11.2). On the 
extracellular portion of the Mel1a Met1 and MET268 are closely positioned to the core of the 
protein, ASN10 on loop A is interacting with the solvent and extending loop A from MET1’s 
position. The disulphide bond between CYS100 on alpha helix C and CYS177 is present as in 
all the other molecular dynamics simulations performed. Helix B appears to maintain the pi-
helix conformation, with the Pro80 to Asn90 section on the extracellular side moving out away 
from the core of the Mel1a GPCR. Loop G on the intracellular side moves outward from the 
core of the protein (VAL221 on loop G in distance from LEU215 on Helix F which is initially 
13.78Å extending to 17.75Å by the final frame of the simulation. CYS314 clings to the POPC 
membrane moving away from the core of the protein, MET339 also is as seen similarly in all 
MD runs (10ns to 30ns) exposed to solute but appears to relocate closer to the POPC 
membrane as the simulation progresses. This leaves loop I spread across a large area of the 
intracellular side of the membrane. 
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6.12 Structural Alignment Analysis of Mel1a from 30ns Run 3. 
The final frame of the Mel1a bi-lipid cell membrane system (30ns Run 31) was saved in VMD 
1.9.3 with the solvent and lipid bi-layer removed (Figure 6.12.1). It was then loaded into Pymol 
and structurally aligned with the initial I-Tasser homology model of Mel1a (Orange) shown in 
Part A. The RMSD between the structures is 4.031Å. Most of the alpha helix 7tm regions 
follow the same profile as the homology model. The exceptions being helix-turn-helix G which 
the turn helix (ASN299 to ILE309) is pointed more towards the core of the structure. The 
extracellular loop sections follow a similar shape to the homology model in comparison to 
other structural alignments.  The initial start of alpha helix F sits further away from the core of 
the protein. compared to the homology model the intracellular side is pushed further out from 
the core. Loop G which transitions between sits further out into the intracellular area as a result.  
The intracellular loops deviate largely from the homology model loop which is expected due to 
being exposed to solvent. Part B shows the structural alignment with the β2 adrenergic GPCR 
(shown in cyan) and the final frame of the 30ns Mel1a model (shown in green), the deviation 
(RMSD) between the structures is 3.671Å.  the loop sections are greatly varied with the 
extracellular portion showing a completely different conformation, also missing the helix-like 
coil in present the b2 adrenergic GPCR. Helix F sits lower in the Mel1a Structure than the 
latter, resulting in the helix being closer to the intracellular side of the protein.  Loop G as a 
result is sitting much further out into the solute region. Helix-turn-helix G sits further in 
towards the core of the protein, while the end of helix A is pushed further away from the core 
of the protein out into what would be the POPC membrane. The lower RMSD figure is likely 
representative of the missing loop sections from the β2 adrenergic receptor due to being fused 
to a T4 lysosome in order to crystallise. Part C shows the structural alignment of the Rhodopsin 
GPCR X-ray crystal structure (shown in magenta), aligned with the final frame of 30ns run 3 of 
Mel1a GPCR (shown in green). The deviation between the structures (RMSD) is 3.706Å. High 
deviation in the loop areas is seen on both the intra and extracellular sides of the protein. Helix 
E and F sit higher than the comparative helixes in the rhodopsin structure. The lower half of 
helix F near the extracellular side bends towards Helix E. The extracellular upper half of Helix-
turn-helix G sits further away from the core of the protein and the intracellular side on the final 
turn of the helix (ASN299 to ILE309) orients towards Helix A.   
6.13 Electrostatic Surface analysis of Mel1a - 30ns Run 3. 
The final frame of 30ns MD on run 2 was saved as a new PDB file in with the solvent and 
POPC membrane removed through VMD 1.9.3 and uploaded into Pymol. The .PDB was 
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converted to a PQR file using the Pymol plugin for APBS electrostatics. Grid spacing was set 
to 0.5, electrostatics were rendered as a Connolly surface using the Non-Linear Poisson-
Boltzmann equation, Utilising a protein dielectric of 2.0 and a solvent dielectric of 78.0. At a 
Temperature 310K using an ion concentration of 150mM (Figure 6.12.1). A distribution map of 
+/- 10 charge was created. The extracellular side of Mel1a is a mix of neutral positive and 
negative zones with a small electronegative channel that follows through to the other side of the 
membrane. The core is similarly seen in figures 4.7.4 and 4.7.15 for the 10ns calculations.  The 
intracellular portion is electropositive in the loop sections with a partially neutral set of zones. 
The side profile of Mel1a is predominantly neutral. The intracellular side visible in the side 
profile is electropositive.  The extracellular side visible in the side profile has varied areas of 
positive negative and neutral charge. 
  
Summary. 
 
The data acquired from the 30 ns trajectory runs shows increased RMSD when backwards 
compared to the 10 ns trajectory data (section 5.0). Each of the trajectory datasets retains the 
GPCR architecture but conformationally changes from the initial I-Tasser homology model. 
The core of the Mel1a GPCR remains extremely stable (an RMSD below 3Å measured from 
the residues of the alpha helix sections) in all 3 trajectories with most of the activity appearing 
in the intracellular and extracellular loop sections. The mel1a GPCR has distinct differences 
from the rhodopsin and β2 adrenergic receptor. The electrostatic data received from each 30ns 
trajectory dataset also suggests that the extracellular side of the protein is negative, while the 
intracellular side is predominantly electropositive. The disulphide bond seen on the 
extracellular side of mel1a (Cys100-Cys177) appears in all 10ns and 30ns trajectories to this 
point suggesting it is a region with a definable biological purpose (Ferguson et al., 1996). 
 
 
 
 
 
 
30ns Run 1 Mel1a GCPR RMSD Trajectory Overlay. 
Red resembles high areas of movement Max 33.14Å, 
blue resembles low areas of movement (min of 0.00Å). 
The Mel1a GCPR is shown in Using the trajectory data 
from the DCD file and displayed in New Cartoon. 
30ns Run 3 Mel1a GCPR RMSD Trajectory Overlay. 
The maximum RMSD is 5Å (maximum of 43.36Å)
higher in relation to the previous 30ns runs. The Mel1a 
GCPR is shown using the trajectory data from the DCD 
file and represented in New Cartoon. 
30ns Run2 Mel1a GCPR RMSD Trajectory Overlay. 
High RMSD is seen in loop sections similarly to 30ns 
Run 1, The Mel1a GCPR is shown using the trajectory 
data from the DCD file and shown in New Cartoon in 
VMD 1.9.3. 
Figure 6.0.1– 30ns Molecular Dynamics of MEL1A -  RMSD coloured by 
trajectory. 
 30 Nanosecond Molecular Dynamics Run 
3 Ramachandran Plot. 
30 Nanosecond Molecular Dynamics Run 
3 Ramachandran Plot. 
30 Nanosecond Molecular Dynamics Run 
1 Ramachandran Plot. 
Figure 6.0.2 - Ramachandran plot analysis and RMSD over 
time in all three Mel1a GCPR 30ns MD.  
Figure 6.1.1 - Temperature of the Mel1a bi-lipid molecular dynamics system (left). Kinetic energy of the previously mentioned system 
(right). 
Figure 6.1.2 - Potential energy in the previously mentioned system (left graph) Van Der Waal interaction energy in the previously men-
tioned system. 
Figure 6.1.3 - Bond Energy of the Mel1a bi lipid cell membrane 
environment (left). 
Figure 6.2.1—Visual analysis of Mel1a GCPR 30ns Trajectory 1. 
Cys100 
Cys177 
Disulphide bond between Cys100 on Helix C, and 
Cys177 on beta turn A. 
Pi-Helix B (Shown in orange) retains its shape in trajec-
tory two, starting at Pro80 and continuing to Asn90. 
Met1 in the initial frame of the calculation sits close to the core, before moving out into solute and reconforming along with 
half of Loop A to the top of Helix A by the end of the calculation 
Cys314. 
Met339. 
Cys314 on the intracellular 
section of the Mel1a GCPR 
moves away from the core 
of the protein traversing the 
POPC membrane. 
Met339 on loop I exposed to 
solvent on the intracellular side 
of Mel1a. 
Part B. Mel1a GCPR 30ns Run 1 shown in Green,  X-
ray crystal structure of β2-adregernic GCPR shown in 
Cyan.  RMSD between the structures is 3.119Å 
MD 30ns Run 1 Mel1a and X-ray β2  
Adrenergic GCPR’. 
Part C. Mel1a GCPR 30ns Run1 shown in Green, X-
ray Crystal Rhodopsin GCPR shown in Magenta. 
RMSD between the structures is 3.234Å 
Part A. Mel1a GCPR 30ns Run 1 shown in Green,  
I-Tasser’s Homology model of Mel1a GCPR 
shown in Orange.  RMSD between the structures is 
3.813Å. 
Figure 6.3.1 - Structural alignment of 30 ns run 1 to initial I-Tasser Homology Model of Mel1a and X-ray Crystal Structures of β2-
Adregernic and Rhodopsin G-Coupled Protein Receptors (GCPR’s). 
MD 30ns Run 1 Mel1a and Rhodopsin 
GCPR. 
MD 30ns Run 1 Mel1a and initial I-tasser 
Homology model of Mel1a GCPR. 
Electrostatics images rendered in Pymol using the 
APBS electrostatics plugin, utilizing the AMBER 
forcefield  to assess the surface interaction  
properties of the first 30 nanosecond run. The final 
frame of the simulation is saved through VMD 
prior to being loaded into Pymol. Areas displayed 
in red are electro-negative, Areas shown in blue 
are positive. Neutral areas have a white appear-
ance. 
(Electro-negative cavity on the internal 
side of the membrane. (Above). 
Extracellular View. Intracellular View and Electronegative 
Cavity. 
Side View (membrane portion). 
Side Slice of Mel1a to show electronegative pocket in the core 
of the GCPR. 
Figure 6.4.1 - Electrostatic analysis of Mel1a MD run 1, 30ns.  
Figure 6.5.1—kinetic energy in the Mel1a bi-lipid system 30ns Run 2 (left) , and temperature in Kelvin of the pre-
viously mentioned system (right). 
Figure 6.5.2 - Van Der Waal Interaction energy in the entire Mel1a GCPR membrane system (left). Potential ener-
gy in the system (right).  
Figure  6.5.3 - Bond Energy in the system (left). 
Figure 6.6.1—Visual analysis of the 30ns Mel1a GCPR trajectory 2. 
Disulphide bond present in 30ns Mel1a GCPR, Trajectory 2 between Cys100 
on Helix C and Cys177 on Beta Turn A. 
Met1 which breaks away from the core of the protein and then reconfirms on the surface of the extracellular side as the 
calculation ends. 
Alpha Helix A is split into two helix sections between 
Thr37 and Val40. (above) 
Thr37. 
Val40. 
Cys177. 
Cys100 
Met1. 
1 3 2 
Figure 6.6.2—Visual analysis of the 30ns Mel1a GCPR trajectory 2. 
Pro80. 
Asn299 
Gln274. 
Ile309. 
Gln274. 
Asn299. 
Ile309. 
Cys314 
Met339 
42.93Å 
38.48Å 
Loop E helix-like conformation before Helix F. 
Gln219 
Lys226 
Loop I spreads out over the POPC membrane on the intracellular 
side. (highlighted in orange). 
Proline (Pro80) induced bend in Helix B in 
the final frame of the calculation. Leading 
to Phe89 
Phe89. 
Measured from Gln274 to Ile309, Helix-Turn Helix G collapses on its axis from 42.94 (left) to 38.48 (right).  
MD 30ns Run 2 Mel1a and X-ray β2  
Adrenergic GCPR. 
Figure 6.7.1 Structural alignment of  Mel1a 30 ns Run 2 to X-ray Crystal Structures of β2-Adregernic and Rhodopsin G-
Coupled Protein Receptors (GCPR’s). 
Part B -Mel1a GCPR run 2 Shown in Green, X-ray crystal 
Structure of β2-adregenic GCPR shown in Cyan. RMSD  
between the Structures is 3.563Å. 
5. Mel1a GCPR 30ns Run 2 shown in Green, X-ray 
Crystal Rhodopsin GCPR shown in Magenta. RMSD 
between the structures is 3.885Å. 
Part A -Mel1a GCPR run 2 Shown in Green, initial I-TASSER 
Homology model GCPR shown in Orange. RMSD between the 
Structures is 4.194Å. 
MD 30ns Runs Mel1a and X-ray Initial I-
TASSER Homology model of Mel1a GCPR. 
MD 30ns Run 2 Mel1a and 
Rhodopsin GCPR. 
Electrostatics surface rendered in Pymol using the 
APBS electrostatics plugin, utilizing the AMBER 
forcefield  to assess the surface interaction properties 
of the second 30 nanosecond run. The final frame of 
the 30ns simulation is saved through VMD prior to 
being loaded into Pymol. Areas displayed in red are 
electro-negative, areas shown in blue are positive. 
Neutral areas have a white appearance. 
Figure 6.8.1 Electrostatic Analysis of Mel1a MD run 2, 30ns. 
Extracellular View. Intracellular View and Internal Cavity. 
Side View (Membrane Portion). 
Side Slice of Mel1a to show electronegative pocket in 
the core of the GCPR. 
Intracellular Cavity from Run 2 takes 
a different conformational state in 
comparison to run 1 - but still persists 
on the internal side of the membrane.
(above) 
Figure 6.10.1 - kinetic energy in they Mel1a 30ns System (left) and temperature in Kelvin of the Mel1a 30ns system, trajectory 3 (right) 
Figure 6.10.2 - Van Der Waal interaction energy in the Mel1a GCPR system (left) and negative potential energy (right). 
Figure 6.10.3 - Bond energy in the Mel1a GCPR system. 
The upper section of Helix B (pro80 to Asn90) remains in pi-helix conformation throughout the calculation, 
but moves away from the core as the calculation continues. 
Figure 6.11.1—Visual analysis of the 30ns Mel1a GCPR trajectory 3. 
Loop A, focus on Asn10 is conforma-
tional searching in the solvent-ion envi-
ronment throughout the calculation. 
Met1 on loop A and met268 are seated closely 
on the extracellular helix sections throughout the 
calculation.  
The disulphide bond between Cys100 on helix C and cys177 on beta 
turn A persists in the 3rd 30ns trajectory for the Mel1a GPCR. 
Figure 6.11.2—Visual analysis of the 30ns Mel1a GCPR trajectory 3. 
Met339 exposed to solute on the intracellular side of the bili-
pid membrane. 
Met339 later in the simulation sitting closer to the bilipid 
membrane on the intracellular side. 
Initially loop G on the intracellular side sits 13.78Å apart 
(measured from Leu215 on helix F to Val221 on loop G).  
13.78Å 
17.75Å 
Met339 
Met339 
Cys314 
Leu215 
Val221 
Val221 
Leu215 
Cys314  and the early residues in Loop I retracted into the membrane 
with the central core via the conformational change of Helix-turn-
helix G 
Loop G on the intracellular side sits 17.75Å apart 
(measured from Leu215 on helix F to Val221 on loop G). 
By the end of the trajectory dataset.  
Figure 6.12.1 - Structural alignment of  the Mel1a GCPR, 30ns Run 3 to X-ray Crystal Structures of β2-Adrenegic and Rhodopsin 
GCPR’s. 
MD 30ns Runs Mel1a and X-ray β2 
Adrenergic GCPR. 
MD 30ns Runs Mel1a and initial I-TASSER 
homology model of Mel1a GCPR. 
MD 30ns Run 1 Mel1a and Rhodopsin 
GCPR. 
Part B—Mel1a GCPR 30ns run 3 show in in Green, X-
ray crystal structure of β2-adregenic GCPR shown in 
Cyan. RMSD between the structures is 3.671Å 
Part A—Mel1a GCPR 30ns run 3 show in in Green, Ini-
tial I-Tasser Homology Model of Mel1a GCPR shown in 
Orange. RMSD between the structures is 4.031Å 
6. Mel1a GCPR 30ns Run 3 shown in Green,  
X-ray Crystal Rhodopsin GCPR shown in Magenta. 
RMSD between the structures is 3.706Å 
Extracellular cavity 
(left) which follows 
through the core of the 
protein to the 
Intracellular side of the 
protein (displayed be-
low) 
Cutaway side view of the protein core to show the 
electronegative central channel within. 
Extracellular View and Cavity. Intracellular View and Cavity. 
Side View (membrane Portion). Electrostatics surface rendered in Pymol using the APBS 
electrostatics plugin, utilizing the AMBER forcefield  to 
assess the surface interaction properties of the third 30 
nanosecond run. The final frame of the 30ns simulation is 
saved through VMD prior to being loaded into Pymol. 
Areas displayed in red are electro-negative, areas shown 
in blue are positive. Neutral areas have a white appear-
ance. Unlike simulations 1 and 2 - the protein has a cen-
tral electronegative channel which travels from one side 
of the membrane to the other. 
Figure 6.13.1 Electrostatic Analysis of the Mel1a GCPR MD Run 3, 30ns. 
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7.0 - Gaussian16 Ligand Generation Analysis and Comparison to 1972 X-Ray 
Crystal Structure of Melatonin. 
The Melatonin ligand, parametrised via the FFtk (Force Field Tool Kit) plugin in VMD 1.9.3 
was compared to the crystal structure of melatonin published in 1972 by (Wakahara, Fujiwara 
and Tomita, 1972). Bond lengths, angles and dihedrals were cross referenced with the crystal 
structure in order to validate the generated forcefield. All the CHARMM36 atom types 
mentioned in the tables below are referenced in Figure 7.0.1, with a key for Melatonin 
explaining the atom types of the structure. This chapter contains data for the Gaussian16 
structure generated using quantum mechanical methods (Frisch et al., 2016), the crystal 
structure data PDB, and the post minimization data of the parameterised structure using 
NAMD. This is shown in tables 1 bond angles, 2 bond lengths and table 3 which shows bond 
dihedrals. A reference figure for the QM derived and X-ray crystal versions of the ligand is 
shown in Figure 7.0.2. The X-ray structure is planar, when compared to the QM structure 
which varies in the N-acetyl section of the molecule, the C10-C10 atoms are angular sitting in 
an upwards direction from the planar indole. The Oxy-methyl section is also angled and not 
planar like the diffracted version of melatonin.  
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7.1 Minimization of the Gaussian16 Parameterized Melatonin Ligand in 
CHARMM36. 
A conjugant gradient minimization was performed using NAMD and sourcing the FFTK 
generated forcefield parameter file from the G16 geometry optimization (PDB) which was run 
on 10 threads for a total of 5000 timesteps. The melatonin ligand was placed into a TIP3P water 
box with 10Å padding around the physical dimensions of the molecule using the auto-solvate 
tool available in VMD1.9.3.  The bond angles, dihedrals, and length data were charted against 
simulation time. The graphs were split up into sub sections of the ligand for ease of 
interpretation.  
 
Oxy-Methyl portion of the ligand. 
Melatonin’s bond angles in the oxy-methyl section of the ligand are shown in figure 7.1.3.  
initial fluctuation is seen at the start of the simulation. However, after the first 500 timesteps the 
data levels out showing a stable angular conformation for all atom-types. C7-O1-C9 displays 
stability at 123.55°, C6-C7-O1 shows angular stability at 104.14° and C8-C7-O1 shows angular 
stability at 129.52°. The final values of the simulation can be seen in table 1. 
The oxy-methyl bond lengths (seen in figure 7.1.4) in the graph show an average stability after 
a settling period spanning the first 500 timesteps of the minimization. C9-01 reduces from 
1.35Å- 1.45Å initially and by the end of the minimization to a bond length of 1.41Å. The C7-
O1 bond similarly settles in the first 500 timesteps balancing in a similar length rage of 1.35Å 
to 1.45Å. The final value for this bond length is 1.40Å. (see table 2)  
  
in figure 7.1.5 dihedral properties of the oxy-methyl section of melatonin throughout the 
minimization begin settle after the first 250 timesteps and. by 1000 timesteps they have 
stabilised.  C8-C7-O1-C9 shows a 47.92° angle after the minimization. Dihedral angle C6-C7-
O1-C9 similarly stabilised after. Final dihedral angle values are shown in table 3. 
 
Tryptophan-Derived Indole Section of the ligand. 
During minimization of the ligand, the bond angle data displays a settling period of 500 
timesteps. (figure 7.1.6) After which the angles settle as melatonin water box reaches a 
minimized state. Data for the final bond angles of the indole can be seen in table 1 
After a settling period of 500 timesteps, the data settles showing narrower information about 
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bond lengths. Since the indole has double bonds in the ring structures which change, the 
lengths periodically change causing a spike in the data. This is due to the CHARMM General 
Forcefield RTF file which alters the bond lengths of the indole to simulate resonance. The final 
bond lengths can be seen in table 2.  
 
5 N-acetyl Section of the ligand. 
Most of the bond angle data settles after 500 timesteps (Figure 7.1.7)- except for the N2-C10-
C11 angle, which fluctuates throughout the minimization. Presenting the impression that it is an 
area which is highly adaptive to its solvent environment in addition to the rest of the melatonin 
molecule and has many angular conformations.  
During the first 500 steps bond length fluctuation (Figure 7.1.8) reduces significantly from 
bond lengths between 1.8Å and 0.2Å, after which bond levels seem to stabilize between 1.6Å 
and 0.6Å implying minimization of the ligand. Final figures for individual bond lengths can be 
seen in table 2. Since many different types of bond exist in the chart not all lengths are in the 
same range. 
Dihedral Data for the N-acetyl section of Melatonin is shown in figure 7.1.9. The dihedral 
angles settle after the first 500 timesteps of minimization except for those which contain C10 
and C11 atoms. They exhibit a degree of conformational flexibility and seem to take longer to 
converge than the remainder of the structure at around 1000 timesteps. The dihedral bonds seen 
in C10-C11-N2-C12 which also contain C11 and C12 are steadier after 500 timesteps possibly 
being more stable on that particular plane. This flexibility may be due to interactions with water 
or other parts of the ligand such as the O2 molecule which is double bonded to C12 or the 
hydrogen atoms closest to the n-acetyl section of the molecule on C8. It may also be a product 
of resonance in the indole section of melatonin. This same flexible data is not seen in dihedrals 
which contain only C10 or C11 suggesting this observation is linked to these paired atoms. 
Final values for all the dihedral angles can be seen in table 3. 
  
 
 
 
 
 
 
58 
 
Table 1:- A summary of all the Bond Angles Found in the Structure of Melatonin. 
Bond Angles G16 geometry optimized 
structure of melatonin. 
(basis set: MP2/6-31G*) 
Crystal Melatonin NAMD Minimized. 
C9 – O1 - C7 116.36° 116.95° 123.55° 
O1 – C7 - C6 124.88° 124.40° 104.14° 
O1 – C7 - C8 113.68° 114.63° 129.52° 
C7 – C6 – C5 121.31° 122.13° 127.35° 
C6 – C5 – C1   117.51° 117.05° 112.82° 
C5 – C1 - N1 130.81° 131.11° 129.27° 
C5 – C1 – C2 122.01° 121.99° 122.82° 
C2 – C1 – N1 107.18° 106.90° 107.89° 
C1 – N1 – C4 109.35° 108.94° 105.88° 
N1 – C4 – C3 109.63° 110.24° 113.84° 
C1 – C2 – C3 107.43° 107.85° 108.61° 
C7 – C8 – C2 118.09° 118.41° 114.55° 
C8 – C2 – C3 132.89° 132.71° 129.76° 
C8 – C2 – C1 119.64° 119.44° 121.58° 
C2 – C3 – C10 126.73° 125.43° 121.80° 
C4 – C3 – C10 126.69° 128.53° 133.87° 
C4 – C3 – C2 106.40° 106.04° 103.72° 
C3 – C10 – C11 111.28° 113.89° 120.02° 
C10 – C11 – N2 112.99° 110.90° 124.22° 
C11 – N2 - C12 120.71° 122.55° 111.33° 
N2 – C12 - C13 115.52° 117.10° 115.23° 
N2 – C12 - O2 122.14° 121.05° 121.40° 
O2 – C12 – C13 122.26° 121.85° 119.97° 
*See Figure 7.0.1 - Melatonin Key for Bond Identification. 
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Table 2:- The Bond Lengths Between the Atoms of the Backbone Structure in Angstroms 
(Å) of Melatonin.  
Bond Lengths. G16 geometry 
optimized structure of 
melatonin. (basis set: 
MP2/6-31G*) 
Crystal Melatonin (1972). NAMD Minimized. 
C9 – O1 1.42Å 1.41Å 1.41Å 
O1 – C7  1.38Å 1.38Å 1.40Å 
C7 – C6 1.42Å 1.40Å 1.38Å 
C7 – C8  1.39Å 1.37Å 1.38Å 
C6 – C5 1.38Å 1.37Å 1.39Å 
C5 – C1 1.40Å 1.39Å 1.32Å 
C1 – C2 1.42Å 1.40Å 1.45Å 
C8 – C2 1.41Å 1.41Å 1.41Å 
C1 – N1 1.38Å 1.37Å 1.36Å 
N1 – C4  1.38Å 1.38Å 1.39Å 
C4 – C3 1.38Å 1.35Å 1.37Å 
C2 – C3 1.43Å 1.42Å 1.40Å 
C3 – C10 1.49Å 1.49Å 1.49Å 
C10 – C11 1.53Å 1.50Å 1.55Å 
C11 – N2  1.45Å 1.45Å 1.41Å 
N2 – C12 1.37Å 1.33Å 1.34Å 
C12 – O2 1.23Å 1.24Å 1.23Å 
C12 – C13 1.52Å 1.49Å 1.50Å 
*Hydrogen bond lengths are not mentioned due to the not being present in the PDB co-ordinate structure file for 
the 1972 crystal structure for Melatonin. See Figure 7.0.1 - Melatonin Key for atom identification. 
Table 3:- Dihedral Angles present in the Ligand Melatonin. 
Dihedrals. G16 geometry 
optimized structure of 
melatonin. (basis set: 
MP2/6-31G*) 
Crystal Melatonin. NAMD Minimized. 
C9 – O1 – C7 – C8  -0.16° 0.07° 47.92° 
C9 – O1 – C7 – C6  179.71° -179.45° -100.07° 
C2 – C3 – C10 – C11  74.83° 174.67° 75.72° 
C4 – C3 – C10 – C11 -99.59° 6.33° -114.86° 
C3 – C10 – C11 – N2 -179.26° 171.76° -124.73° 
C10 – C11 – N2 – C12  76.72° -170.64° -90.75° 
C11 – N2 – C12 – C13 178.92° 176.37° -165.37° 
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C11 – N2 – C12 – O2  -4.25° -4.09° 35.46° 
O2 – C12 – C13 – HM6  -81.37° -73.85° 138.79° 
*See Figure 7.0.1 - Melatonin Key for Dihedral Location Information. 
 
 
Summary. 
Differences are seen in the NAMD minimized version of the data generated with Gaussian16 
most significantly in dihedral angles. These differences are due to the interaction with solvent 
since the ligand has been parameterized in a vacuum devoid of external influence, dihedrals 
angles are expected to change. Gaussian 16 optimizes small molecules to be used under a 
specific forcefield by matching the data to the forcefield. The differences between the 
minimized melatonin and X-ray crystal version of the same molecule will inherently have 
different bond lengths angles and dihedrals due to the crystallization conditions used to create 
the lattice.  The parts of the ligand which are not as flexible fit into the same range in terms of 
dihedral angle, bond angle and length given the atom types. The N-acetyl section of the ligand 
appears to be the most flexible section of the molecule, which is why the data is varied in these 
atoms (table 3). Bond lengths between the crystal structure, the minimized structure and the 
Gaussian16 optimized versions are highly similar. The lengths vary in very minor lengths 
between 0.01Å and 0.03Å (table 2). The melatonin bond angles vary slightly in the Oxy-methyl 
section and the N-acetyl section but do not deviate significantly in the indole section (table 1). 
The optimized ligand is representative of Melatonin. After analysis of the NAMD minimized 
ligand it was docked into the previously performed Mel1a GCPR 30 nanosecond - Run 2 and 
saved as a new PDB and PSF file ready for minimization. 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.0.1 Reference Melatonin Atom Diagram for Bond length, Bond Angle and Dihedral analysis . 
7.0.2- Gaussian16 Generated QM melatonin (Left) and 1972 X-Ray Crystal Structure of Melatonin (Right). 
Gaussian16. 1972 X-Ray Crystal. 
Figure 7.1.3 - Bond Angles in the Oxy-methyl section of the 
ligand  
 
The final values of the simulation can be seen in Table 1:- A 
summary of all the bond angles found in the structure of mela-
tonin. 
Figure 7.1.4 - The Oxy-Methyl bond lengths 
 
The final values for the bond lengths are shown in Table 2:- A 
Table listing All the Bond Lengths Between the Atoms of the 
Backbone Structure in Angstroms (Å).  
Figure 7.1.5 - Dihedral Properties of the oxymethyl section of Mel-
atonin throughout the minimization of the ligand in a water box 
 
 
The final figures are shown in Table 3: Dihedral Analysis present in 
the ligand melatonin. 
Figure 7.1.6 - Bond angles in the indole ring section of Melatonin during minimization.  
Figure 7.1.7 - Bond lengths within the indole ring section of Melatonin over the timesteps of minimization.  
Figure 7.1.8 - Bond angle data for the N-acetyl section of 
Melatonin.  
Figure 7.1.9 - Bond length data for the N-acetyl section of 
Melatonin.  
Figure 7.1.10 - Dihedral Data for the N acetyl section of  
Melatonin.  
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8.0 – Minimization and Heating of the Mel1a GPCR/Melatonin Docking System. 
The melatonin molecule was docked to the final frame of the second 30ns trajectory using 
Chimera 1.1.2 and Autodock Vina. Since the system has changed, the Mel1a-melatonin 
system needs re-minimization and heating, followed by equilibration to prepare it for MD 
analysis. The addition of melatonin to the system allows observation of the Mel1a GPCR’s 
conformational state, and to determine if the chosen docking co-ordinates cause a binding 
effect on the extracellular side of the Mel1a GPCR. 
Data was loaded from the NAMD log file for the melatonin-Mel1a bound complex and 
analysed in VMD 1.9.3 using the NamD plot module with a stride of 1 (therefore loading the 
entire trajectory).  
Bond angle data gives an average figure of 2,680.76 Kcal/mol over the calculation, initial bond 
angle energy is 10,477.06 Kcal/mol the final timestep displays a value of 2,605.28 Kcal/mol. 
This is recorded at such high levels due to the melatonin molecule being introduced to the 
CHARMM Forcefield. Dihedral energy shows an average of 6,802.65 Kcal/mol with an initial 
value of 8,196.43 Kcal/mol, and a final value at the end of the calculation of 6,597.27Kcal/mol. 
improper energies in the system give an average figure of 42.05 Kcal/mol, with an initial value 
of 200.6 Kcal/mol and a final value of 40.59 Kcal/mol (Figure 8.0.1) .  Average bond energy in 
the docking system was 275.67 Kcal/mol with an initial value of 5,572.7 Kcal/mol this is also 
likely to be caused by the addition of melatonin, the final value was 521.94 Kcal/mol. The 
potential energy provided an average figure of -76,823 Kcal/mol with an initial value of -
116,062.86 Kcal/mol and a final value of -119,026.58 Kcal/mol (Figure 8.0.2). 
RMSD data was generated using VMD 1.9.3’s built in RMSD visualizer tool. The 
Mel1a/Melatonin docking system (selection protein, backbone) stabilised at approximately 
frame 90 of the minimisation (Figure 8.0.1). An RMSD trajectory analysis was also carried out 
on the protein backbone using VMD’s trajectory tool with the selection “protein”, the data had 
an average RMSD of 0.239Å, a minimum of 0.057Å, maximum of 0.285Å and a standard 
deviation of 0.053Å. The mel1a GPCR back was again harmonically constrained, but the 
melatonin molecule was not. The bond angle data clearly shows an initially large figure. Which 
is due to the addition of melatonin and appears to be provoking a reaction from the Mel1a 
GPCR. 
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Summary. 
Potential energy in the system is significantly more negative than the initial minimization of 
Mel1a (section 5.0.) This may be due to the addition of the melatonin molecule, present in the 
system showing an interaction which affects the Mel1a GPCR. Bond angle, dihedral and 
improper energy values are also lower in reference to the previous minimization at the end of 
the calculation. Protein backbone trajectory RMSD is also higher in the Mel1a-melatonin 
minimization than the non-melatonin minimization calculation. Local RMSD within 10Å of the 
Melatonin residue is an average of 0.125Å, with a minimum RMSD of 0.05Å and a maximum 
RMSD of 0.137Å the standard deviation is 0.015Å. this may account for the higher RMSD 
seen in the Mel1a GPCR. It also suggests that the melatonin molecule is in a desirable position 
on the extracellular side.  
 
 
8.1 Heating of the MEL1a -Melatonin system. 
 Data was extracted from the NAMD log file and was analysed using VMD 1.9.3’s NAMD plot 
module with a stride of 1, incorporating the entire data set for heating (steps 0 to 
310,000). Bond energy has an average figure of 1,476.71 Kcal/mol with an initial value of 
473.59 Kcal/mol and a final value of 2,536.52 Kcal/mol. Average potential energy of the 
Mel1a-melatonin docking system is -104,640.53 Kcal/mol with an initial potential energy of -
118,972 Kcal/mol and a final potential energy of -86,449.55 Kcal/mol (Figure 8.1.1). The 
temperature data shows an initial temperature of 0 K and a final figure of 309.75 K. The 
average Van Der Waal interaction energy is 6,796.82 Kcal/mol, with an initial of 8,150.05 
Kcal/mol, and a final calculation value of 3,859.32 Kcal/mol (Figure 8.1.2) Van Der Waal 
energy decreases over the heating phase as the mel1a-melatonin system is given temperature 
(therefore kinetic energy). This happens as the Mel1a GPCR begins to conform to the binding 
effect of melatonin seen in the minimization stage and VDW interaction energy. The RMSD 
trajectory tool (via selection of the protein backbone) showed the average RMSD of the 
simulation to be 0.226Å with a minimum of 0.015Å, a max of 0.370Å and a standard deviation 
of 0.091Å. RMSD remains low after minimization and heating due to the harmonic constraints 
applied to the Mel1a GPCR, and the limited time it can conformationally adjust as the kinetic 
energy in the system increases along with temperature. 
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8.2 – Equilibration of the Mel1a-Melatonin Docking System. 
After heating trajectory data was analysed for equilibration of the Mel1a-melatonin system 
using VMD’s built in RMSD trajectory tool. The average RMSD (protein backbone) was 
0.852Å (min of 0.496Å, max of 0.982Å) with a standard deviation of 0.084Å. This RMSD data 
was colour mapped onto the model in order to visualise it directly in the context of the protein 
(Figure 8.2.1) The core of the protein is stable in the central transmembrane core (an average 
RMSD of below 1.5Å) with the majority of higher RMSD being in the loop sections. A 
Maxwell Boltzmann distribution of temperature was also generated using the data from the log 
file in order to assess the if the system had approached thermal equilibrium (Figure 8.2.2). In 
addition, the log file from the trajectory was analysed for kinetic energy, bond energy, Van Der 
Waal energy and total potential energy.  
The average kinetic energy in the Mel1a GPCR-melatonin docking system was 28,380.32 
Kcal/mol with an initial figure of 28,220.39 Kcal/mol and a final value of 28,347.58 Kcal/mol, 
which is 142.78 Kcal/mol less than the final kinetic energy reading in the rescale equilibration 
run in the non-melatonin Mel1a GPCR system shown in Figure 8.2.3, which does not represent 
a significant change with the presence of Melatonin. Potential energy in the data shows an 
average of -88.913 Kcal/mol, with an initial value of -86.386 Kcal/mol and a final value of  
-89,136.66 Kcal/mol. In comparison to the initial Mel1a equilibration figures (-86,395.28 
Kcal/mol at the final frame of equilibration) potential energy became more negative in the 
melatonin bound state by -2,741.38 Kcal/mol (Figure 8.2.3). This is good evidence suggesting 
that melatonin in the proposed site causes a conformational change in the Mel1a GPCR. 
Average temperature is 309.97 K, with an initial value of 308.23 K and a final calculation of 
309.62 K. Bond energy in the docking system shows an average of 2491.69 Kcal/mol, with an 
initial figure of 2476.57 Kcal/mol and a final value of 2,520.29 Kcal/mol (Figure 8.2.4). Van 
der Waal interaction energy shows an average over the calculation of 2,955.09 Kcal/mol, an 
initial figure of 3,997.90 Kcal/mol and a final calculated figure of 2,734.49 Kcal/mol (Figure 
8.2.5)  
Van Der Waal Interaction energy fluctuates initially followed by a downward trend towards 
stability at the 1.5-millionth timestep. Fluctuation in the system is likely due to the presence of 
the melatonin molecule causing the Mel1a GPCR to undergo conformational change due to 
ligand binding. This would explain the VDW energy variation followed by a region of stability. 
Since harmonic constraints are applied during equilibration then it is assumed that the Mel1a 
may not be in its ideal conformation for melatonin binding although note that the constraint is 
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not applied to the ligand which is free to move within the binding site during equilibration.  
After equilibration analysis, the system was moved forward into molecular dynamic simulation 
for 30 nanoseconds.  
8.3. 30 ns Molecular Dynamics of the Mel1a GPCR - Melatonin System. 
Data from triplicate 30 ns trajectories were individually uploaded into VMD 1.9.3 for analysis 
and RMSD analysis and colour mapping of this data was generated (Figure 8.3.1). In addition, 
the log file was also analysed using the NAMD plot plugin to check components of the 
potential energy function. Ramachandran plots were also generated for the final frame of each 
triplicate run (Figure 8.3.2). Electrostatic surface analysis of each dataset was performed using 
Pymol and the APBS plugin. Additionally, structural alignments of the i-tasser homology 
model of mel1a, the final frame of the second 30ns trajectory, the β2 adrenergic and rhodopsin 
GPCR’s were also performed in Pymol and These steps were performed to note any key 
conformational changes between the unbound Mel1a GPCR and the Mel1a bilipid system in 
the presence of melatonin at its proposed binding site. Finally, a cluster analysis was performed 
in VMD on each trajectory to visualise protein conformational clusters and close to the 
melatonin molecule in the binding site, ideally looking for conformational change due to 
melatonin.  
Plots of RMSD against time (Figure 8.3.3) for all three trajectories show consistent 
conformational exploration with one exception in trajectory 3, which samples a comparatively 
different conformational space between frames 200 500. After frame 500, trajectory 3 finds a 
stable conformation like that observed in the other simulations. The Ramachandran plots are 
taken from the final frame of all three docking runs and show most of the residues in the Mel1a 
GPCR structure adhere to expected types of secondary structure with few outliers, which 
suggest some residues in the structure are in undesirable conformations or are transition 
residues which are intermediaries between different types of secondary structure form. 
The log files from the three separate calculations of the Mel1a-melatonin system were analysed 
using VMD 1.9.3’s NAMD plot module and data was turned into representative graphs 
(Figures 8.4.1, 8.4.2, 8.4.3 for run 1, 8.10.1, 8.10.2 and 8.10.3 for run 2 and 8.16.1, 8.16.2 and 
8.16.3) the summarized values from the data are shown in table 8.3.1 below; 
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*Table 8.3.1 – a summary of the data collected from all 30 ns docking MD runs. 
 
 
 
Table 8.3.1 Initial. Average. Final. 
Kinetic energy (30ns docking run 1). 28,404.82 
Kcal/mol 
31,350.5 
Kcal/mol 
31,321.62 
Kcal/mol 
Kinetic energy (30ns docking run 2). 28,404.82 
Kcal/mol 
31,352.15 
Kcal/mol 
31,434.78 
Kcal/mol 
Kinetic energy (30ns docking run 3). 28,404.82 
Kcal/mol 
31,346.73 
Kcal/mol 
31,359.2 
Kcal/mol 
Potential energy (30ns docking Run 1). -89,292.58 
Kcal/mol 
-86,878 
Kcal/mol 
-87,051.5 
Kcal/mol 
Potential energy (30ns docking Run 2). -89,292.58 
Kcal/mol 
-86,858 
Kcal/mol 
-86,953.14 
Kcal/mol 
Potential energy (30ns docking Run 3). -89,292.58 
Kcal/mol 
-86,853.86 
Kcal/mol 
-86,528 
Kcal/mol 
Bond energy (30ns docking Run 1). 2,505.7 
Kcal/mol 
5,509.25 
Kcal/mol 
5,576.95 
Kcal/mol 
Bond energy (30ns docking Run 2). 2,505.7 
Kcal/mol 
5,507.44 
Kcal/mol 
5,521.15 
Kcal/mol 
Bond energy (30ns docking Run 3). 2,505.7 
Kcal/mol 
5,507.95 5,548.26 
Kcal/mol 
Temperature in Kelvin (30ns docking Run 
1) 
279.8 K 308.82 K 308.55 K 
Temperature in Kelvin (30ns docking Run 
2) 
279.8 K 308.83 K 309.65 K 
Temperature in Kelvin (30ns docking Run 
3) 
279.8 K 308.78 K 308.9 K 
Van der Waal interaction energy (30ns 
docking run 1) 
2,494.6 
Kcal/mol 
2,678.68 
Kcal/mol 
2,597 
Kcal/mol 
Van der Waal interaction energy (30ns 
docking run 2) 
2,494.6 
Kcal/mol 
2,671.68 
Kcal/mol 
2,458.05 
Kcal/mol 
Van der Waal interaction energy (30ns 
docking run 3) 
2,494.6 
Kcal/mol 
2,671.68 
Kcal/mol 
2,458.05 
Kcal/mol 
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8.5 Visual Analysis of the System Run 1. 
The DCD file was loaded into VMD 1.9.3, with a stride of 1 incorporating all 15,000 frames of 
the simulation (Figure 8.5.1). The extracellular portion of Mel1a has the same di-sulphide bond 
as seen in all MD runs between CYS100 on alpha helix C with CYS177 of beta turn A. Residue 
MET1 (the N-terminus) is in contact with the top of the extracellular helix sections until frame 
6,950 out of 15,000 where it relocates into solvent for the duration of the calculation. A portion 
(Pro80 to Asn90) of alpha helix B near the extracellular side moves away from the ligand, 
altering the upper half of the helix resulting in the structure straightening, helix B was the 
extracellular region which resembled a pi-helix conformation in the 30ns Mel1a GPCR 
simulations. Alpha helix A moves towards melatonin moving closer to the core of the protein 
on the extracellular side. The central core of the protein remains exceptionally stable 
throughout the simulation (core RMSD of below 6Å). In frame 1418 (out of 15,000) 
SER103HG:1 sits 1.99Å from the MEL1:O2 atom, SER176 is placed 5.35Å from MEL1’s O2 
atom and 2.92Å away from MEL1’s HN1 atom but the residue shifts between the mentioned 
O2 atom and the HN1 atom throughout the calculation and appears to be interacting through 
Van Der Waal interaction. Melatonin’s N acetyl section (Figure 7.0.1, section 7.0) is seated 
between the oxygen atoms of CYS100 and CYS 177. Melatonin HM5 atom (bonded to atom 
C13) is making a Van Der Waal interaction with the CYS177 at distance of 2.47Å (final frame, 
distance measured from the centre of the HM5 melatonin atom to the centre of the O atom in 
CYS177).  Melatonin atom HM6 (bonded to atom C13) is in range of the CYS100 oxygen 
atom with an interaction distance 2.92Å. The loop sections on the intracellular and extracellular 
side of the protein show less overall movement during the trajectory (compared to the Mel1a 
simulations at 30ns). One exception is the C-terminus end (VAL350) in loop I which is 
exposed to solvent. CYS314 and MET 339 are embedded in the POPC membrane with the 
sulphur atom directed towards the bi-lipid membrane due to being hydrophobic on both 
residues. 
 
8.6 Structural Alignment Analysis Run 1. 
The final frame of the trajectory for melatonin-Mel1a GPCR was saved as a PDB file and 
uploaded into Pymol for structural alignment (figure 8.6.1). This was to describe any 
conformational changes caused by the addition of melatonin to the previously calculated 
structures of Mel1a in the absence of melatonin (30ns trajectory 2) and any key conformational 
differences between the β2 adrenergic and rhodopsin crystal structures. Figure 8.6.1 Part A 
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shows the structural alignment of melatonin-Mel1a (shown in green) with the initial homology 
model of Mel1a produced using I-Tasser (shown in orange), with an RMSD of 4.295Å. The 
structures are similar in overall GPCR architecture but there is considerable variation across the 
loop domains of each model.  For example, some of the helix domains remain in approximately 
the same position as the initial homology model with some exceptions. Alpha helix A bends in 
towards helix-turn-helix G. The alpha helix B has a completely different conformation to the 
homology model and is now facing away from the core of the protein after transitioning from 
loop B. Alpha helix-turn-helix G is compressed into a smaller volume than in the I-tasser model 
while alpha helix F in melatonin-Mel1a, has a straighter conformation. Most of the dynamic 
change in the core of the melatonin-Mel1a is seen at the apex of each transmembrane helix 
closest to the melatonin molecule, while the centre stays relatively stable. The loop sections, as 
in all structural alignments, do not align in a recognisable pattern. Figure 8.6.1 Part B shows the 
structural alignment of the 30ns Mel1a GPCR trajectory 2final frame (shown in red), with the 
final frame of the melatonin-Mel1a (shown in green). The RMSD between the structures is 
2.982Å which is comparatively lower than the i-Tasser homology model structural alignment in 
part A. Some obvious conformational changes are visible. Alpha helix A in mel1a-melatonin 
leading on from loop A is bent in an inwards direction towards the core of the protein 
compared to the final frame of the 30ns Mel1a (Trajectory 2) model due to the presence of 
melatonin. The loop domain in the centre of alpha helix A persists in nearly the same 
conformation in both structures.  Alpha helix B in the Mel1a-melatonin model also bends 
outwards from the core, retaining its helical conformation, unlike helix B in the control run 
(trajectory 2) which loses its 3-10 helix conformation and becomes more pi-helix in appearance 
as it transitions into loop C.  Loop I has a different conformation compared to the 30ns control 
(trajectory 2) and loop sections sit closer to the intracellular core of the protein. Figure 8.6.1 
Part C shows the structural alignment with the β2 adrenergic GPCR (shown in cyan) to Mel1a-
melatonin trajectory 1. The RMSD between the structures is 3.970Å. Unlike the previous 
alignments there are many conformational differences that are observed primarily in the helical 
domains. Alpha helix A has a central loop and has a completely different form compared to the 
β2 adrenergic receptors equivalent helix. Helix B sits further out from the core compared to the 
β2 adrenergic counterpart this is caused by the presence of melatonin in the mel1a-melatonin 
docking structure. The lower half of helix-turn-helix G is much more compressed in the Z-axis. 
The helix section in the extracellular loop area of the β2 adrenergic structure is not present in 
Mel1a-melatonin structure. The loop domains on the intracellular side are not resolved in the 
β2 adrenergic receptor crystal structure. All the alpha helices hold a different conformational 
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position and the RMSD is higher than when compared to the I-tasser homology model or the 
Mel1a, but the GPCR conformation is overall still conserved. In comparison to the 30ns control 
and initial I-Tasser homology structural alignments, it appears the binding of melatonin alters 
the conformation of the Mel1a GPCR. Figure 8.6.1 Part D shows the structural alignment of 
Mel1a/-melatonin trajectory 1 (shown in green) with the rhodopsin GPCR (shown in magenta). 
The RMSD between the two structures is 4.664Å. Nearly all the helical domains of the 
rhodopsin GPCR share a different conformational positioning to the melatonin-Mel1a model. 
Most notable are alpha helix-turn-helix G which follows a different conformational positioning 
to the point where they no longer are in an overlapping alignment. Alpha helix B also sits 
further away from the core of the protein. Helix F sits closer to the core on the intracellular 
side. Helix A on Mel1a has a central loop section leading to a conformational deviation in 
comparison to the helix on the rhodopsin structure. Intracellular loop sections conform very 
differently, but due to most of the highly mobile loop domains being missing from the crystal 
structure, it is hard to compare loop I in mel1a to the intracellular side of Rhodopsin, the 
extracellular side has higher similarity to rhodopsin, but is still notably different in helix A and 
B. the structural alignments show that the addition of melatonin elicits a conformational change 
in the Mel1a GPCR. while there is conformational change, the overall architecture of the 
receptor is still recognizable. 
 
8.7 Electrostatic Surface Analysis Run 1. 
The Mel1a GPCR was saved as PDB and uploaded into Pymol for electrostatic surface 
analysis. The .PDB was converted to a PQR file using the Pymol plugin for APBS 
electrostatics. Grid spacing was set to 0.5, electrostatics were rendered as a Connolly surface 
using the Non-Linear Poisson-Boltzmann equation, Utilising a protein dielectric of 2.0 and a 
solvent dielectric of 78.0. At a Temperature 310K using an ion concentration of 150mM, with a 
charge pf +/- 10 (Figure 8.7.1). There is an electronegative central channel which traverses 
from the extracellular side to the intracellular side of the protein which is filled with water. The 
side profile of the protein shows that the membrane portion of the GPCR is neutral in charge 
while the intracellular portion is positive with small areas of electronegativity. The extracellular 
domain has no polarization in charge. This could mean that the binding of melatonin to the 
causes the extracellular side to depolarize, delivering a signal to the intracellular side, via 
conformational change. It is documented that alpha subunits interact with the intracellular 
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portion of GPCR’s in order to send a signal to the cell upon conformational change of the 
receptor. 
8.8 Cluster Analysis and Unique Hydrogen Bond Analysis of Melatonin and Extracellular Loop 
Sections Run 1. 
The DCD file for the trajectory 1 of melatonin bound to the MEL1a GPCR was loaded into 
VMD with a stride of 10. Using the WMC PhysBio Clustering plugin, similar positioning of 
residues in the dataset are clustered visually (Figure 8.8.1). For cluster analysis the region 
defined was all protein residues within 10Å of melatonin (resname MEL1) as its focal point. 
The cutoff distance was set to 3Å and set to RMSD with a weight of 1 for the cluster analysis 
programme. Figure 8.8.1 Part A shows the residues that are clustered at less than a 10Å 
distance from the melatonin residue throughout the 1,500 frames which are loaded into VMD 
and the appearance shows little mobility (local average RMSD within 10Å of melatonin of 
2.9Å with a stride of 10) in the GPCR due to melatonin over the 30ns period of the calculation 
and all 1500 frames fitted within the 3Å cutoff. In addition to this, a hydrogen bond donor and 
acceptor analysis was performed on all residues within 5Å of melatonin (resname Mel1). A 
detailed log was created showing all unique hydrogen bonds within this region. Part B of figure 
8.8.1 shows the results. Unique hydrogen bond analysis for all 1,500 frames in VMD returned a 
32.13% occupancy hydrogen bond between Ser103-side-OG donor interaction with acceptor 
MEL1-side-O2. In addition, 21.47% Occupancy was seen between donor Ser176-side-OG and 
acceptor MEL1-side-C12. An occupancy of 21% was also seen in hydrogen bonding between 
donor Ser103-side-OG and acceptor MEL1-side-C12, and a final hydrogen bond occupancy of 
13.20% between Ser176-side-OG donor and MEL1-side-C5.  Van Der Waal interaction 
analysis was also performed visually in VMD to note any orbital interaction between residues 
and melatonin during the docking calculation. Initial frame Interaction between Ser87’s OG 
atom at a distance of 2.28Å from the MEL1:HN1 atom.  
 
The data provides the impression that melatonin’s binding is via VDW interaction, and that the 
main residues in the Mel1a GPCR responsible are Cys100 and Cys177 in the disulphide bond, 
Ser83 on helix B. Lastly, residues Ser103 on helix C and Ser176 on beta turn A.  
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8.11 Visual Analysis of the System Run 2. 
The DCD file for the first 30ns calculation was loaded into VMD 1.9.3 with a stride of 1 
incorporating all 15,000 frames of the simulation (figure 8.11.1). The MET1 N-terminus on the 
extracellular side of the protein (loop A) remains consistently localized. The disulphide bond 
between Cys100 (on alpha helix C) and Cys177 (on beta turn A) is present as in all the MD 
calculations. Little conformational movement is seen in the extracellular loop sections of the 
protein. The intracellular loop sections of Mel1a also remain stable and packed except for Loop 
I. CYS314 recedes into the membrane as helix-turn-helix G reconfirms shortening the position 
of conformation between Tyr285 and Cys289. The Tyr282 residue (HH atom) moves closer to 
the melatonin residue and seems to interact through water interaction (TIP31435) to HA1 
(Hydrogen bonded to the C5 of the benzene structure of the indole in melatonin).  The Asn299 
to ILE309 section of helix-turn-helix G compressing towards the core of the protein seems to 
cause the initial loop I residues to relocate into the membrane and appears to restrict solvent 
interaction. Met339 however still sits within a pocket of the POPC membrane with the 
hydrophobic portion of the residue avoiding solvent interaction.   The remaining loop sections 
of the extracellular side show little conformational exploration.  
In comparison to the first Mel1a-melatonin trajectory dataset, the Mel1a GPCR seems more 
stable and less conformationally changed by the binding effect of melatonin in similar areas 
previously mentioned in section 8.5 (The extracellular helix portions). The largest changes are 
seen in Helix-turn Helix G. and the most RMSD is seen in the intracellular Loop sections of the 
Mel1a GPCR. The core of Mel1a is stable with an average RMSD of 3.5Å.  
 
8.12 Structural Alignment Analysis Run 2. 
The final frame of the second 30ns run of the docked melatonin and Mel1a GPCR system was 
removed from the bi-lipid system and saved as a fresh PDB file in VMD and uploaded into 
Pymol (Figure 8.12.1). Structural alignment was performed on the final frame of the protein to 
compare the conformation of MEL1a-melatonin with its initial homology model, the final 
frame of the 30ns control runs without melatonin, the β2 adrenergic and rhodopsin GPCR’s. 
(Figure 8.12.1) Part A shows the alignment between the final frame of the 30ns Mel1a-
melatonin docking run 2 (shown in green) and the initial I-Tasser homology model of Mel1a 
(shown in orange). the RMSD between the structures is 4.709Å. Neither the intracellular or 
extracellular loop sections share similarity in conformation, however the final frame of run 2 
seems overall more closely conformed to the core on the extracellular side. Alpha helix A has a 
loop split in the middle of the helix and sits further away from the core of the protein in 
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comparison to the initial I-Tasser homology model. Alpha helix B also shares a divided loop 
section on the extracellular side prior to transitioning into loop C, which then folds into a helix 
section for the remaining residues after Pro80. Alpha helix F follows a similar form but moves 
away from the core of the protein towards the intracellular side. Alpha helix-turn-helix G is 
more compressed on the Z-axis and has a sharper turn which pushes the intracellular portion of 
the helix out from the core, as a result the end section ASN299 to ILE309 sits further from the 
core than in the I-Tasser homology model. Loop I progresses from the end of Helix-turn-helix 
G in an upwards direction towards the GPCR’s helix A, before navigating towards the 
intracellular solvent environment. Part B of figure 8.12.1 shows the structural alignment 
between the final frame of the Mel1a 30ns MD run 2, and the final frame of the 30ns Mel1a-
melatonin docking trajectory 2. The RMSD between the structures is 3.427Å, which is 
comparably smaller than the deviation between the i-Tasser homology model of Mel1a shown 
in part A. The extracellular portion of alpha helix A sits further up and closer to the melatonin 
residues location than the comparable helix of the control run. Helix A also sits further out that 
the control runs comparative helix from the central core of the protein.  Helix B also sits further 
away from the core than the non-melatonin control. The extracellular loop sections resemble 
each other in similar conformations with minor spatial deviations. Part C of figure 8.12.1 shows 
the structural alignment between the β2 adrenergic GPCR (shown in cyan) and the Mel1a-
melatonin trajectory data set 2 (shown in green) the RMSD between the structures is 4.241Å. 
Most of the helix sections do not share similar positioning. Alpha helix A sits further away 
from the core of the protein than the equivalent helix on the β2 adrenergic receptor. While the 
upper portion of helix A sits closer to Helix-Turn-Helix G. the extracellular short helix section 
seen in the β2 adrenergic GPCR is not seen in the Mel1a-melatonin structure. Helix B still has 
the loop like section on the extracellular side pointing the top of the helix towards the core, 
where melatonin is situated. Part D of figure 8.12.1 shows the structural alignment between 
Rhodopsin (shown in magenta) and the mel1a-melatonin trajectory dataset 2. The RMSD 
between the structures is 4.107Å. most of the helix sections between the Mel1a-melatonin 
structure and the rhodopsin structure follow a similar architecture. Helix A sits further from the 
core in the upper extracellular region after the loop which splits it on the Mel1a-melatonin 
structure. Helixes E and F sit closer to the extracellular side of the protein than the equivalent 
helixes of rhodopsin. Helix-Turn-Helix G has a bending conformation between Asn299 and 
Ile309 which traverses towards the core of the protein in the Mel1a-melatonin structure, 
whereas the equivalent structure of rhodopsin is straight. The extracellular loop sections follow 
very different conformation.  
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8.13 Electrostatic Surface Analysis Run 2. 
The Mel1a GPCR was removed from the Mel1a/melatonin Docking system using VMD 1.9.3 
and saved as a separate PDB in isolation before being uploaded into Pymol for electrostatic 
surface analysis. The .PDB was converted to a PQR file using the Pymol plugin for APBS 
electrostatics. Grid spacing was set to 0.5, electrostatics were rendered as a Connolly surface 
using the Non-Linear Poisson-Boltzmann equation, Utilising a protein dielectric of 2.0 and a 
solvent dielectric of 78.0. At a Temperature 310K using an ion concentration of 150mM, with a 
charge of +/- 10, using the AMBER forcefield (Figure 8.13.1). The extracellular side of the 
Mel1a GPCR has a central crater-like pocket which is mostly neutral in charge with 3 small 
electronegative pockets contained within. Two of the three are only negative on the surface, 
while another continues into the central core of the protein.  This traverses to the extracellular 
cavity, which expands into a very wide channel that finishes on the exterior side. The 
intracellular side is a mix of electropositive and neutral in charge a loop section stands out from 
the core of the protein and the electronegative central channel forming an almost “horseshoe” 
shaped section of the protein which is on the lower half of the intracellular side imagine in 
figure 8.13.1. The side profile is mostly neutral with weak electronegative patches. The 
intracellular side is mostly electropositive, and the extracellular side is mostly neutral with a 
mix of positive and negative zones. It appears the addition of Melatonin depolarises the 
extracellular side of Mel1a, while the intracellular side remains electropositive. 
 
8.14 Cluster Analysis and Unique Hydrogen Bond Analysis of Melatonin and Extracellular Loop 
Sections Run 2. 
The DCD file for the first Docking run of melatonin to the MEL1a GPCR was loaded into 
VMD with a stride of 10. Using the WMC PhysBio Clustering plugin, similar positioning of 
residues in the dataset are clustered visually. For cluster analysis the region defined was all 
protein residues within 10Å of melatonin (resname MEL1) as its focal point. The cutoff 
distance was set to 3Å and set to RMSD with a weight of 1 for the cluster analysis programme. 
Part A of Figure 8.14.1 shows the resultant cluster analysis of the 10Å area around the 
melatonin molecule. High stability of the surrounding structure is seen with an average RMSD 
of 2.346Å. Unique hydrogen bond analysis was performed on the 1,500 frames taken from the 
DCD file with a cutoff of 5Å from the melatonin molecule (resname Mel1) to determine 
occupancy of any unique hydrogen bonds between the ligand and the protein (Part B, Figure 
8.14.1). A hydrogen bond occupancy of 31.13% between donor Ser176-side-OG and acceptor 
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MEL1-side-C12 was the highest occupancy recorded by the analysis. Residue Ser103-side-OG 
also had a donor interaction occupancy of 12.93% with acceptor MEL1-side-O2. Cys177-main-
N had an occupancy of 11.80% with acceptor MEL1-side-O2. Ser176-side-OG has a donor 
interaction with MEL1-side-C5 acceptor with an occupancy of 10.33%. Van Der Waal 
interaction was also assessed visually using VMD. The final frame of the calculation saw a 
separation distance between TYR281:HB1 and MEL1:O1 of 2.42Å. Another interaction was 
seen in between SER87:OG and MEL1:HN1 at a distance of 2.84Å. At frame 350/1,500 a 
2.73Å separation VDW interaction was seen between TYR281 and MEL1:O2. SER87:OG also 
showed interaction at a distance of 2.96Å from MEL1:HN1. In frame 1350, MEL1:O2 sits at 
1.86Å from SER176:HG1. The initial frame of the calculation shows CYS177:O 2.68Å from 
MEL1:HG1, and TYR281:HB1 2.5Å from MEL1:O1.  
 
Analysis of the proposed site around Melatonin indicates that most of the interaction happens 
via unique Hydrogen bond interaction, with Ser176, Ser 103, and the disulphide partner Cys177 
(on beta turn A) showing occupancy between 32% and 10% in hydrogen bond analysis. Other 
interactions are seen via VDW analysis with the residues Tyr281 and Ser87.  
 
8.17 Visual Analysis of the System Run 3. 
The DCD file for the first docking 30ns of the Mel1a and melatonin calculation was loaded into 
VMD 1.9.3, with a stride of 1 incorporating all 15,000 frames of the simulation (Figure 8.17.1). 
Extracellular loop A is closely conformed to the core of Mel1a for the duration of the 
calculation but changes positioning in reference to ASN91 on loop C (first residue of loop C). 
VAL15 on loop A moves relative to ASN91 from 4.53Å at the beginning of the simulation to 
23.51Å in the final frame. The rest of the extracellular loop sections show little deviation. A 
small amount of conformational change is seen in the extracellular sections of alpha helix A 
which move towards the melatonin ligand (residues Pro23 to Ile38). Helix-turn-helix G moves 
away from the melatonin molecule. Alpha helix B slightly away from melatonin. The central 
core of the GPCR is highly stable (under 4Å in the helix core section of Mel1a) except for the 
mentioned interaction with melatonin seen in the helixes. The intracellular loop G is initially 
close to helix E and F and progressively searches conformational space resulting in a position 
further away from the core of the protein. From reference residue PHE234 on helix F, ARG220 
initially sits 5.84Å away, by the end of the calculation it is separated from PHE234 by 17.39Å. 
Loop I is not very mobile and seems to pack to the central core of the protein (packed to helix 
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turn helix G and alpha helixes A,B and D. MET339 is still packed into the POPC membrane 
with the sulphur atom avoiding solvent. 
The third trajectory analysis reveals the protein is more stable due to the addition of Melatonin 
in the proposed active site for Mel1a. the core remains very stable (4Å in the helix core) and 
little RMSD in the loop sections, especially Loop I, which in comparison to the previous runs is 
much less mobile, and seems to stay close to the intracellular portion of Mel1a. Loop G shows 
the largest Activity on the intracellular side. This may be due to conformation adjustment that 
is initiating a signalling pose to the interior of the cell membrane.         
8.18 Structural Alignment Analysis Run 3. 
The final frame of the third 30ns run of the docked melatonin and Mel1a GPCR system was 
removed from the bi-lipid system and saved as a fresh PDB file in VMD and uploaded into 
Pymol (Figure 8.18.1). Structural alignment was performed on the final frame of the protein to 
compare the conformation of MEL1a-melatonin with its initial homology model, the final 
frame of the 30ns control runs without melatonin, the β2 adrenergic and rhodopsin GPCR’s. 
Part A in figure 8.18.1 shows the structural alignment of the Mel1a/melatonin docking system 
(shown in green), with the initial I-Tasser generated homology model (shown in orange). The 
RMSD between the aligned structures is 4.198Å. Helix A of the docking system only slightly 
overlays with the counterpart helix on the homology model and maintains the central loop not 
seen in the i-tasser generated structure. The first half of the helix after loop A bends due to the 
loop section further towards helix-turn-helix G. Helix-turn-helix G also has a different 
orientation and the ASN299 to ILE309 portion of the helix after the final turn is pointed 
inwards towards the core. Helix F sits higher towards the extracellular side of the GPCR when 
compared to the homology model. The entire helix is located further outwards away from the 
core but maintains its form. Helix E sits more towards the intracellular side of the membrane 
maintaining its 3-10 helix form. Helix B’s top half before transitioning into Loop C loses helix 
form and separates into a loop shape before regaining shape for one whole turn prior to helix C. 
the loop I domain on the intracellular side (loops A, C, E, F and H) are more packed towards 
the central core in comparison to the homology model. Loop I’s residues also appear closer to 
the membrane in positioning and ‘higher’ than some of the core helix sections. Loop G is 
further away from the core of the GPCR than seen in the homology model. Figure 8.18.1 Part B 
shows the structural alignment of the final frames of 30ns Control Mel1a Run 2 (red) with the 
final frame of the 30ns docking Mel1a/melatonin run 2 (green).  The RMSD between the two 
structures of the Mel1a GPCR is 2.674Å. The similarity between the aligned structures is more 
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apparent in part B than aligned with the initial I-tasser homology model of Mel1a in part A. the 
extracellular loop sections share a similar conformation and are close to the core except for 
Loop A which sits further away from the core in both the 30ns Mel1a control and 30ns 
Mel1a/melatonin docking GPCR structures. Helix A and helix B in the control sit further away 
from the extracellular side than the comparatively seen helixes in the docking GPCR. the 
central loop seen in the helix is seen in both the non-melatonin and Mel1a-melatonin models. 
Helix B overlays closely with the early half of the helix after transitioning from loop B but 
deviates in the upper half of the helix as it turns into a loop (residues Met86 to Phe89). The 
upper half of the docking GPCR’s helix B sits further away from the core than the comparative 
helix B on the control model. This is likely due to influence from the melatonin molecule 
which has been placed near helix B/C in the docking simulation. Helix-turn-helix G sits lower 
overall than the comparative control model, and the final helix after the turn (ASN299 – 
ILE309) sits at a slightly lower angle than the controls equivalent residues.  Helixes E and F 
share the same form as the equivalent ones on the control with slight deviation in the 
extracellular portions of both helixes. The extracellular side of Helix C also sits closer to the 
core than the control run. Figure 8.18.1 Part C shows the structural alignment between the 
Mel1a melatonin docked GPCR and the β2 adrenergic GPCR, the RMSD between the 
structures is 4.191Å. Loops on the Extracellular side of the protein do not show similarity and 
all the extracellular alpha helix sections follow a different conformation. Alpha helix F folds in 
towards the core of the extracellular side while helixes G and A are further out from the core. 
Part D shows the structural alignment between the Mel1a-melatonin trajectory 3 structure and 
the Rhodopsin GPCR. Helix-turn-helix G has a different orientation to the equivalent helix on 
rhodopsin’s structure. The ASN299 to ILE309 section faces in towards the core of the protein 
whereas the equivalent section of rhodopsin does not. Alpha helix E on the intracellular side 
sits further away from the core of the protein. alpha helix F sits closer to the core of Mel1a, and 
further upwards towards the extracellular side of the structure. Loop sections are missing from 
the intracellular side of Rhodopsin due to the loops being highly mobile and difficult to 
crystallize, little comparison is possible due to this. But loop G is longer on the Mel1a docking 
model than its equivalent loop on the Rhodopsin GPCR and reaches further to the intracellular 
side of the protein. 
The structural alignments show that the Mel1a-melatonin GPCR has deviated significantly 
from the 2 adrenergic and rhodopsin GPCR’s due to the melatonin which is docked to Mel1a. 
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which has gone through conformational change while maintaining the general architecture of a 
GPCR.  
 
8.19 Electrostatic Surface Analysis Run 3. 
The Mel1a GPCR was removed from the third iteration of the Mel1a/melatonin Docking 
system using VMD 1.9.3 and saved as a separate PDB in isolation before being uploaded into 
Pymol for electrostatic analysis. The .PDB was converted to a PQR file using the Pymol plugin 
for APBS electrostatics (Figure 8.19.1) . Grid spacing was set to 0.5, electrostatics were 
rendered as a Connolly surface using the Non-Linear Poisson-Boltzmann equation, Utilising a 
protein dielectric of 2.0 and a solvent dielectric of 78.0. At a Temperature 310K using an ion 
concentration of 150mM, with a charge of +/- 10, using the AMBER forcefield. Red areas of 
the surface map indicate electronegative portions of the protein, while blue areas represent 
positive areas of the protein. White zones represent areas of the GPCR which are neutral in 
charge. The extracellular side of the protein is a mixture of electro positive, negative and 
neutral areas with no obvious cavities and has no polar appearance. The intracellular side of the 
protein is mostly electropositive and has a small central cavity which is deep within the centre 
of the extracellular side. In the side profile of the protein an electronegative cavity is seen 
which runs towards the intracellular portion of the protein. This leads to the intracellular cavity 
seen in the centre of the intracellular side. The side slice also shows the central core does not 
traverse from the extracellular to intracellular side of the GPCR in this final frame of docking 
run 3.  
 
The electrostatic surface map of the Mel1a-melatonin trajectory dataset 3 shows that the 
extracellular side has become de-polarized due melatonin binding to Mel1a, the intracellular 
side remains positive which implying that the binding action of melatonin sends a signal to the 
interior of the cell wall for appropriation by other molecules to continue the signal.  
 
 
8.20 Cluster Analysis and Unique Hydrogen Bond Analysis of Melatonin and Extracellular Loop 
Sections Run 3. 
The DCD file for the third trajectory of Mel1a-melatonin was loaded into VMD with a stride of 
10. Using the WMC PhysBio Clustering plugin, similar positioning of residues in the dataset 
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are clustered visually. For cluster analysis the region defined was all protein residues within 
10Å of melatonin (resname MEL1) as its focal point. The cutoff distance was set to 3Å and set 
to RMSD with a weight of 1 for the cluster analysis programme. Part A of Figure 8.20.1 shows 
the resultant cluster analysis of the 10Å area around the melatonin molecule (Local average 
RMSD of 2.193Å). Similarly, to 30ns docking runs 1 and 2, Little deviation is seen in the 
nearby sections of Mel1a (Part A). In addition to the cluster analysis unique hydrogen bond 
analysis was undertaken on the 1,500 frames loaded into VMD (Figure 8.20.1, Part B). The 
highest hydrogen bond occupancy of 30.87% was seen between donor SER103-side-OG and 
acceptor MEL1-side-O2. An occupancy of 21.67% was seen between donor CYS177-main-N 
and acceptor MEL1-side-O2. SER176-side-OG had A donor occupancy of 18.73% with 
MEL1-side-C12. SER176-side-OG also had a hydrogen bond with MEL1-side-C5 with an 
occupancy of 11.07%. VDW interaction was also visually analysed for the same stride of 10 on 
the DCD file for the docking calculation. Contact is seen between TYR281:HB1 at a distance 
of 2.51Å from MEL1:O1 in the initial frame, other VDW interactions are between SER103 and 
MEL1:O2 at 1.95Å and SER87:OG at a distance of 2.41Å from MEL1:HN1 in the initial 
frame, by frame 430/1,500, TYR281:HB1 has a VDW interaction distance of 1.65Å from 
MEL1:O1, SER103:HG3 interacts with MEL1:O2 at a distance of 1.90Å. In Frame 
1049/1,500, SER103:HG3 is seen 1.65Å from MEL1:O2 and TYR281:HB1 is placed 2.49Å 
from MEL1:O1. Frame 1105 sees SER176 2.42Å from MEL1:O2. The final frame of the 
calculation shows SER176 2.42Å from MEL1:O2.  
 
Summary. 
The proposed docking site for melatonin seems to be mostly achieved by VDW interaction, 
with small amounts of hydrogen bond occupancy. The local RMSD around melatonin is an 
average 2.193Å showing the site to be very stable throughout the 1500 frames. The residues 
involved are similar in all the trajectory datasets for the Mel1a-melatonin system promoting 
that Ser176, Cys177, Tyr281, and Ser103 are most prominently involved in the conformational 
uptake of melatonin.  
 
 
Figure 8.0.1 - Bond angle, dihedral and improper data for the Mel1a/Melatonin Docking system (Left) RMSD 
plot of selection “protein” in the RMSD visualiser tool in VMD 1.9.3 (Right) 
Figure 8.0.2 -  Bond energy of the Mel1a/Melatonin docking system (Left). Potential energy of the previously 
mentioned system (Right) 
Figure 8.1.1– Bond energy of the Mel1a/Melatonin Docking system during calculation (Left). Potential energy plot for the previously 
mentioned system throughout the heating phase (Right). 
Figure 8.1.2 - The temperature in Kelvin of the Mel1a/Melatonin Docking System (left) Van Der Waal interaction Data for the previously 
mentioned docking system (Right)  
Figure 8.2.1- RMSD overlay of Mel1a with docked QM Melatonin. Coloured in RBG with red being high 
RMSD, blue being low and medium being intermediary the system exhibits a maximum RMSD of 6.17Å. 
Protein is shown VMD using the trajectory data from the calculation located in the dcd file Representation 
style : New Cartoon. 
Figure 8.2.2 - Heat distribution in the docking system. Y-axis: Relative frequency describes the portion of 
system at a specific temperature, X-Axis shows the temperature in Kelvin (K). 
Figure 8.2.3 - Kinetic energy in the entire Mel1a GCPR/melatonin docking system. (left) Potential energy in the previously mentioned 
system (right). 
Figure 8.2.4 - The temperature of the Mel1a/melatonin GCPR simulation (left)  Bond energy of the previously mentioned system. (right) 
Figure 8.2.5 -  Van Der Waal interaction energy (left) 
Mel1a With Docked Melatonin 30ns Run 1 Mel1a 
GCPR RMSD Trajectory Overlay. 
Red resembles high areas of movement Max 33.14Å, 
blue resembles low areas of movement (min of 
0.00Å). 
The Mel1a GCPR is shown in Using the trajectory 
data from the DCD file and displayed in New Car-
toon.  
Mel1a With Docked Melatonin 30ns Run 3 Mel1a 
GCPR RMSD Trajectory Overlay. 
Red resembles high areas of movement Max 33.14Å, blue 
resembles low areas of movement (min of 0.00Å). 
The Mel1a GCPR is shown in Using the trajectory data 
from the DCD file and displayed in New Cartoon.  
Mel1a With Docked Melatonin 30ns Run 2 Mel1a GCPR 
RMSD Trajectory Overlay. 
Red resembles high areas of movement Max 33.14Å, blue 
resembles low areas of movement (min of 0.00Å). 
The Mel1a GCPR is shown in Using the trajectory data from 
the DCD file and displayed in New Cartoon.  
8.3.1– trajectory by colour (RMSD) for triplicate 30ns Mel1a/Melatonin Docking MD runs 1, 2 and 3. 
RMSD trajectory plot for all three docking runs (left) show consistent conformational exploration with one 
exception in run3, which samples a comparatively different conformational trajectory. 
30 Mel1a Docking Run 1 Ramachandran 
(Final Frame). 
30 Mel1a Docking Run 2 Ramachandran 
(Final Frame). 
30 Mel1a Docking Run 2 Ramachandran 
(Final Frame). 
Figure 8.3.2- RMSD trajectory and Ramachandran plots for the final frames of  MEL1a, 30ns Docking runs 1,2 and 3. 
Figure 8.4.1— Kinetic energy in the Mel1a and melatonin docking system 30ns Run 1 (left) Temperature of the 
system in kelvin (right). 
Figure 8.4.2 - Van Der Waal interaction energy plot of the previously mentioned system (left) Potential Energy 
Plot of the same system (Right). 
Figure 8.4.3 - Bond energy in the previously men-
tioned system.. 
Figure 8.5.1-Visual Analysis of the 30ns Mel1a GCPR-melatonin trajectory 1. 
Ser103, Cys100 on helix C, Cys177 and Ser176 in VDW range of 
Melatonin in the final frame of the calculation. Helix A at the beginning of the calculation (left) and helix A at the end of the calculation (right). 
The extracellular region has conformed towards the Melatonin residue. 
Melatonin 
Melatonin 
Melatonin 
Melatonin 
Melatonin Ser103 
Cys100 
Cys177 
Ser176 
Melatonin 
Met1 
Met1 at frame 6,950 where it moves away from the protein 
core into the solvent on the extracellular side. 
Pi-helix B at the beginning of the calculation conforms close to the melatonin ligand (left), as the 
simulation reaches the final frame, pi-helix B conforms away from the ligand but retains its pi-helix 
shape (right).  
 Part A. - the 30ns Mel1a/melatonin docking 
structure (green) aligned with the initial ho-
mology model of  Mel1a (orange). The RMSD 
between the structures is 4.295Å. 
Part B. - The 30ns Mel1a/Melatonin docking 
structure (green) aligned with the final frame 
of the control 30ns final frame of Run 2 (red). 
the RMSD between the structures is 2.982Å 
Part C. - The 30ns Mel1a/Melatonin docking 
structure (green) aligned with the X-ray crystal 
structure of the β2 adrenergic GCPR (Cyan). 
The RMSD between the structures is 3.970Å 
Part D. - The 30ns Mel1a/Melatonin docking 
structure (green) aligned with the X-ray crystal 
structure of Rhodopsin (magenta). The RMSD 
between the structures is 4.664Å. 
Figure 8.6.1 - Structural alignment of the 30ns Docking run 1 with Mel1a and melatonin against the initial homology and 30ns control (Run 2) structure of Mel1a, and 
the X-ray crystal structures of the β2 adrenergic and Rhodopsin GCPR’s. 
Structural Alignment Between the I-
Tasser Homology Model of Mel1a and 
the Final Frame of Mel1a/Melatonin 
Docking 30ns Run 1. 
Structural Alignment Between the x-ray 
crystal structure of Rhodopsin and the 
Final Frame of Mel1a/Melatonin Dock-
ing 30ns Run 1. 
Structural Alignment Between the Mel1a 
30ns Control run 2 and the Final Frame 
of Mel1a/Melatonin Docking 30ns Run 1. 
Structural Alignment Between X-ray 
crystal structure of the β2 adrenergic 
GCPR and the Final Frame of Mel1a/
Melatonin Docking 30ns Run 1. 
Extracellular View and  
Cavity. 
Intracellular View and Cavity. 
Side View (membrane Portion). 
Figure 8.7.1– Electrostatic Surface Analysis of 30ns Docking Mel1a Run 1. 
Electrostatic surface analysis rendered in Pymol using the 
final frame of the simulation for mel1a/melatonin dock-
ing run 1 which is saved via VMD1.9.3, utilizing the 
AMBER forcefield. Areas in red display electronegative 
surfaces, areas in blue represent positive regions. White 
areas show areas of the protein which are neutral in 
charge. 
Electronegative extracellu-
lar pocket on the outermost 
part of the protein.  
Intracellular pocket on the 
internal part of the protein. 
On the inside of the cell 
wall. 
Cutaway side view of the electronegative 
channel which runs from the external side to 
the internal side of the membrane. 
Figure 8.8.1 - Cluster analysis of MEL1a and Melatonin, Unique Hydrogen Bond Analysis. 30ns Docking Run 1. 
Part A. 
Part B. Unique Hydrogen Bond Analysis. 
SER103 OG 
Mel O2. 
Mel C12 Mel C12 
SER176 OG 
SER176 OG 
Mel C5 
Cluster analysis using the WMC PhysBio plugin in V.M.D 193, all 1,500 
frames fit within the 3Å Range. Local average RMSD from the melatonin 
residue is 2.9Å 
Part C. - VDW interaction Figures between melatonin and  
surrounding residues. 
Figure 8.10.1—kinetic energy in the Mel1a/Melatonin 30ns Docking system run 2 (left) and temperature in 
Kelvin in the previously mentioned system (right). 
Figure 8.10.2—Van Der Waal Interaction energy (left) in the Mel1a/Melatonin system (run2) and potential 
energy in the previously mentioned system (right).  
8.10.3 - Bond energy of the Mel1a/melatonin dock-
ing system (left) 
Figure 8.11.1-Visual Analysis of the 30ns Mel1a GCPR-melatonin trajectory 2. 
Disulphide bond between Cys100 (Helix C) and 
Cys177 (Beta Turn A) interacting with the docked 
Melatonin Molecule in the final frame. 
Helix Turn Helix G retracts into the membrane from the intracellular side, restricting the initial residues of loop I from 
the solvent environment.  
Tyr282 interacting with Melatonin, in the initial frames flips from one polar side of the Tyr282 residue to 
the other. 
Met339 located in a pocket of the POPC membrane  in the final frame, 
spreading  Loop I away from the GPCR. 
Cys100 
Cys177 
Melatonin 
Melatonin 
Melatonin 
Asn299 
Asn299 
Ile309 
Ile309 
Met339 
Structural Alignment Between the I-
Tasser Homology Model of Mel1a and 
the Final Frame of Mel1a/Melatonin 
Docking 30ns Run 2. 
Structural Alignment Between the Mel1a 
30ns Control run 2 and the Final Frame 
of Mel1a/Melatonin Docking 30ns Run 2. 
Structural Alignment Between X-ray 
crystal structure of the β2 adrenergic 
GCPR and the Final Frame of Mel1a/
Melatonin Docking 30ns Run 2. 
Structural Alignment Between the x-ray 
crystal structure of Rhodopsin and the 
Final Frame of Mel1a/Melatonin Dock-
ing 30ns Run 2. 
Part A. - the 30ns Mel1a/melatonin docking 
structure (run 2, green) aligned with the initial 
homology model of  Mel1a (orange). The 
RMSD between the structures is 4.607Å. 
Part B. - The 30ns Mel1a/Melatonin docking 
structure (green) aligned with the final frame 
of the control 30ns final frame of Run 2 (red). 
the RMSD between the structures is 3.427Å 
Part C. - The 30ns Mel1a/Melatonin docking 
structure (run 2, green) aligned with the X-ray 
crystal structure of the β2 adrenergic GCPR 
(Cyan). The RMSD between the structures is 
4.241Å 
Part D. - The 30ns Mel1a/Melatonin docking 
structure (run 2, green) aligned with the X-ray 
crystal structure of Rhodopsin (magenta). The 
RMSD between the structures is 4.107Å. 
Figure 8.12.1 - Structural alignment of the 30ns Docking run 2 with Mel1a and melatonin against the initial homology and 30ns control 
(Run 2) structure of Mel1a, and the X-ray crystal structures of the β2 adrenergic and Rhodopsin GCPR’s. 
Extracellular Side and Cavity. Intracellular side and Cavity. 
Side view (membrane portion). 
Figure 8.13.1 - Electrostatic Surface Analysis of 30ns Docking Mel1a Run 2. 
Electrostatics images rendered in Pymol using 
the APBS electrostatics plugin, utilizing the 
AMBER forcefield  to assess the surface inter-
action properties of the second 30 nanosecond 
run. The final frame of the simulation is saved 
through VMD prior to being loaded into 
Pymol. Areas displayed in red are electro-
negative, Areas shown in blue are positive. 
Neutral areas have a white appearance. 30ns 
Docking Run 2 has a larger channel than the 
first run. But the external side has less exposed 
electronegative surface that the first (30ns Run 
1). 
Extracellular cavity on the 
external side or the Mel1a 
(above, left), surrounded by 
mostly neutral areas in run 2. 
electronegative surface is 
greatly reduced. Binding of 
melatonin may cause re-
striction of the active site to 
other biomolecules. 
Intracellular cavity has opened 
up into a wide electronegative 
channel (right) which  
continues through to the  
extracellular side of the protein. 
Side slice of Mel1a Shows the wide electronegative 
channel passing through the centre of the protein 
from the extracellular to intracellular sides of the 
membrane. 
Figure 8.14.1 - Cluster analysis and unique H-Bonds of Mel1a with Melatonin. Docking run 2. 
Part A.—Cluster Analysis 
Part B Unique Hydrogen Bond Analysis. 
CYS177 N 
MEL O1 
SER103 OG 
MEL O1 
SER176 OG 
MEL C5 
SER176 OG MEL C12 
Cluster analysis using the WMC PhysBio plugin in V.M.D 1.9.3, all 1,500 
frames fit within the 3Å Range. Local average RMSD 10Å from the melatonin 
residue is 2.346Å  
Part C. - VDW interaction Figures between melatonin and  
surrounding residues. 
Figreu 8.16.1—kinetic energy over the entire Mel1a/melatonin docking  system simulation (left)  and temperature 
of the previously mentioned system.. 
Figure 8.16.2—Van Der Waal interaction energy of the whole system in the previously mentioned docking system 
(left), and potential energy in the  same docking system. 
8.16.3 - Bond energy in the Mel1a/melatonin 
docking system. 
Figure 8.17.1-Visual Analysis of the 30ns Mel1a GCPR-melatonin trajectory 3. 
Melatonin 
Melatonin 
Melatonin 
Melatonin 
Melatonin 
Cys100 
Cys177 
Asn91 
Val15 
Asn91 
Val15 
Disulphide bond between Cys100 (Helix C) and Cys177 (Beta Turn A) interacting 
with the docked Melatonin Molecule in the final frame. Alpha Helix A (highlighted in orange) in the initial frame of the simulation (left) helix A conforming closer 
to the Melatonin Residue in the final frame of the calculation (right). 
4.53Å 
23.51Å 
Val15 moves from 4.53Å in the initial frame (left) to 23.51Å by the final frame reconfirming 
along with Loop A on the extracellular side (right). 
Structural Alignment Between the I-
Tasser Homology Model of Mel1a and 
the Final Frame of Mel1a/Melatonin 
Docking 30ns Run 3. 
Structural Alignment Between the Mel1a 
30ns Control Run 2 and the Final Frame 
of Mel1a/Melatonin Docking 30ns Run 3. 
Structural Alignment Between X-ray 
crystal structure of the β2 adrenergic 
GCPR and the Final Frame of Mel1a/
Melatonin Docking 30ns Run 3. 
Structural Alignment Between the x-ray 
crystal structure of Rhodopsin and the 
Final Frame of Mel1a/Melatonin Docking 
30ns Run 3. 
Figure 8.18.1 - Structural alignment of the 30ns Docking run 3 with Mel1a and melatonin against the initial homology and 30ns control (Run 2) structure of Mel1a, 
and the X-ray crystal structures of the β2 adrenergic and Rhodopsin GCPR’s. 
Part A. - the 30ns Mel1a/melatonin docking 
structure (run 3, green) aligned with the initial 
homology model of  Mel1a (orange). The 
RMSD between the structures is 4.198Å. 
Part B. - The 30ns Mel1a/Melatonin docking 
structure (run 3, green) aligned with the final 
frame of the control 30ns final frame of Run 
2 (red). the RMSD between the structures is 
2.674Å 
Part C. - The 30ns Mel1a/Melatonin docking 
structure (run 3, green) aligned with the X-ray 
crystal structure of the β2 adrenergic GCPR 
(Cyan). The RMSD between the structures is 
3.944Å 
Part D. - The 30ns Mel1a/Melatonin docking 
structure (run 3, green) aligned with the X-ray 
crystal structure of Rhodopsin (magenta). The 
RMSD between the structures is 4.191Å. 
Figure 8.19.1— Electrostatic surface analysis of 30ns Docked Mel1a Run 3. 
Intracellular View of protein. Extracellular View Of Protein. 
Side View (Membrane Portion). 
Electrostatics images rendered in Pymol using 
the APBS electrostatics plugin, utilizing the 
AMBER forcefield  to assess the surface inter-
action properties of the third 30 nanosecond 
docking run. The final frame of the simulation 
is saved through VMD prior to being loaded 
into Pymol. Areas displayed in red are electro-
negative, Areas shown in blue are positive. 
Neutral areas have a white appearance.  There is no traversing internal channel (above) in the 
core of this electrostatic analysis, but cavities are still 
present on the extracellular and intracellular sides - alt-
hough there is no obvious route into the cavities.. There 
is an electronegative portion on the side of the protein in 
the bi-lipid membrane of the system. (right). 
The external and internal sides have no obvious 
cavities unlike the other 2 docking runs through the 
core of the protein. But there is a cavity on the side 
of the protein (Below) which does not enter the 
central core section of the molecule. This is seen in 
the intracellular view and side view images on the 
right upper and lower images.  
Figure 8.20.1  - Cluster analysis and H-bond analysis of 30ns MEL1a and Melatonin, 30ns Docking run 3. 
Part A—Cluster Analysis. 
Part B Unique Hydrogen Bond Analysis. 
SER103 OG 
SER176 OG 
SER176 OG 
MEL O2 
CYS177 N 
MEL O2 
MEL C5 
MEL C12 
Part C. - VDW interaction Figures between melatonin and  
surrounding residues. 
Cluster analysis using the WMC PhysBio plugin in V.M.D 1.9.3, all 1,500 
frames fit within the 3Å Range. Local average RMSD 10Å from the melatonin 
residue is 2.193Å  
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Discussion. 
A highly stable representative model of the GPCR Mel1a was achieved through all-atom 
molecular dynamics after initial homology modelling on the I-tasser web server, while 
appearing closely related in architecture to the Rhodopsin and B2 adrenergic GCPR’s. 
Triplicate datasets show a myriad of different conformations in both the 10 ns and 30ns 
trajectory datasets. A high degree of stability is seen in the membrane core of the Mel1a GCPR 
while the intracellular and extracellular loops show a larger degree of free movement (section 
5.0) with the simulation times being increased from 10 ns to 30 ns, there was an overall 
increase in RMSD seen in the model, repeating the stability in the core and high deviation in 
the intracellular and extracellular portions while retaining the GPCR common characteristics 
when compared to Rhodopsin and the B2 adrenergic receptors (section 6.0).  
The Melatonin ligand which was generated through Gaussian 16 represents a close match for 
the X-ray crystal version retrieved by Wakahara et al in 1972 and presents a more accurate 
version of the ligand than CGenFF could predict. Melatonin, with the addition of the hessian 
basis set data (MP2-36G*). It is more likely to ellicit an accurate response from the homology 
model of Mel1a than its CGenFF counterpart with notable differences in its Dihedral data being 
noted in a vacuum, and post monimization in solvent may lead to a more accurate final result 
than achieveable through CHARMM. 
After the addition of melatonin to the system it is clear that the active site on the extracellular 
side of the protein and is based around the characteristic disulphide bond common to the GPCR 
family of proteins (Cys100 and Cys177). This appears to be mostly achieved by Van der Waal 
interaction after docking site analysis (section 8.0). RMSD within the Mel1a GPCR remained 
stable when backwards compared to the 10 and 30 ns trajectory data (sections 6.0 and 8.0).  
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With further generated trajectory data for the bound and unbound states described in the results 
section, commonality may be found between the datasets which better describe an average 
conformation. It appears that the binding of melatonin on the extracellular side of the 
membrane leaves the Mel1a GPCR de-polarized, while the intracellular side remains in a 
positive state. In the 30 ns Mel1a-melatonin trajectory a transmembrane negative portion is 
visible, implying it may traverse the surface of the POPC membrane possibly looking for an 
interaction with a partner membrane bound protein as a result (Ferguson et al., 1996). This 
depolarization is likely the first step in a signal which it relayed to the interior of the cell 
membrane, which is then acted upon by further proteins within the circadian rhythm pathway. 
The molecular dynamics study of Mel1a and its primary agonist melatonin describes the 
difficult nature of molecular description in dynamic models. Every simulation has a set of 
trajectories which is unique to the previous, which means every simulation is different to the 
last. The action of melatonin which is seen on the Mel1a GCPR in this study is a controlled 
environment - in isolation from the rest of the pathway from which the receptor is derived. 
Consequently, only the binding interaction between the ligand and its receptor can be 
described. This inherently asks more questions than it answers. As the ligand shows interaction 
with the protein, what does the binding action of melatonin cause in the internal side of the 
membrane?   
It is known through experiment that GCPRs have heterotrimeric guanine nucleotide-binding 
proteins (G-proteins) anchored to the internal side of the lipid membrane. Awaiting stimulus on 
the internal side of the bi-lipid membrane consisting of an alpha, beta and gamma subunits 
(Rosenbaum, Rasmussen and Kobilka, 2009). This may explain the non-conformity seen in the 
results of the initial MD simulations where Mel1a is in a state of ‘conformational flux’ in the 
control trajectories. It may also be resolved by simulation time being extended further for more 
conformational exploration. There is no signal to be delivered further from the receptor, nor a 
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clear open pathway to induct a signal in this system after the addition of melatonin. Additional 
study involving g-proteins will yield results which further the understanding of conformational 
change in the system which has been built. 
The absence of any clear active site for melatonin in the control section of the results also 
generates a new question. Since the action of rhodopsin-like G-protein coupled receptors is to 
transmit a signal like a switch, it is conceivable the binding of proteins anchored on the internal 
side of the membrane cause conformational change for external ligands to be appropriated by 
the Mel1a GPCR. Arrestins are small family of proteins important for signal transduction and 
are known to act on GCPR’s like Mel1a post activation, to return them to an inactive state 
(Ferguson et al., 1996). A trajectory analysis of an arrestin family protein bound to the 
glycosylated intracellular side of a GCPR could potentially also reveal an active site on the 
proteins extracellular region following protein-protein interaction (Hirsch et al., 1999). Proteins 
are a network system which are comprised of many different types of biomolecules. Further 
study of the signal transduction pathway inclusive of Mel1a will provoke answers into the full 
understanding of the GCPR and its partner interactions. 
The data accrued through this study can be taken further by comparatively using simple 
compounds which have been tailored through the drug discovery process, such as tasimelteon, 
agomelatine and ramelteon which were designed to target the Mel1a GCPR - to study the 
dynamic effect each drug causes in backwards comparison to Melatonin – further extending 
knowledge into the possible efficacious and side effects (attrition) on the all atom scale. 
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